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ABSTRACT
An abstract of “An Investigation of Sales Management Practices in the Irish 
Ethical Pharmaceutical Industry” by Laura Cuddihy.
This research sets ou t to exam ine the sales m anagem ent practices o f  the Irish  ethical 
pharm aceutical m anagers In addition, the author aim s to  establish  bo th  a literature and 
a docum entation  o f  the role o f  the dual-m andated sales and m arketing m anager, as this 
position  had  no t previously  been docum ented in the academ ic literature
T his sector w as chosen for research because o f  the great im portance it places on 
personal selling in the bringing o f  its products to the m arketplace In addition, these are 
the only grouping o f  Irish  sales m anagers w ho have com e together and form ed a 
professional sales m anager association, nam ely the Pharm aceutical M anagers 
A ssociation
The author earn ed  out a census o f  the In sh  pharm aceutical com panies, using the m ail 
questionnaire as her prim ary research instrum ent W ith a response rate o f  seventy-four 
per cent, extensive data w ere collected and subsequently  analysed by SPSS
The au thor’s hypothesis w as supported in this industry  there indeed exists the position  
o f  dual-m andated  sales and m arketing m anagers w hose title is an accurate descrip tor o f  
the w ork  they do, and also, by virtue o f  being dual-m andated, these m anagers spend 
proportionately  less tim e on sales m anagem ent activities than  do their single-m andate 
sales m anager colleagues In addition, the study provides the first com prehensive data 
on the w ork o f  the In sh  ethical pharm aceutical sales m anagers
Sim ilar research  m  o ther m dustnes w ould further both the literature and know ledge 
base regarding the role and practices o f  th is dual-m andated m anager, w hose presence is 
likely  to becom e m ore prevalent in the future
xi
CHAPTER 1 PHARMACEUTICAL MARKETING
10 INTRODUCTION
In this innovative, com petitive and traditionally  h ighly profitable industry  
m arketing is now  m oving centre stage and playing a key role m  influencing and 
directing activities from  the m anufacturer to the patient In m any m ultinational 
pharm aceutical com panies m arketing is now  their single b iggest business 
expense, taking up around 30 per cent o f  total com pany expenditure U  S N ew s 
and W orld R eport (1993) estim ated that 23 per cent o f  the prescrip tion  cost goes 
to m arketing  and advertising M ilm o (1993, p 17) stated "for the first tim e in  the 
h istory o f  the pharm aceutical industry m arketing expenses are running at tw ice 
the level o f  investm ent on research and developm ent" The em ergence o f  
m arketing "as a corporate change agent is encouraging the adoption o f  the 
m arketing concept as the driving m anagem ent philosophy in the pharm aceutical 
industry in the m id-1990 's” (Jam es, 1992, p 36) G iven this shift in em phasis, 
pharm aceutical m arketing now  requires further exploration
1 1 PHARMACEUTICAL PRODUCT CATEGORISATION
The pharm aceutical industry m anufactures and sells products that can  be 
categonsed  into four broad classifications
1 Prescription Medicines
Products that have to be prescribed by a  qualified m edical doctor They m ay 
be patented  or non-patented and are com m only referred to  as ethical 
pharm aceuticals A ll prescription/ethical m edicines during their developm ent 
are g iven a generic nam e, that is its official m edical nam e recognised by the 
W orld H ealth  O rganisation, w hich describes the ingredients M any o f  these 
also have a proprietary brand nam e for the purpose o f  identify ing the generic 
products w ith  a specific m anufacturer E xam ples here w ould  include 
C aptopril w hich is m arketed by B M  Squibb as C apoten B encard  developed 
the generic drug A m oxycillin  and m arketed it as A m oxil
P a g e  I
There m ay be several brands o f  the sam e generic substance, each produced 
by a  different m anufacturer Som e o ther m anufacturers m ay sell the drug 
w ithout any brand nam e These are know n sim ply by their generic nam e and 
are generally  m ore than 30 per cent cheaper than  the branded equivalent 
(C onsum er C hoice, 1994, p 4 8 )  This p n ce  advantage has been achieved 
through  a  num ber o f  factors Less extensive research and clinical testing  is 
ea rn ed  out, as th is has already been done by the ongm al m anufacturer w hose 
drug has now  gone o ff  patent Furtherm ore, there tends to be less advertising  
and prom otion  costs since there is no brand nam e to  support, and w here there 
exists several genenc producers o f  equivalent drugs, p n ce  com petition  tends 
to be prevalent
In  addition  to genenc drugs, an additional substitu te m ay also be available in 
the form  o f  a branded genenc, w hich also tends to  be cheaper than  the 
ong inal branded drug but not as cheap as the generic product since 
prom otion  o f  the brand nam e is required R efem n g  to the previous 
A m oxycillin  exam ple, there are now  m any branded genenc versions o f  this 
drug, for exam ple C lonam ox, Pinam ox, O ram ox and G eram ox, all being 
m arketed by separate com panies Table 1 1 com pares the 1994 price o f  
branded drugs w ith  either genenc or branded generic equivalents In each 
case the tw o drugs w hose prices are com pared contain  the sam e active 
ingredient
TABLE 1.1 Branded Drugs Vs Generic Equivalents
What it doc* Size
Cheaper
alternative
Branded
drug
Maker Price
I Allopurinol Goul treatment 10« x lOOmg (  aplenal Zylonc
Berk
Wellcome
9 23 
29 13
1 Amoxycillin Treatment or bacterial infections 1(H) x 250mg
Pmomox
Amoxil
PmewodJ 
Ben card
2! 30  
24 74
1 Atenolol Treatment of angina and blood pressure 28 x 50mg
Atenolol
Tenormin GerrarJZenecairi
6 S3 
9 43
1 CimetidiM Ulcer treatment 120 x 200rag CimeltlineTagamet
Clonmel 
SB Pharm
22 71 
27 49
1 Diazepam Relief of severe disabling anxiety 10» x 2 mg
Anxiealm
Valium
Clonmel
Roche
2 39  
167
I Mcfenamk add Anti -inflammatory pain relief 10« x 250mg
Ponmel
Ponstan
Clonmel 
Parke Davis
7 85 
1221
1 Metoclopramide Relieves nausea and vomiting 100 x lOtng
Pnmperan
Maxolon
Berk
SKBeccham
a 73
15 75
1 Tdrmcjrcl ne Antibiotic sometime! foracnc trcaimcnl 100 * 250mg
7 rtrocvchnr 
Achromyci
P MUtfW 
Lcdene
S 90 
8 35
Drugs listed In liai c are the cheaper alternatives
P a g e  2
Source Consumer Choice, February, 1994, pp 47-49
\
R aym nond G ossehn  (G osselin  et al, 1 9 8 4 ) w as the first to classify  prescrip tion  
drugs as "directed consum er goods", by w hich he m eant that the sale o f  a 
prescrip tion  drug is no t based on any choice o f  the consum er, but that 
"direction" com es prim arily  from  the general p ractitioner and also from  drug 
com m ittees, governm ent agencies, individual pharm acists, and th ird  party 
program m es such as private health insurers U sing W ebster and W ind 's (1972) 
m odel as illustrated by D onaldson (1990, p 82), the patient is the user w hile the 
general p ractitioner acts as the decider Influencers include those parties 
m entioned above w ho also "direct" the choice o f  drug to be prescribed
2 Over-the-Counter (OTC) Products
Products, usually  for com m on ailm ents, that do not require a prescrip tion  and 
can be purchased in retail pharm acies and other retail outlets by the 
consum er
3 Animal Health Products
Products designed for use in treating anim als, and preventing  disease in 
anim als
4 Bulk Chemicals, Capsules, etc
Products sold by one m anufacturer to another in an interm ediate stage in the 
m anufacturing process
T he author chose to confine her research prim arily to  com panies involved in 
selling ethical products through a personal sales force w hose selling activ ities 
included "detailing" calls m ade to general practitioners In this type o f  selling, 
m issionary  sales, "detailing" refers to the sales representative’s presentation  m ade 
to a doctor or group o f  doctors
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1.2 THE MARKETING CONCEPT
M any contributions to defining m arketing have been noted and docum ented. O ne 
o f  the earlier papers w hich attem pted to draw  together existing definitions and 
classify  them  on the basis o f  com m on characteristics cam e from  C rosier (1975, 
pp. 21-25). He concluded t h a t " we need to recognise that the w ord marketing is 
used in practice in three different contex ts” (p.24), and identified those contexts to 
be in term s o f  the m arketing process, the m arketing concept, and the m arketing 
orientation.
Fundam entally , the m arketing concept is a business philosophy defined by K otler 
(1994, p. 18) as ”a m anagem ent orientation that holds that the key tasks o f  the 
organisation  is to determ ine the needs and w ants o f  target m arkets and to adapt 
the organisation to delivering the desired satisfactions m ore effectively and 
efficiently  than its com petito rs”.
The basic m arketing techniques used in the ethical pharm aceutical industry  are 
broadly sim ilar to those o f  other consum er product industries but certain  unique 
characteristics require a m odified m arketing approach.
F or exam ple, although technological com petition is intensive, there m ay be little 
d irect price com petition for a new  m edicine from  other drugs. This occurs 
because the product is unique, protected by a patent and hence is effectively in a 
m onopoly. G enerally, in countries w here a third party, the governm ent for 
exam ple, pays the greater part o f  the price for a prescribed drug, there is little 
price elasticity, since the patient does not take m ore o f  the m edicine because it is 
cheaper.
A n ethical drug is invariably sold in m any m arkets about the w orld, and often 
those m arkets' governm ents, directly or indirectly, largely pay for them . 
Subsequently  they exercise stringent control over the prices or even the selection 
o f  the product to be sold. A lso, as the m ethods o f  regulation, pricing and 
prom otion differ, often significantly, from  one country to another, global 
m arketing requires a degree o f  local adaptation. M any m ultinational
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pharm aceutical com panies are currently strengthening their strategic planning 
departm ents to  aid  their global developm ent, thereby try ing to ensure that "they 
w ill not m iss any opportunities" (K ennedy, 1990, p 16) that are presented as a 
resu lt o f  ever-changing dynam ics in the w orld 's m arkets
In  essence, pharm aceutical m arketing is a  m ixture o f  bo th  industrial and 
consum er m arketing and its practice requires a know ledge and understanding  o f  
both  these areas T he rest o f  this chapter w ill h igh ligh t the specificities and 
differences o f  pharm aceutical m arketing under the com m only-used head ings o f  
m arketing  practice
1 3 CLASSIFICATION OF ETHICAL DRUGS
Som e confusion arises in the attem pt to classify pharm aceutical/ethical drugs 
along the traditional categorisations o f  consum er goods, industrial goods and 
services O TC products are sim ilar to  consum er goods and are m arketed w ith  that 
approach
E thical drugs how ever, share som e characteristics w ith  industrial goods and som e 
w ith  consum er goods C orstjens (1992, p 10) h ighlights the sim ilarities o f  ethical 
drugs to industrial products under the headings o f
1 the m ulti-party  aspect o f  the buying process,
2 the investm ent intensity in R esearch and D evelopm ent and the patentability  
o f  drugs,
3 the lengthy R esearch and D evelopm ent process from  chem ical com pound to 
finalised product
L ike m ost consum er goods, ethical drugs are often aim ed at large populations o f  
custom ers but, im portantly, in this industry, prom otion directly to the consum ers 
is no t currently perm itted  m  m ost m arkets A s a consequence, prom otion  is aim ed 
at the doctor, the m ajor m fluencer in the decision-m aking process
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Like most consumer goods, ethical drugs are often aimed at large populations of 
customers but, importantly, m this industry, promotion directly to the consumers 
is not currently permitted m most markets As a consequence, promotion is aimed 
at the doctor, the major influencer in the decision-making process
1.4 PHARMACEUTICAL MARKETING ENVIRONMENT
"Organisations are open systems and must interact with the environment to 
survive They both consume resources from and export resources to the 
environment" (Daft, 1986, p 10) Lidstone (1987, p 56) stresses the importance 
and relevance of domg an environmental audit as part of a formal marketing 
planning process Mickey C Smith (1991, p 16) provides a visual illustration of 
the pharmaceutical marketing environment See Figure 1-1
Figure 1.1 The Pharmaceutical Marketing Environment
Currently the pharmaceutical environment is changing on many fronts forcing 
companies to alter or adapt their marketing and other strategies
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F or exam ple, the pharm aceutical industry  lives and th rives because o f  
technological advances m  therapy B reakthroughs in  the understanding o f  the 
im m une system  or the increasing potential o f  laser technology in non-invasive 
surgery w ill have m ajor im pact on pharm aceutical practices Inform ation on, and 
in terpretation of, political trends is vital for the m ultinational pharm aceutical 
p layer O n the econom ic front, depression, continuing h igh  inflation, w orldw ide 
free trade and m any other factors can have profound effects on the pharm aceutical 
industry  in general, o r on  a  specific individual com pany
O f  all industries, it could be argued that the pharm aceutical industry  is the m ost 
actively regulated and controlled D rugs affect and can alter a  nation 's health  This 
industry  takes it's responsibility  to  society very senously  and operates under a 
stringent industry-w ide code o f  ethics in addition to legislative and regulatory  
control C urrent regulatory codes and other environm ental issues w ill be looked at 
in greater detail in C hapter 4 entitled The Irish Ethical Pharm aceutical Industry
Schaum ann (1992, p 3 0 )  rightly  points out that future prospects for the 
pharm aceutical industry are inextricably linked to the industry 's m acro- and 
m icroenvironm ents and stresses the necessity o f  properly  defining and regularly  
updating  the basic driving forces for com pany grow th and security
The author decided to exam ine the rem aining specificities and differences o f  
pharm aceutical m arketing  under a broad fram ew ork o f  m arketing  p lanning  as 
described by K otler (1994, p  12) T his involves exam ining the  larger issues in 
planning and then looking at the basic building b locks o f  a m arketing strategy, 
nam ely the custom ers, m arket segm entation, positioning and com petitive 
analysis The im pact o f  R esearch and D evelopm ent on m arketing strategies is also 
exam ined Finally, tw o key m arketing m ix elem ents are addressed prom otion  and 
p n ce
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In com m on w ith  standard m arketing m anagem ent, the m arketing  function in a 
pharm aceutical com pany is responsible for tw o crucial tasks the developm ent 
and im plem entation  o f  m arketing strategy
Long research and developm ent lead tim es, characteristic o f  the ethical 
pharm aceutical m arket, enforce a long-term  view  o f  the m arket B uild ing a 
m arket-dnven  organisation  in  this clim ate dem ands close integration  o f  corporate 
and m arketing strategy
H ow ever D oyle and M onteiro (1994, p 2 8 2 )  suggested that the leaders in this 
industry  w ere "overw helm ingly research-led and sales-dnven" They pu t th is 
perceived  lack o f  m arketing focus dow n to  the very factors that they felt 
d istinguished the ethical drug m arket from  other m arkets, nam ely  the regulatory  
environm ent w hich restricts them  from  prom oting directly to the consum er and 
the exceptionally  h igh  profits the com panies had previously  been  enjoying 
(p 283)
In term s o f  the pharm aceutical industry 's com m itm ent to m arketing planning, 
F letcher and H art (1989) conducted an em pirical study o f  the B ritish  
pharm aceutical industry  and found that overall the industry  did p lace im portance 
on this activity , w ith  the vast m ajority  o f  them  having one person w ith  overall 
responsib ility  for m arketing, w ho tended to w ork closely  w ith  other departm ents 
In addition the m ajority  o f  firm s had form al strategic p lans covering a five-year 
tim e horizon T heir conclusion (p 66) that the B n tish  pharm aceutical industry  is a 
"w ell-m tegrated and forw ard looking" one w ould appear to be som ew hat at odds 
w ith  the opinions o f  D oyle and M onteiro
G enerally , a  pharm aceutical firm  defines it's scope m  term s o f  the set o f  product- 
m arket targets in w hich it w ishes to develop or m aintain  a p resence D ifferent 
therapeutic areas represent different types o f  opportunities for a pharm aceutical 
com pany For exam ple, the pharm aceutical com panies Syntex and Searle are 
narrow  in scope, w ith both  obtaining m ore than 95 per cent o f  their sales from
1 5 MARKET PLANNING
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only three therapeutic areas H ow ever B ristol-M yers Squibb, C iba-G eigy and 
P fizer are m uch broader in scope, all w ith  a  presence in  a  vast range o f  
therapeutic  areas
In this industry  Strategic B usiness U m ts (SB U 's) are usually  defined in term s o f  
therapeutic  groups, and a com m only used typology (C orstjens, 1991, p 2 5 )  
d istinguishes ten  SBU  types
1 cardiovascular
2 nutritional
3 pain  control
4 internal m edicine
5 m ental health
6 topical
7 anti-infective
8 respiratory
9 cancer therapy
10 others
A lthough m ost pharm aceutical firm s w ould ideally like to pursue a broad product 
portfo lio  strategy by d iversifying into m any therapeutic areas, research earn ed  out 
by  Y eoh (1994, p 4 0 )  dem onstrated that they are p rim arily  constrained by the 
skills and abilities o f  their technical w orkforce Inefficient use o f  resources w hen 
m oving out o f  their core areas o f  therapeutic expertise into different therapeutic 
areas, w hich by defin ition  involves drugs w ith  different chem ical properties, is 
also a m ajor constrain t
D ifferent m odels are available for the m arketing people in a pharm aceutical 
com pany w hen selecting m arket opportunities Tw o approaches com m only 
recom m ended in  the industry literature (C orstjens, 1992, p 2 6 ,  L idstone, 1987, 
p  19) are the B oston C onsulting G roup m ethod and a com posite portfolio  
approach H ow ever, w hen questioned about their use of, and fam iliarity  w ith , ten 
nam ed analytical techniques, the F letcher and H art study discovered tha t over tw o 
-thirds o f  the sam ple o f  B ritish  pharm aceutical com panies had never heard  o f  the 
PIM S study or D irectional Policy M atrix T heir conclusion that th is finding w as 
"perhaps to be expected as these techniques are very specialised" (p 66) would
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seem to indicate that, in practice, these companies tend to stick to the product 
areas in which they have expertise, thus supporting Yeoh's (1994) findings
1 6  THE CUSTOMERS
The aggregate demand for ethical pharmaceutical products at any given time is 
primarily dependent on
(a) the size and the composition of the population
(b) the standard of living
(c) the incidence of disease (Slatter, 1975, p 21)
As all these factors are outside the control of the industry, managers must 
concentrate their efforts on demand factors over which they have some control, 
namely the rate of product innovation and governmental attitude For an 
individual product, the key influencer of demand has been the extent to which the 
product gams doctor acceptance
"The pharmaceutical market is unique in the importance of the influence o f a 
nonpurchaser on the purchasing habits of the ultimate consumer" (Smith, 1991, 
p 75) In the decision-making processes used by doctors, their choice of chemical 
entity to prescribe for a diagnosed illness is generally deemed to be rational, but 
they then may use completely emotional criteria for the choice of brand of drug to 
employ (Smith, 1991, p 102)
Webster and Wind's 1972 description of the buying centre members (Kotler, 
1994, p 342) has a certain relevance in examining the purchase decision process 
in the pharmaceutical industry The compliant patient is the ultimate user o f the 
product The general practitioner to whom the patient has gone is the ultimate 
decider of the product to be prescribed but there may be many influencers of that 
decision, directly or indirectly These could include the company's own sales 
representatives, pharmacists, wholesalers, the government, referent and 
membership groups, health boards and formulary committees Gatekeepers 
present themselves in many forms, such as competing sales representatives,
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practice receptionists, and regulatory bodies Pitt and Nel (1989, p 7) state that an 
individual doctor can fall into each of these actor categories depending on what 
the situation demands If advising a mother on a choice of baby food they are 
mfluencers, as purchasers of medical equipment they are users, and, as writers of 
prescriptions, they are deciders
Hemminki in 1975 proposed a simplified model to describe the decision-making 
process for prescribing drugs
A simplified model of the factors that affect drug prescription Note Diagnosis considered
Demands and expectations
Source Hemminki, C The Role of Prescriptions in Therapy Medical Care, 13 151, 1975 
Figure 1.2 H em m inki’s Model of Factors that affect Drug Présentions
At that time (1975) she reported that the major influences on prescribing were 
research and pressures from the drug firms However, Hemminki also included 
the patient’s demands and expectations as an influencing factor In 1976, Kasteler 
et al reported "a growing awareness that patients are willing to become more
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involved in decisions relating to their healthcare" A study earned out on 
Amencan doctors (U S News and World Report, 1993) showed that four out of 
five doctors would consider presenbing a drug if a patient requested it Nolan 
(1994, p 183) states that in response to the 1990’s patient demand for more 
information about the constituents, indications, dosage regimes and side effects of 
their medicines, the European Umon as part of the EC 1992 programme, issued a 
directive which requires manufacturers to
1 Increase the amount of information on all medicme packs
2 Provide a patient information leaflet with every pack (unless all the 
information can be accommodated on the package) The cntical requirement 
for these leaflets is that they must be wntten in a format and language the 
patient can understand
This directive, coupled with the spread of self-medication and the increasing 
numbers of what were traditionally prescription products becoming available 
over-the-counter (OTC), pharmaceutical companies are having to reconsider their 
communication strategies The techniques of fast moving consumer goods 
marketing are increasingly being employed in a response to this development, 
with companies giving greater importance to building up brands, developing 
visible brand packaging and investing in corporate image creation
Likewise, the sources of information used by individual doctors in their 
prescnption decision are undergoing change In attempting to influence the 
presenbing style of general practitioners much drug information is delivered 
(through personal and non-personal sources) by the pharmaceutical industry 
Eaton and Parish (1977, p 63) reported that the two prominent sources of drug 
information used by doctors in the U K tended to be the pharmaceutical industry 
and the Department of Health Today, the information sources are ranked 
somewhat differently to the results of the Eaton and Pansh study In a 1993 
Amencan study of 5314 physicians, reported by Huston, three sources-medical 
journal articles, symposia/conferences, and sales representatives dominated the
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doctors' choices of most useful sources of information about pharmaceutical 
products (p 49)
A report prepared by Dr Justin Greenwood (1991) on behalf of Remit 
Consultants in the U K found that the medical sales representative has the 
greatest effect on awareness of products amongst British general practitioners 
(p29) His research had been earned out in 1985 and was based on a postal 
survey to 332 GPs in the Trent region, which yielded a 79 per cent response rate 
He also found that the medical representative was the greatest single source of 
influence upon these doctors presenbing behaviour (p 39) This had also been the 
finding of Pitt and Nel in their 1988 study of 210 GP's (p 10)
Where traditionally pharmaceutical companies concentrated their marketing 
efforts on assisting the individual doctor's decision-making process, there is now 
a growing awareness that the emphasis needs to include the new forces dnving 
the prescnption decision Milmo (1993, p 17) states that the role of the individual 
and organisational influencers, and their information needs, must be addressed 
For the majonty of these influencers the main factor determining the selection of 
medicines is cost effectiveness and value for money Milmo argues that this has 
forced a change in the traditional product-led ways pharmaceutical companies 
operated to a more market-dnven approach
1 7  MARKET SEGMENTATION
Market segmentation is the process of dividing a market into distinct subsets of 
customers from which many benefits are derived,1 most importantly, it improves 
the strategic allocation of marketing resources" (Boyd et al, 1990, p 187) Doyle 
(1994, p285) states that for prescnption medicines segmentation starts with 
identifying what cntena presenbers employ in making decisions It then requires 
a determination of how alternative drugs are ranked by doctors along these 
dimensions
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Corstjens (1992, p 52) reports that pharmaceutical marketers have traditionally 
used segmentation criteria such as demographics (size of practice, doctor 
speciality), geographies, socioeconomics, buyer or presenber behaviour and 
attitudes ( heavy / light presenber, pnce sensitivity, benefits sought such as 
potency or side effects), and finally psychographics For illustrative purposes he 
cites a doctor typology based on life-style cntena which U S pharmaceutical 
companies can subsenbe to and then receive a named list of doctors within each 
category (p 54) Doyle and Monteiro (1994, p283) however, found that until 
recently in the Bntish pharmaceutical industry "segmentation and positioning 
based on marketing rather than technical cntena has been almost absent"
However segmentation is becoming increasingly important for companies looking 
to target certain doctors for personal calls from their sales force Maier and 
Saunders (1990) developed a model (p 41) for using segmentation to guide sales 
force allocation and selling tactics With the co-operation of an Amencan ethical 
pharmaceutical firm operating in the U K market they used cluster analysis to 
identify mne market segments, seven of which were deemed to be attractive to the 
company Subsequently," the chosen strategy collected the nine segments of GPs 
into three overlapping groups which were either harvested, built or used during 
innovation" Tracking of the implementation provided the feedback that the 
model had led to improved performance of the salespeople and a better company 
performance
The management of Zeneca (formerly I C I ) introduced General Practitioner (GP) 
targeting m 1991 for their field sales force Their selection of target doctors was 
based on two criteria, the market potential of each doctor ( based on the number 
of prescnptions they wrote) and their record of seeing sales representatives They 
reported encouraging results such as the fact that a targetted doctor is twice as 
likely to use the product after a year’s detailing than a non-targetted doctor 
(Swailes,1992) This more efficient targeting is being adopted by many 
pharmaceutical salesforces so that time is not wasted on those doctors who may 
be low or non-presenbers of a company's products
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Traditionally the search for product uniqueness which subsequently drove 
positioning strategies was a primary task of the Research and Development 
function in a pharmaceutical company, le  positioning strategies tended to 
concentrate almost exclusively on technical aspects of the product Today, two 
major factors are broadening the concept of positioning in this industry Firstly, 
there is the current difficulty of creating new chemical entities or compounds 
(Holden, 1992, p 2 estimates that for every 10,000 compounds investigated by the 
industry for possible development into a new drug, only one emerges through all 
the trials and reaches the marketplace) Coupled with this is the fact that a large 
number of new pharmaceutical products do not have a real differential advantage 
based on the product itself Hence it is becoming vitally important to broaden the 
concept of existing products through the application of marketing techniques in 
order to create greater scope for alternative differential advantages (Cortsjens, 
1991, p 68)
Aaker (1988, p43) identified six positioning types which can be adapted to the 
needs of the pharmaceutical marketers
1 Positioning based on a specific attribute(s)
This is the most commonly used positioning approach in the pharmaceutical 
industry with attributes such as potency, side-effects, and tolerance being 
frequently adopted
2 Positioning with respect to use or application
Pfizer have launched Zithromax, a second-phase antibiotic, on the Irish 
market this year with a "once-a-day" dosage positioning as opposed to the 
traditional three times daily dosage of the competitors
3 Positioning with respect to the end user(patient)
Drugs can be positioned as most appropriate for adults or children, acute or 
chronic sufferers and such like
4 Positioning with respect to a product class
1 8 POSITIONING
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SmithKline Beecham positioned Tagamet as the first drug in a new product 
class, m this instance, H2 antagomsts
5 Positioning with respect to a competitor
Some drug companies piggy-back on the good image of a competitor's 
product and add a differential advantage This would be a widely used 
strategy by the manufacturers of generic drugs, agreeing with the claims of 
the branded manufacturer and adding pnce as their differential advantage
6 Positioning with respect to place o f  origin
Pfizer, Syntex, Rhone-Poulenc Rorer and Clonmel Chemicals are examples 
of ethical drug manufacturers in Ireland who emphasise their Irish 
manufacturing operations in their promotion
Doyle and Monteiro’s (1994) study had the objective of illustrating how 
companies can utilise the perceptions of prescnbers in aiding positioning Using 
the anti-hypertensives market (l e drugs for the treatment of high blood pressure 
and heart disease) they identified the underlying dimensions of choice, 
determined the relative importance of these dimensions, and grouped the drug 
according to similarity in the prescnber's perceptual space The authors argue that 
in the current climate, pharmaceutical companies will have to use positioning 
strategies or risk " seeing their margins erode rapidly as doctors and patients 
focus on buying from brand leaders or cheaper generics" (Doyle and Monteiro 
p 290)
1 9  COMPETITIVE ANALYSIS
"Three types of events currently characterise the pharmaceutical mdustry-the 
proliferation of megamergers, the negotiation of strategic alliances, and market 
stagnation "(Cetera, 1992,p 50) Given this assessment there is little doubt but that 
these events will inevitably make competition more acute
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Cetera uses a warfare analogy which is also adopted by Ries and Trout (1986 
p vi) who, when writing on competitive analysis, stated ’’marketing is war where 
the enemy is the competition and the customer is ground to be won"
Competitive analysis aids managers to make better predictions of future 
competitive moves, to identify areas of competitive weaknesses and to predict 
likely competitive reactions to corporate decisions For the companies m the 
pharmaceutical industry the traditional tools for analysis are applicable, such as 
Porter's framework of industry structure (1980, p 4 ) In terms of identifying 
competitors at brand or therapeutic level Corstjens ( p i l l )  recommends the use of 
competitive force analysis using market segmentation, product positioning and 
analyses of R&D capabilities rather than relying on partial statistics and biased 
personal experience
"Often, management’s understanding of competition continues to be casual, 
clumsy, and frequently inaccurate" (Corstjens p i l l )
Carrying out analysis on strategic groups of competitors is also integral to 
longer-range or strategic planning This task was made somewhat easier by work 
carried out by Sammon (1985) who categorised the major ethical pharmaceutical 
players in the U S A into strategic groups
Value chain analysis, portfolio analysis, market share analysis and hierarchy of 
effects are all relevant tools in carrying out the competitive analysis In addition 
to these formal techniques, qualitative information is also required to complete 
the picture in order to determine the competitors’ motivation and philosophy ì e 
how do they perceive themselves'? Predicting a competitor's strategy requires one 
to think as the competitor would and Porter's Competitive Response Framework 
is a useful structure for developing this information (Porter, 1980, p 49)
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1.10  RESEARCH AND DEVELOPMENT (R&D) AND NEW PRODUCT  
MANAGEMENT
For many years the output of every drug company was driven by its Research and 
Development department. Marketing was simply the selling annexe. Its input into 
Research and Development was negligible and vice versa. As the research 
productivity of the drug companies declined, marketing has become more 
important in the company. Because of this decline in productivity Milmo (1993) 
proposes that the drug companies will have to become less reliant on earnings 
from new products, and therefore extract more profits out of their older drugs- 
both those in and out of patent.
Three distinct approaches to R&D are practised by the industry.
The original methodology was that of screening, or trial and error, where drug 
companies sought to develop new chemical entities (NCE's) and then tested their 
effects on health problems. This approach also includes starting from new 
synthetic variations on familiar chemical compounds and investigating their side- 
effects. Cortsjens (1991, p. 128) cites the example of America's National Cancer 
Institute screening up to 10,000 synthetic compounds each year as potential anti­
cancer agents, yet during the eight years up to 1987 none had reached the market 
in the form of a new product. This approach is generally deemed not to be cost- 
efficient and has also led to a proliferation of copy-cat or me-too products.
An alternative approach starts from diseases and an understanding of their nature, 
which then drives the process of developing chemical substances to modify or 
cure the cause of the disease. This methodology is known as rational drug 
discovery. Williams and Glenn (1987, p.37), in describing this process, state that 
it starts off with a hypothesis about the target disease, and via a receptor or an 
enzyme, one tries to develop chemical substances that can selectively modify the 
targeted disease.
Biotechnology is a third and complementary approach to rational drug discovery. 
ACOST (1990) define this process as "...a broad term to describe the production
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of innovative products, devices and organisms by exploitation of biological 
processes 1 This most recent development offers the pharmaceutical industry a 
number of advantages it can decrease the reliance of the industry on the scatter- 
gun approach o f screemng in their search for NCE's, it affords the opportunity of 
producing large quantities of previously scarce biological compounds using 
genetic engineenng, and it furthers the search for knowledge and understanding 
of living processes A major problem for the pharmaceutical companies with this 
process, however, is the question of patents New drugs without the financial 
incentives offered by patents are less commercially attractive Proteins, the 
outcome of biotechnology processes, are natural biological substances, and it can 
be argued that their development and use cannot be patented by any single 
company
An indication of the huge cost of developing new drugs can be obtained from the 
fact that there are about 250 research-based pharmaceutical companies in the 
world who collectively spend about 15 billion dollars per annum on R & D 
However each year they manage to introduce only two or three new drugs that are 
capable of achieving major financial success (Redwood, 1991, p 18)
Costs of researching a new drug are escalating rapidly Yeoh (1994 p 30) gives a 
cost figure of $230 million stretching over a 12-year period for the typical 
development of a new drug currently, compared to a figure of $54 million during 
the 1963-75 period
The official span of patent life in most countries, Ireland included, is twenty 
years However, effective patent life-from first marketing to patent expiry-is only 
10-12 years as the patent protection is granted at a very early stage of 
development (Corstjens, p 181) Patent expiry brings generic competition and 
often a rapid fall in price and profitability, see Section 1 12
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Today's pharmaceutical market shows many of the signs of maturity Fewer new 
products being launched, increasing cost structures, declining profitability, 
companies being squeezed out of some segments and mergers predominant m 
others are all factors indicative of a market in maturity Given this industry 
situation, management of the promotional mix variables is quite consistent across 
all the ethical pharmaceutical companies This is also due to the very precise 
regulatory and self-administered codes within which the companies must operate 
The Irish regulatory environment for promotional management will be detailed m 
Chapter 4
Although theoretically the ethical pharmaceutical companies have a wide choice 
of promotional elements to choose from, without exception, these companies 
devote the most significant part of their marketing communication budgets to the 
cost of maintaining a personal sales force In addition to their sales 
representatives, the companies also promote their products through sponsored 
meetings, symposia, journal advertising, public relations, sales promotions, direct 
mail, product sampling, audio-visual media and exhibitions
Thus ethical pharmaceutical companies are looking for ways to create market- 
driven promotional strategies The answers are increasingly being found in 
differentiating themselves and their products through added value, íe  the 
provision of additional benefits to a medicine, either in the form of a product 
enhancement such as a low dosage o f a drug, or the provision of back up services 
Examples of these added value services on the Irish market would include Astra’s 
provision of practice-meetmgs m G P s' surgeries for asthmatic patients and 
SmithKhne Beecham’s funding of continuing medical education programmes
At an industry level both the Irish Pharmaceutical and Healthcare Association 
(I P H A ) and the Pharmaceutical Managers Association (P M A ) extensively 
use public relations to persuade the decision-makers and general public that the 
benefits of modem medicines far outweigh the costs (Schwartz, 1992) At the 
company level public relations is particularly relied on at pre-launch and launch
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stages of a new product (Corstjens, p219), in the form of conferences and 
symposia Mitchell (1993) reports research carried out by Kingston University 
Business School which placed public relations third behind the salesforce and 
professional relations
Below-the-line spend in the form of sales promotions aimed at the G P  is 
estimated to have cost m the region of stg £3-4m m the U K in 1993 (Nash, 1993, 
p 39) These promotions are used as a mechanism for reminding a prescnber 
about a brand The giveaways vary from diagnostic aids, surgical instruments, 
surgery and stationery items to patient leaflets and items for the car Holden 
(1992, p 41) descnbes these items as always being welcome and "probably good 
value for money"
Advertising is used both for new pharmaceutical drugs and the promotion of 
existing ones Welch (1992, p 86) feels that pharmaceutical advertising rarely 
wins awards for creativity as judged by the consumer industry because of 
restrictions imposed by Codes of Practice, a largely conservative audience, and 
the multi-layered approval process i e legal / medical / registration / marketing
Traditional advertising media have included medical journals, trade/professional 
press, desktop media, and audio-visual means but other routes are emerging, 
particularly in the area of OTC lines, such as Marion Merrell Dow's antihistamine 
Tnludan which was advertised on the Bank of Ireland Pass automated teller 
machines during the summer of 1994
In recognition of the globe-trotting habits of some leading doctors, a European 
mass market of 340 million consumers, and an estimated market value of $55 6 
billion many of the pharmaceutical companies are actively "Eurobranding" their 
products The major tasks here are involved with creating a consistent core image 
for the brand through harmonisation of the brand name, the packaging, and the 
indications Laitin and Klaperman (1992, p 68) consider that "consistent branding 
and core positioning are the keys to reaching Europe's medical community" and 
that "harmonisation will be the watchword o f the next decade"
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In the current climate pnce is increasingly growing in importance as a tactical 
tool due to factors such as greater genenc competition, proliferation of "me-too" 
drugs, and stncter governmental control and involvement in the prescnbing of 
doctors
However, the marketing literature is sparsest with regard to this strategic vanable 
Smith (1991, p 216) feels this could be due "in part to the recumng cnticism- 
official and grassroots-of the high cost of drugs"
The same factors which influence pricing strategy in non-pharmaceutical areas 
are relevant here such as demand, determination of elasticity, costs, competitors, 
channel members, and buyers Perhaps the most significantly different factor is 
that of the role of the government The pnces of new drugs and drug pnce 
increases are controllable by the government in most countnes either through 
direct price controls, reimbursement schemes or both, or through control of 
corporate profits of pharmaceutical companies Governmental pressure on the 
Insh market has come in the form of GP's prescnbing targets, known as indicative 
drug budgeting Each general practitioner who has a panel of public/medicai card 
patients receives a monthly prescribing target based on the size of that panel 
Doctors whose prescribing costs are less than their indicative target are credited 
with fifty per cent of the savings These credits can be then used for practice 
development purposes, such as the purchase of practice equipment or the 
improvement of practice premises However, as yet, there is no sanction for those 
doctors who fail to stay within their indicative drug budgets
The government push for genencs poses difficult pricing issues for the 
pharmaceutical companies whose drugs are shortly due to come off-patent 
Deciding how far to reduce the pnce in order to off-set the impact of the genenc 
offerings is a problem that is testing the pricing skills of many pharmaceutical 
managers currently
1 12 PRICE
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Additionally, parallel importing, i.e. wholesalers buying large quantities of drugs 
in a country where their price is cheaper and selling them on into the local 
pharmacists on the home market, is evident due to heterogenity of price controls 
across different countries. Cortsjens (1992, p. 174) reports that, at a wholesale 
level, drug prices vary by a factor of three between the least and the most 
expensive European countries. Drugs are relatively cheap in Belgium, France, and 
Italy, relatively expensive in Denmark, Germany, and the Netherlands, with the 
U.K. and Ireland in an intermediate position.
In a 1986 study of U.K. doctors Stem (1994, p. 178) reported that overall there 
was a low level of generic prescribing with branded drugs prescribing accounting 
for about 70% of all prescriptions in the two therapeutic areas examined. This is 
due in part to the fact that this study pre-dated the introduction of fund-holding in 
U.K. general practice (which offers a financial incentive to reduce drug costs), 
and also to the then limited prevalence of generic offerings in one of the two 
fields studied. Macarthur (1994, p.35) reported that sales of generics have really 
only penetrated four of the twelve EU member countries-Denmark, Germany, the 
Netherlands and the U.K. Starzewski (1995, p.228) states that 80 per cent of 
European generic drug sales takes place in these four markets. In Germany, 
generics have an 18 per cent share of the total prescription market, in the U.K. the 
share is 17 per cent, Denmark 20 per cent, and the Netherlands 18 per cent. 
Starzewski (1995, p.227) believes generics have fared less well in the other 
European markets because of their lower prevailing prices for branded products 
which makes the generic option less attractive.
Current figures for the Irish market indicate that the annual growth rate for 
generic drug sales is five times that of proprietary brands. Hunter (1995), states 
that for the year ended 1994, the proprietary brand market increased from £175 
million to £187 million, showing a growth rate of seven per cent, while the 
generic market increased from £11 million to £15 million, a growth rate of 36 per 
cent. These figures are a reflection of the effect of indicative drug budgeting,
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introduced into Irish general practice by the Department of Health m 1993 and 
currently m it’s third year of operation
Not surprisingly, the pharmaceutical industry do feel threatened by the longer- 
term implications of generics and hence the frenzy of activity as more large 
pharmaceutical companies enter the genenc market themselves, through 
acquisition or mergers, and under their own name or a new name Starzewski 
(1995, p227) concludes that " the development of a portfolio of products in 
which the commercial value of both brands and genencs may be optimised will 
become of cntical importance to companies wishing to do business with health 
providers”
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CHAPTER 2 SALES MANAGEMENT LITERATURE REVIEW
2 0 INTRODUCTION
Sales management is not an exact science It is also a relatively young discipline 
A wealth of literature does however exist regarding sales force research Bush 
and Grant (1991 p 47) noted that sales force research had come a long way m the 
last decade to overcome its "second-class" status among academic researchers and 
practitioners alike Bush and Grant (1994, p 65) state that based on the outcome 
of their sales management content analysis research, salesforce research is 
moving positively toward scientific maturity
Historically, the role of face-to-face selling and, subsequently, it's management, 
has been viewed as being a sub-set of the promotional element of the marketing 
mix Authors of marketing texts have persistently adopted this view and have 
therefore contributed to the perpetuation of selling and sales management being 
considered peripheral as opposed to central to marketing In reality, marketing 
and the salesforce must operate with a duality of purpose Donaldson (1990, p 4) 
blames many marketing texts' authors for adopting a pedagogical approach to the 
differences between a production orientation, a selling orientation and a 
marketing orientation, thereby leaving readers with an overly negative view of 
selling In addition this approach can lead the readers to view selling and 
marketing as being opposites rather than complementary Drucker (1974), in his 
book entitled Management Tasks, Responsibilities, Practices, can take a fair 
share of personal responsibility for this perception due to his claim th a t" the aim 
of marketing is to make selling superflous" However, in some quarters, this view 
is changing Baker (1991, pxxiv) states that the major potential for strategic 
advantage available to companies in many markets lies with the sales force As 
the role of personal selling in an organisation increases in importance, so too does 
the management of that process
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2 1 MANAGEMENT OF SALES
Definitions of sales management abound Originally the term referred solely to 
the direction of sales force personnel but in the 1990's the term has taken on a 
broader significance The emphasis is now on the word "management" The 
nature and role of sales management has become more professional
The traditional definition emanated from the American Marketing Association 
(1960, p20) and reads " sales management means the planning, direction and 
control of personal selling, including recruiting, selecting, equipping, assigmng, 
routing, supervising, paying, and motivating as these tasks apply to the personal 
sales force"
Donaldson (1990, p 11) encompasses the current management onented approach 
by defining sales management as " the process of planning, organising , staffing, 
directing and controlling the sales operation to achieve the firm's objectives 
through subordinates"
Dalrymple and Cron (1995, p 8) acknowledge the role the modem sales manager 
can play in corporate decision-making with their definition stating that sales 
management involves " the planning, implementing, and control of personal 
contact programs designed to achieve the sales and profit objectives of the firm"
Perhaps the most widely accepted framework for analysing the field of sales 
management is that of Churchill, Walker and Ford (1993, p 11) illustrated in 
Table 2 1
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Table 2 1 An Overview  of Sales Management
Under this framework the sales management process involves three interrelated 
sets of decisions
1 The formulation of a strategic sales programme, covering the environment, 
marketing strategy, and sales management activities such as organisation, 
sales planning and deployment
2 The implementation of that programme, namely selection and recruitment, 
training, motivating, and compensating the salesforce
3 The evaluation and control of sales force performance
The strategic dimension, in particular, of this framework ties in to the seminal 
work of Ryans and Weinberg who conceptualised sales management in three 
stages strategic, tactical and operational (1981, p 76) Their classification would 
appear to typify the way many sales organisations are structured with a sales 
director (strategic level), a sales manager (operational level) and first line 
supervisor ( field / area manager) In some organisations one person may embrace
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all three decision levels but as Donaldson (1990, p 13) points out the 
classification is a useful aid to understanding the nature of decisions in all 
organisations
Formulating a strategic sales programme involves an analysis of the influences 
and constraints imposed by the external environment, and likewise the firm’s 
internal environment Integration of the sales programme with the firm’s 
marketing strategy is vital to the achievement of the company's objectives 
Finally, the outcome of these efforts should be the planning and organisation of 
the company's overall personal selling efforts
2 2 CHARACTERISTICS OF EFFECTIVE SALES MANAGERS
So, what characteristics are necessary for effective management of the decisions 
identified in the framework just outlined9 Loen (1964, p 108) pointed out the 
difference between a capable sales manager and a not-so-capable sales manager 
can make a significant difference in sales, profits, and whether or not the cost of a 
marketing programme pays off
Bagozzi (1980, p 16) claimed that ’’the fact of the matter is that we know very 
little about the behaviours and characteristics of salespeople, and even less about 
the people who manage them" However, operating in the dark is not the most 
effective way of using scarce resources therefore an examination of the literature 
regarding characteristics of effective sales managers is timely and appropriate
The literature consistently suggests that "leadership" is the trait which 
distinguishes the effective manager from the weak or ineffective one Sometimes 
described as motivation theory in action, effective leadership should stimulate 
subordinates to achieve desired levels of productivity There are different types of 
leadership which includes formal leadership, charismatic leadership, 
representational leadership, expert leadership, and functional leadership In 
different situations different aspects of these become important or even critical 
Hersey and Blanchard (1988) proposed a situational leadership model which
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described four different types of leadership styles telling, selling, supportive, and 
delegating They proposed that the appropriate leadership style depended on the 
maturity of the salesperson, (that is their competence and commitment), with 
whom the sales manager is mteracting, thereby requiring that managers be 
flexible in leadership style
Johnson et al (1994, p380) identify the leadership skills required for sales 
managers as perception, conceptual ability, and self awareness Jolson et al (1993, 
p 105) believe that "transformational leadership", that is the process of shaping or 
moulding sales people into what the leader wishes them to be, improves the 
performance of salespeople beyond typical expectations However, the authors 
claim most U S sales executives are "transactional leaders" (p 98) who rely on 
contingent reinforcement to motivate their sales forces and are practitioners of 
management by exception
On the contrary, John Lynch (1990, p 13) maintains that the ovemding 
qualification for being a good sales manager is not one of leadership, but that one 
has been a successful sales person previously However, promoting a sales person 
on their selling ability alone can, and often is, disastrous for the individual 
involved, the sales team and the achievement of corporate goals On the other 
hand, promoting a successful sales person who recognises the essential 
differences between managing and doing (Loen, 1964, p 109) can result in 
creating an effective leader whom the sales people respect
Wortman (1989, p44) declared that all effective sales managers share one 
charactenstic-they plan Chonko, Tanner and Weeks (1992, p 70) proposed four 
qualities of good managers enthusiasm, ego, empathy and energy Chnstie (1992, 
p 63) maintains that while most managers are able to achieve their corporate 
goals, only the very best are able to gamer the respect of their co-workers Carew 
(1989, p25) listed four major complaints sales professionals frequently have 
about their managers
1 They do not spend enough time with their salespeople
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2 They do not listen to their salespeople's concerns
3 They do not take their salespeople’s concerns seriously
4 They do not follow up
Bums (1989, p27) in expanding on the characteristic of inspiration says that 
people are inspired by believing in themselves and by emulating others He 
maintains that sales managers will succeed to the extent that they can inspire 
themselves and those around them
In a study by Armstrong et al (1993, p 15) the authors utilised historical data to 
explore the effects of sales management succession in a large resources-based 
manufacturing company Over a four year period 19 successions had taken place 
for which full 12 months of before-after performance records were available 
Results demonstrated a positive effect due to the succession event, thus 
confirming the common-sense notion that the sales manager does matter and that 
performance improves as a result of succession
The preceding research covered different products, different markets and quite 
significantly different time periods For this reason much of the data may be non- 
transferable and out-of-date However, Kelly (1995, p 123) carried out a census of 
ethical pharmaceutical sales representatives in Ireland and, within this research, 
included an open-ended question asking the respondents what characteristics they 
considered important for sales managers to possess in order to be effective 
leaders The ranked results are as follows
1 Motivation
2 Honesty
3 Good communication skills
4 Enthusiasm
5 Ability to listen
6 Leadership skills
7 Empathy
8 Fairness
9 Understanding
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10 Support
The majority of these skills relate to those termed by Johnson et al (1994, p 380) 
as "human relations skills" It is understandable that pharmaceutical sales 
representatives place more emphasis on skills of these type as they directly affect 
the way they will perform Other unprompted characteristics mentioned included 
competence, organisational skills, personality and sales experience This last- 
mentioned characteristic would indicate a divergence in opinion between Irish 
pharmaceutical salespeople's perspective regarding the importance of this factor 
with that of John Lynch referred to above
2 3 THE TRAINING OF SALES MANAGERS
Loen (1964, p 108) declared that many companies were spending a great deal of 
money training their sales personnel whilst appearing to expect their sales 
managers to learn their jobs by osmosis Corcoran (1990, p 10) reckoned that if 
one were to walk into any U S sales organisation they would find, on average, 
that more than three-quarters of their sales managers had come up directly from 
the sales force Often, these incumbents have got to their sales management 
position as a reward for their ability to make or exceed quota and their spectacular 
selling skills, rather than for their ability to motivate and direct other members of 
the sales team Garfield (1990, p 10) supports this view, saying many companies 
have suffered from incorrectly appointing sales managers from their best 
salespeople, even though there may have be no indication that they are good 
teachers, trainers, or administrators In essence, many of the failures in 
management development can be attributed to an unplanned and unsystematic 
approach being taken to training
Making an effective transition from selling to managing requires certain personal 
characteristics as well as company support in the form of self-development 
programmes and management training Management development refers to the 
progress a person is making in learning to manage Falvey (1989, p 45) suggested 
that since selling and managing require nearly opposite skills those sales
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representatives who want to participate in management should be given an 
intermediate assignment as an assistant manager for nine to eighteen months m 
order to learn from a proven practitioner under normal business conditions before 
receiving their first management assignment
One of the more difficult aspects of the transition from selling to managing can be 
the giving up of control (Kelley, 1992, p 35) Effective sales managers must 
delegate, but most sales people do not have that experience in their selling role 
Other difficult changes on transition include learning to be behind-the-scenes 
players, the lack of gratification from successful sales encounters, and the move 
from a relatively short-term outlook to a broader, longer-term management 
perspective
A useful analogy of the differences between selling and managing was given to 
this researcher during one of the in-depth interviews conducted prior to the postal 
research The sales and marketing manager maintained the real difference is like 
being in an orchestra, where on promotion from selling to sales management "one 
goes from being a soloist to conductor"
Guest and Meric (1989, p 50), with data gathered from 22 per cent of Fortune 500 
companies, found that only 27 per cent of respondents always trained their first 
level sales managers prior to appointment However an additional 50 per cent of 
the respondents said they provided induction training "sometimes"
Shepherd and Ridnour (1995, pp 69-74) earned out a study of sales management 
training practices using data received from 82 per cent of the membership of the 
Amencan National Society of Sale Training Executives They discovered that 
businesses continue to concentrate on traditional management topics, such as 
coaching, motivatmg skills, and time management m their induction training 
programmes for sales managers To a lesser extent the companies included the 
transition to management and problem-solving
The authors found a distinct lack of focus on training for specific business 
management skills such as competitive analysis, quota setting, forecasting and
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developing a strategic business plan Given that most sales managers are 
operating in an increasingly competitive environment, with challenging economic 
conditions and accelerating change, the lack of training in the more sophisticated 
business management skills seems unwise Fulmer et al (1993, p 36) argue that in 
order to use learning as a competitive tool in this changing business environment, 
companies should adopt anticipatory learning as opposed to maintenance learning 
and, in addition, emplace management development into their companies as a 
system rather than a series of discrete events
2 4  THE FUNCTIONS OF THE SALES MANAGER
Effective management requires a solid understanding of the activities one is 
trying to manage Dalrymple and Cron (1992, p 10) maintain that the basic 
responsibilities of the sales manager are to direct and control the sales people who 
report to them However, Tom Peters (1993, p43) sees the role of the sales 
manager in a much broader light, where partnering customers is paramount and 
therefore requires the sales manager " to become more of a coach, more of a 
facilitator, more of a person who works on interpersonal relationships-getting 
people together rather than acting as a whip-cracker and a person who worries 
about whether the quotas are made"
O'Connell and Keenan (1990, p38) report American research which supports 
Peter's view of the way forward In the study of sales force productivity 76 per 
cent of the sales manager respondents believed that the most important objectives 
of their sales forces ought to be retaimng existing accounts and, secondly, gaimng 
share with existing accounts
Wilson (1993, p 137) maintains that because of the developing strategic 
importance of selling in the 1990s, the sales manager's essential role will be to 
direct the sales force in forging and sustaining a portfolio of client relationships 
through which strategic advantage may be wrested from the market place
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In order to understand the role of the sales manager in the ethical pharmaceutical 
industry, the nature of the selling job earned out by pharmaceutical sales people 
must be understood
Moncnef (1986, p 263) proposed a taxonomy for classifying sales jobs which 
identified five categones
1 Missionary
2 Trade servicer
3 Trade seller
4 Order taker
5 Institutional seller
Pharmaceutical sales people are classified under the first category, that is 
missionary or detail sales people This type of selling is charactensed by sales 
people calling on doctors who are specifiers of the product but may neither stock 
nor use it In the main, the emphasis is on good coverage and presentation, to 
make sure these mfluencers and specifiers know the products, their benefits and 
competitive advantages The ethical pharmaceutical salesperson is trying to 
influence the specifier instead of the purchaser or end user of the product Also 
known as "detail" salespeople, the focus for these representatives is not on 
actually completing the sales transaction and gaming an immediate sale, but as 
Weilbaker (1990, p 47) points out, is on stimulating demand for the product and 
on developing goodwill for the company Pharmaceutical salespeople are a good 
example of those salespeople who, as Wilson (1993, p 130) wntes, operate within 
the context of ongoing relationships rather than discrete sales events
In effect, pharmaceutical salespeople seldom wnte an order The doctors, as 
specifiers and decision-makers, write prescriptions for the sales representatives’ 
products and when the prescnption is presented at a local retail pharmacy for 
filling, a wholesale drug order is the eventual result Consequently, the ethical 
pharmaceutical sales person is only indirectly in this loop This position in turn 
creates an unusual sales management situation What is it that the pharmaceutical
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sales manager is actually managing9 Falvey (1992, p 12) claims that what these 
managers manage is the selling process, that is they manage their salespeople as 
they work through the industry's generally accepted selling cycle
Returning to Churchill et al's framework for analysing the field of sales 
management illustrated in Table 2 1, the role of the modem pharmaceutical sales 
manager can be encapsulated under their three broad categories of activities
2 4 1 S A L E S  S T R A T E G Y  FO R M U LA T IO N
This requires that the sales function be managed with clearly articulated 
objectives based on in-depth analysis of the company's internal and external 
environment and the need of its products and markets
Sales management strategy involves the selection and co-ordination of policies 
and tactics in those areas controllable by the sales manager Most of these 
decisions will involve trade-offs, for example hiring experienced sales people vs 
new recruits, or extensive /expensive training vs minimal / inexpensive training 
When taken together, these decisions in the controllable areas can be viewed as a 
system or pattern known as the sales management mix It is the sales manager’s 
strategic responsibility to assemble a sales management mix that best fits the 
environments within which the sales organisation operates Additionally, it is the 
sales manager’s responsibility to change or adapt this mix in response to, or 
preferably m anticipation of, changes in the environments
Viswanathan and Olson (1992, p 56) argue that it is necessary not only to take 
account of the environmental factors that influence marketing and subsequently 
sales strategies, but that business units following different competitive strategies 
will require differing sales management programmes and policies
Strahle and Spiro (1986, p 16) had earlier written a seminal paper highlighting the 
importance of making strategic decisions on the different levels in the 
organisation which are consistent and supportive of one another This work 
focused primarily on the relationship between marketing strategy and sales
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strategy Therefore today’s sales manager is certainly required to be a professional 
manager in order to be effective at this level
This strategic approach is very much occupying the minds of sales management 
educators currently, with it being the major topic for discussion at the pre­
conference session of the Sales and Sales Management Special Interest Group of 
the 1995 Winter AMA Meeting
Other sales management activities also included in this broad range of decisions 
relating to the formulation of a strategic sales programme include account 
management policies, sales force organisation, sales planning and deployment
2 4.2 A C C O U N T M A N A G EM EN T P O L IC IE S
Account management policies, according to Churchill (1993, p 125), specify 
which individuals within each type of customer organisation the salesperson 
should attempt to contact, what kinds of selling and service activities should be 
engaged in, and how those activities should be conducted With the increasing 
prevalence of pharmaceutical companies segmenting general practitioners in 
order to target the high-volume prescnbers (Deardorff, 1992, p 84), the modem 
pharmaceutical sales manager needs to understand, and wisely use, both the 
internally-generated and syndicated or bought- in data to aid correct segmentation 
of doctors The theoretical benefits of using segmentation in a sales environment 
follow from the underlying principles of the contingency approach to selling as
documented by Weitz et al in 1986 Subsequently, Maier and Saunders (1990,
*p 41) proposed a generalised model for the application of segmentation to sales
\management, using the data of an American based ethical pharmaceutical 
company operating in the British market whose prime focus was on general 
practitioners They found that segmentation has the capability of increasing sales 
representative performance while making their job more rewarding-both 
financially and psychologically
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2 4 .3  SALES FORCE ORGANISATION
Sales force organisation, according to Dalrymple and Cron (1992, p352), has 
traditionally been one of the most neglected areas of sales management Back in 
1968, Drucker wrote "good organisation structure does not by itself produce 
good performance but a poor organisation structure makes good performance 
impossible” Often the structure of the sales force evolves over time, layers of 
supervision and staff specialists are added to solve particular problems that may 
arise Structure has tended to be ignored until major profit and sales problems 
arise In the ethical pharmaceutical industry structure has recently been getting 
more management attention due to the number of mergers of salesforces as a 
result of acquisitions and take-overs
In the first instance, a corporate decision is necessary on whether the company 
should have it's own personal sales force or contract with an external agent to 
perform that activity on the company's behalf Anderson and Weitz (1986, p 3) 
termed these respectively as "make” or "buy” decisions
If the corporate decision is to maintain a personal sales force of its own, then the 
fundamental decisions that the sales manager must make in relation to its 
organisation are, according to Donaldson (1990, p 131), determining how sales 
force effort should be allocated to specific sales tasks, to groups of customers, to 
geographical regions or to specific products or product groups Ruekert et al 
(1985, p 19) in proposing a a contingency approach to structure counsel that no 
single structure is equally appropriate for all types of tasks or all environmental 
circumstances However, Avlomtis, Manolis and Boyle (1985, p 8) in a study of 
sales management practices in the U K manufacturing industry, found that 57 per 
cent of their sample companies relied exclusively on one method of sales force 
structure, with 88 per cent of these companies using geographical regions as their 
method of deployment
In a study of Irish sales management practice Lambkin and deBurca (1991, p 28) 
found that the single most important factor considered by sales managers in the 
organisation of their sales force was the sales objective/potential of the territory
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(with a mean score of 4 3 out of 5), followed closely by geographic coverage (4 2) 
and number of accounts (4 1), using a scale ranging from 1, unimportant, to 5, 
very important
In recent years many advances have taken place which have influenced the 
structures of organisations Changing selling styles and a greater emphasis on 
relationship building have meant that managers have had to re-examme their 
structure and question it's effectiveness One of the most documented emerging 
selling styles is that of selling teams ( Blessington, 1989, Rapp, 1989, Cespedes, 
Doyle and Freedman, 1989) Moon and Armstrong (1994, p21) extend the 
previous literature by defining two types of selling teams core selling teams and 
selling centres The important distinction between these two structures is that the 
core selling team is a customer-focused group whose primary objective is to 
establish and maintain strong customer relationships In contrast, the selling 
centre, modelled on Wind's buying centre framework, is a transaction-focused 
group whose objective is successful completion of the specific sales opportunity it 
has been formed to pursue The scant literature on organisation structures in the 
ethical pharmaceutical industry does not include references to the existence of 
either type of selling team
Another consideration in organisation structure is the issue of the use of part-time 
sales people With the cost of a field sales call rising, sales managers in their 
search for cost-effectiveness, can look to the use of an "interim sales executive” 
(Trumfino, 1994, p 35), or contract selling, for activities such as special project 
assignments, heavy growth penods or even to test a new territory before 
expansion Ruekert et al (1985, p 13) propose the use of transaction cost 
economics for analysing whether particular activities should be organised 
internally or externally Horchover (1993, p 67) counsels that for companies 
considenng the third party route for selling, direct cost benefits will only result 
from focusing on activities and outlets that build sales most effectively, thus 
avoiding waste In their assessment of future trends m pharmaceutical marketing 
Lopuch and Mummers (1994, p 23) predict the rising cost of the sales force will
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cause regional managers to evaluate overall effectiveness in terms of return on 
investment, a likely outcome of which will be the increasing use of part-time 
sales people Indeed, the U K pharmaceutical trade press is increasingly carrying 
advertisments for "outside sales forces" such as that of RDL Pharmaceuticals 
(1994, p21) whose expertise is being endorsed by the General Manager of 
Rhone-Poulenc Rorer, a client of the company
2 4.4 S A L E S  T E R R IT O R IE S
Directly linked to sales force organisation is another aspect of the formulation of 
a strategic sales programme, sales territories In particular, territory design is one 
of the most critical decisions for sales managers (Churchill, 1993, p225) For 
ethical pharmaceutical companies, the sales force investment decision is crucial 
because the sales force is the predominant way of marketing products Lodish et 
al (1988, p 19) documented the experience of the U S operation of Syntex 
Laboratories who introduced a formal, computerised decision model to aid sales 
territory design and achieved a continuing $25 million eight percent annual 
increase in sales
Sales territories should not be treated as immovable once established Factors 
such as varying sales potential and workload, new product introductions, turnover 
of sales personnel, and changes in company structure can make the need for 
territory boundary revision necessary
Territory management has become an area that many sales managers focus on in 
order to look for answers to sales force productivity O'Connell and Keenan 
(1990, p 39) estimated a sales person only spends 33 percent of their time in face- 
to-face selling, thus productivity gams should follow if available selling time is 
increased New technology such as laptop computers and mobile telephones can 
aid in reducing non-selling time, but territory management issues such as 
focusing on strategic products and physicians need sales management input in the 
planning and implementation stages
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Sales planning activities are generally deemed to include the estimation of market 
potential and, as a consequence, sales potential, the preparation of sales forecasts 
and again , as a consequence, the development of sales targets and the creation of 
the sales budget
Sales forecasting is another sales management activity that is critical to the 
achievement of corporate objectives Inaccurate forecasting can cause major 
repercussions throughout an organisation The estimation of market potential may 
be the preserve of the marketing department in some companies but sales 
managers should have a major input into the preparation of the ensuing sales 
forecasts
During the m-depth interviews that this researcher held with six managers in the 
industry, it was quite clear that these interviewees felt uncomfortable with the 
financial and quantitative aspects of their jobs, of which forecasting is an element 
Therefore, Henry R Luce's observation as quoted in Dalrymple and Cron's text 
(1992, p305) that "business more than any other occupation is a continual 
calculation" would not appear to be very comforting for those who feel 
inadequately skilled m this area
All sales management texts devote chapters to the sales forecasting process 
(Churchill,Ford and Walker, 1993, Dalrymple and Cron, 1992, Donaldson, 1990 
and Lancaster and Jobber, 1994) Indeed there are texts which exclusively deal 
with this sales management activity (Battersby, 1968, Elby and O'Neill, 1975, 
and Makridakis, 1987) Consequently, there is no shortage of guidance for sales 
managers when undertaking this task
There is broad agreement across the range of available material regarding the 
types of forecasts a manager may use These are commonly broken into two 
major groups qualitative or subjective techniques and quantitative or objective 
techniques The qualitative category usually includes methods such as user 
expectations, sales force composite, jury of executive opinion and the Delphi
2 4.5 SALES PLANNING
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technique Quantitative approaches are generally of two major types time series 
analysis and statistical demand analysis, usmg regression
The decision on which approach to use is tempered by a number of issues such as 
desire for accuracy (Churchill et al, p 2 0 6), the company's level of technical 
sophistication (Georgoff and Murdick, p 115) and the existence of historical sales 
data (Herbig et al, p 55)
Dubmskey and Barry (1982, p 135) in a study of 121 U S  chief sales executives 
found that significantly more large firms than small firms tend to use extensively 
forecasts that are set by salespeople Both groups, however, appeared to establish 
forecasts primarily by usmg the opimon of top executives This predominant use 
of executive opinion was again documented by Dalrymple (1987, p 385) in a 
study of 134 U S firms Neither of these studies explored whether this outcome 
meant that the ensuing forecasts were imposed on the sales managers, thereby 
ignoring their inputs
Finally, Herbig et al (1993, p56) offer some generalisations to guide sales 
managers
1 More accurate forecasts are possible when a greater amount of data is 
available
2 The higher the rate of technological change in an industry, the greater the 
chance that established patterns will change and the less certain forecasts will 
become
3 The lower the barriers to entry, the more inaccurate the forecasting is likely 
to be
4 The more elastic the demand, the less accurate the forecasts
Once the forecast has been made and temtonal targets agreed, the sales manager 
then must set quotas for his/her salespeople Sales quotas are one of the most 
widely used tools in sales management Dalrymple and Cron (1992, p 531) and 
Churchill et al (1993, p265) give similarity worded reasons for their 
establishment
1 To provide incentives/motivation
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2 To direct salespeople's efforts
3 To provide standards for performance evaluation
Essentially there are two general types of quotas
1 Performance quotas-typically related to sales-volume and stated m monetary 
amounts or physical units, and profit-based quotas
2 Activity ^woios-based on factors controllable by the salespeople In the ethical 
pharmaceutical industry relevant examples of such quotas could include calls 
on new doctors, meetings arranged, samples distributed and seminars 
organised
As quotas are an integral part of the sales management activity of performance 
evaluation the author will deal in greater depth with them in Section 2 6
One often overlooked aspect of a sales manager's planning responsibilities is
highlighted by Falvey (1992, p 13) That is the internal marketing issue Falvey
advises sales managers to consider their sales force as internal customers and 
therefore develop a marketing and sales plan specifically for them An example of 
this would be the sales managers' ability to sell the salespersons' target to them 
Internal marketing is proposed on the grounds that if a sales manager sells to the 
salesforce effectively and constructively, the results will find their way to external 
customers Intelligent use of sales force communication methods such as 
stimulating and relevant sales meetings, monthly newsletters and professional- 
looking sales aids can help achieve this task
2 5 IMPLEMENTATION OF THE SALES PROGRAMME
The second broad category of activities as outlined by Churchill, Ford and Walker 
is the implementation of the polices and procedures drawn up in the formulation 
of the strategic sales programme The major sales management activities involved 
here are selection and recruitment of sales personnel, sales training, motivation, 
compensation and the use of incentive programmes As there is such a wealth of
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literature in all of these management areas a complete assessment of each is 
beyond the scope of this chapter. The author therefore proposes to outline the 
basic elements of each function, include an assessment of the most recent 
literature in each area and, where possible, draw attention to literature that is 
specific to the ethical pharmaceutical market.
2.5.1 SALES FORCE SELECTION AND RECRUITMENT
The selection of salespeople is a significant activity for two main reasons. First, 
the selection process requires considerable cost and management time. Second, 
mistakes in hiring are detrimental to customer relations and sales force 
performance, and will in return require more money and management time to 
replace those unsuccessful on the job.
Andersen et al (1992, p.230) explain that the recruiting process furnishes the sales 
manager with a pool of applicants from which to choose. The selection process 
involves choosing the candidate who best meets the qualifications and has the 
greatest aptitude for the job.
Factors to be considered in the recruitment process include the preparation of a 
job analysis (Strafford and Grant, 1986, p.67) or reality check (Dalrymple, 
1995,p.421), and a job description and job specification (Lancaster and Jobber, 
1994, p.207). The job specification requires sales management judgement on such 
highly subjective areas as the requirement for previous industry-relevant sales 
experience, age, and educational background. For example, in a study of the 
educational backgrounds of high-tech salespeople, Traynor et al (1992, p.80) 
studied many types of industries and found in the drugs/medicine category, 47 
percent of the sales people had a technical degree, but an additional 28 percent 
had a business degree, while 13 percent had a marketing degree. Avlonitis et al 
(1986, p.49) utilised the results of their 1985 study and examined the selection 
criteria used within the different categories of industry more closely. The 
missionary selling category, which included the responses of the ethical
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pharmaceutical industry, ranked relevant product experience, ambition 
development potential and personal characteristics as the most important criteria
Wotruba (1970, p 41) earned out research into the study of the salesman selection 
process, looking specifically for evidence of relationships between three factors 
the relative cost of usmg a tool, its position in the order of use, and its relative 
helpfulness or effectiveness in identifying desirable salespeople Unfortunately, 
although the sample of companies was drawn from the Fortune 500 list o f largest 
U S industnal corporations the reporting does not include figures relevant to any 
specific industry category
Equally, the studies of sales management practices by Dubmsky and Barry (1982) 
and Lambkin and deBurca (1991) include analysis of selection and recruitment 
practices in general, but not of the pharmaceutical industry in particular
Churchill et al (1993, p468) maintain the pnmary objective of the recruiting 
effort should be to maximise the total number of job applicants The Insh 
pharmaceutical managers interviewed in the first phase of this research would not 
concur with this objective Given the current Insh labour market situation, with 
an abundance of third-level graduates coupled with a large number of paramedical 
personnel anxious to exit from Health Board and hospital employment, 
maximising the quantity of applicants is not the issue One sales and marketing 
manager desenbed his expenence of advertising for a medical sales representative 
in one regional newspaper only, which generated seventy-nine applications from 
suitably qualified people
In addition to the demographic issues the sales manager must address for the job 
specification, another fraught area is that of the desirable personal characteristics 
the candidate should possess Researchers have for many years attempted to 
define the charactenstics necessary to be a successful salesperson The results 
have however been inconclusive and inconsistent across a range of different 
selling types and various selling situations
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Churchill et al (1995, pp 442-451) report the results of a meta-analysis they 
earned out on over four hundred published and unpublished studies between 1918 
and 1983 relating to determinants of sales performance Their conclusions suggest 
the performance of a given salesperson is a function of a vanety of influences, 
including both personal traits and organisational factors In addition, they 
concluded that different personal traits, aptitudes, and skills are required for 
success m different kinds of sales jobs
As already stated, ethical pharmaceutical sales representatives are classified in the 
missionary selling category Weilbaker (1995, p 49) earned out research relevant 
to the ethical pharmaceutical sales representative in order to identify those 
specific personal charactenstics that are required to perform the task activities 
relevant for missionary selling His research goal was to assess views about 
salespeople’s selling abilities from the three different parties in the pharmaceutical 
sales process salespeople themselves, sales managers, and physicians Using 
Kendall's approach to determining the importance of each individual ability the 
following ranked results (p 51) were recorded
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Table 2 .2 : Im portant A b ilities fo r Pharm aceutical Salespeople
Abilities Sum of Ranks
Adaptability 5
Ability to learn 7
Communication Skill 7
Comprehension 9
Interrogative skill 13
Observational Skill 21
Confidence 24
Organisational Skill 26
Enthusiasm 28
Empathy 29
Handle Rejection 31
Creativity 31
Perseverance 31
Likabihty 32
From this we can learn that the most important abilities for a pharmaceutical 
salesperson are the first five, namely adaptability, ability to learn, communication 
skill, comprehension, and interrogative skill The remaining abilities are also 
important for salespeople but not to the same degree as the five mentioned above
Ingram et al (1992, p 226) put together a battery of personal factors that led to 
failure and 126 sales managers rated the significance of each factor in 
determining salesperson failure in their industry The six most important factors 
included
1 Poor listening skills
2 Failure to concentrate on top priorities
3 A lack of sufficient effort
4 Inability to determine customer needs
5 Lack of planning for sales presentations
6 Inadequate product-service knowledge
Although this study was not specific to the pharmaceutical industry, cognisance 
of these factors may help sales managers to make better selection decisions
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Having prepared a job description and a personnel specification, the next step in 
the selection and recruitment process is to access the available pool of potential 
employees suitable for the position Internal sources may produce a suitable sales 
representative but often external sources are also accessed For most companies, 
the external sources would include newspaper advertising, employee referrals, 
recruitment agencies, educational institutions, and unsolicited applications 
Avlorutis et al (1985, p 9) reported that their Group 2 respondents (proprietary 
pharmaceuticals, watches and clocks, hand tools) found personal contacts, 
advertisements, and in-company transfers to be the three most favoured sources
Selection of the most suitable candidate from the pool generated as a result of the 
recruitment process also requires subjective judgement on the part of the sales 
manager As it is unlikely that an alternative to the personal interview as the 
predominant selection tool for sales representatives will be found, it is important 
to inject as much objectivity as possible into the selection process in order to 
increase the likelihood of successfully matching the candidate to the job Randall 
et al (1990, p85) reported that firms typically use a combination of selection 
tools, namely application blanks, personal interviews, reference checks, physical 
examinations, and psychological tests
Stanton and Buskirk (1983, p 115) propose a planned scientific approach to the 
selection process in order to maximise objectivity This would include the use of 
application blanks for all candidates Gable et al (1992, p 52) proved that data 
from a weighted application form for sales applicants can be utilised pnor to the 
point of hiring to facilitate the selection and retention of productive sales people
After drawing up a short-list of candidates from the application blanks, there then 
comes the interview Since interpersonal skills are so important in sales, the 
importance of personal interviews is indisputable However, research into the 
validity of the interview as a predictor of future effectiveness of the candidate is 
not encouraging Hunter et al (1984, p 96) found that evaluations based on 
interviews have a correlation of 0 14 with candidates subsequent performance,
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compared to ability composite tests at 0 53, job tryout 0 44, biographical 
inventory 0 37, and reference checks 0 26
Churchill et al (1993, p479) report on a 1982 study by Arvey and Campion 
which recommends that several different people interview the candidate and then 
compare their evaluations, thereby increasing the likelihood of choosing the best 
candidate They also documented greater correlation between personal 
interviewers' ratings of candidates and their subsequent job performance when the 
interviewers have a detailed knowledge of the requirements of the job to be filled 
This finding would seem to support the practice of promoting salespeople into 
sales management positions, particularly for their input mto the salesperson 
selection process
Notwithstanding Hunter’s research, there are advantages to holding interviews 
when recruiting a salesperson The personal interview allows the recruiting 
company an opportunity to sell itself to the candidates In addition, the face-to- 
face meeting permits the company to give the prospective employee a more 
realistic picture of the sales job on offer Dubmsky et al (1986, p 201) tested a 
model of salesforce assimilation and found that the impact of realism on job 
satisfaction comes via better role definition which in turn provides better 
resolution of conflicting demands at work The personal interview creates an 
opportunity to provide that role definition
Supplementary selection aids such as reference checks, physical examinations, 
psychological testing and role playing can also inject objectivity mto the selection 
process Jobber (1994, p219) advises that where testing is being used as a 
supplementary selection aid, validation of these tests beforehand is sensible, as is 
the use of a trained psychologist in both administering and interpreting the results 
In addition, Dalrymple et al (1995, p441) recommend that supplementary 
selection aids be used as part of the selection process but not as the sole decision 
criteria
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2.5.2 SALES TRAINING
It is incumbent upon every sales manager to try and improve the performance of 
the salespeople under his control (Donaldson, 1990, p. 199). One way this can be 
achieved is by training.. Robert Stockham, the Sales and Marketing Director of 
Astra, the second largest ethical pharmaceutical company (in revenue terms) in 
the U.K says that compared to competing companies, Astra are very demanding 
on the level of activity they expect from their salesforce. He acknowledges "a 
tremendous investment in training" so that the representatives can achieve the 
expected levels. Similarly, the vice-president of Merck & Co., which has a U.S. 
salesforce of 3000, and received the 1993 Sales and Marketing Management Sales 
Company of the Year award declared "training is the key" (Keenan, 1993, p.62).
Generally, sales training is structured using the four-step process of determining 
needs and setting objectives, designing the training programme, conducting the 
programme and, finally, evaluating results (Honeycutt et al, 1994, p.67). 
Traditionally, the content of initial or induction sales training programmes has 
differed in emphasis from that of on-going or retraining programmes (Avlonitis et 
al, 1985, p. 10).
El Ansery (1993, p.83) studied the training practices of 171 sales forces of paper 
and plastics merchant wholesales-distributor companies in the U.S. One of the 
more significant results to emerge was that top performing sales forces do not 
outspend their lower performing counterparts on training. However, the top 
performing companies allocated their training budgets in a different way to the 
lower performing companies. For example , the top performers provided three to 
nine months of induction training, while the lower performers provided less than 
three months. Lower performance sales managers over-emphasised classroom 
training and role playing for their on-going training programmes. Puri (1993, 
p. 104) showed that industrial sales managers and purchasing managers rate a 
salesperson’s attributes differently and therefore it follows that the content of sales 
training programmes should take cognisance of the attributes and skills preferred 
by customers.
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Finally, induction training programmes offer a company a good opportunity to 
introduce the new recruit to the company's salesforce culture. Jackson et al (1995, 
p.35) describe culture as the "glue" that holds salesforces together, an integrated 
pattern of a salesperson's values and beliefs acquired as a member of the 
salesforce. Merck & Co.'s overriding value is "the patient always comes first". 
Their induction training includes the instillation of these values (Keenan, 1993, 
p.62), in the belief that if the patient is put first, profits will follow.
2.5.3 SALES FORCE MOTIVATION
Although organisational and industrial psychologists view motivation as a very 
broad issue covering choice to initiate action, expend effort, and persist with this 
effort on a certain task, from a sales management point of view both Churchill 
(1993, p.541) and Donaldson (1990, p.251) attach a more specific meaning to it. 
They both declare motivation to be the amount of effort a salesperson desires to 
expend on each activity associated with the sales job.
General theories of motivation abound, some being used more frequently in the 
sales management literature than others. Examples of these would include 
Maslow's Need Theory (1970), Herzberg's Motivation-Hygiene Theory (1968), 
Vroom's Expectancy Theory (1964), and Adams's Inequity Theory (1965). None 
of these theories are universal in the sense that they explain all aspects of 
motivation. Given the complexity of human thought and the environment in 
which people live, Dalrymple (1992, p.519) believes we can logically expect that 
new theories will evolve over time and existing ones be refined.
Effective motivation offers one of the most direct and powerful means for 
increasing organisational performance hence the myriad studies that have been 
carried out in this area. Studies particular to motivation in sales management 
include those carried out by Donnelly and Ivancevich, 1975; Walker, Churchill 
and Ford, 1979; Doyle and Shapiro, 1980; Ingram and Bellenger, 1982; Churchill 
and Pecotich, 1982; Sujan, 1986; Shipley and Jobber, 1991; Chonko et al, 1992;
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Dubinsky et al, 1993, and Jobber and Lee, 1994 Indeed, these represent a minute 
proportion of the research done on this topic
Stanton and Buskirk (1983, p244) believe that once the essential general 
motivational elements are in place, such as effective communication, appropriate 
managerial attitude towards salespeople and a clear understanding of the sales 
job, then and only then, can the sales manager chose the specific elements which 
he/she feels are relevant to the personal selling team The specific rewards that 
can be used as part of a motivational package are many and varied They include 
promotion opportunities, job security, remuneration, incentives, recognition of 
achievement, management development and attractive working conditions
The wealth of literature indicates that sales force motivation has always been and 
still a "hot topic" with sales managers (Dalrymple et al, 1995, p 614) Part of the 
reason that this is so is that there are a number of issues particular to salesforce 
motivation which remain unresolved One such problem is that each sales force is 
made up of a number of individuals, each possibly holding different expectancies, 
instrumentalities and valence for rewards, consequently a generic approach to 
motivation will not accommodate all the salesforce members This therefore leads 
to a compromising of the efficiency of those representatives whose motivational 
needs have not been fully met Thus, desigmng effective team-based motivational 
packages is extremely difficult
A number of studies have been carried out in order to shed light on this issue For 
example, Cron (1984, p44) developed a framework based on a salesperson's 
career stage characteristics which outlines appropnate motivational action for 
managers responsible for these salespeople Empincal research of the Insh 
pharmaceutical sales representatives indicated support for Cron's contention 
(Kelly, 1995, p 132)
Dubinsky et al (1993, p26) were the first to investigate comprehensively 
salesmen and saleswomen's perceptions of motivational components They found 
that female sales personnel perceived a stronger linkage between their efforts and
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their achievements, that is, they had higher expectancy estimates than salesmen 
Otherwise, the findings indicated minimal differences between the two (p 34) 
Kelly's research (1995, p 128) found that twice as many Insh female 
pharmaceutical sales representatives are motivated by career advancement than 
their male colleagues Again, implementation of the findings of these and other 
studies requires a sales manager to tailor-make individual motivational packages, 
which most sales managers have neither the time nor the resources to do
Another major difficulty in effective motivation is the established fact that there 
is a considerable lack of congruity between the perceptions of sales managers and 
their salespeople as to what factors act as motivators and demotivators for 
salespeople (Jobber and Lee, 1994, p 331) Results from the Lambkin and 
deBurca study (1991, p 58) indicated that managers considered acknowledgement 
of effort, achievement of targets and remuneration the top three motivators In 
addition, factors such as satisfaction of customers and being part of a team 
received similar scores to the third-placed remuneration On the other hand Kelly 
(1995, p 128) found that direct financial rewards, recognition of achievement and 
career advancement were the pnme motivating factors for the Insh ethical 
pharmaceutical sales people
Finally, Carr (1994, p 15) maintains that the sales manager himself/herself can set 
a constantly reinforced cycle of demotivation through poor sales meeting 
agendas, interference dunng sales calls and lack of support
In conclusion, there appears to be no magic solution to effective motivation and 
this topic will demand sales managers' time and energies for the foreseeable 
future
2 5 4 S A L E S  F O R C E  C O M PEN SA TIO N
Very closely allied to motivation is the sales manager's responsibility for 
salespeople's remuneration Indeed, Futrell (1994, p273) includes basic
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compensation and special financial incentives as two elements of his seven 
element motivation mix
Three major options for salesforce remuneration are considered by sales managers 
when desigmng remuneration packages straight salary plans, straight commission 
plans, and a combination plan which includes both a fixed salary element and an 
incentive element
Numerous studies have shown combination plans to be the most popular method 
of salesforce remuneration (Lambkin and deBurca, 1993, Avlomtis et al 1985, 
Shipley and Jobber 1991 and Dubinsky et al 1982) Sales managers have to 
determine what should be the respective portions of the salary and incentive 
features in the combination plan Stanton et al (1983, p 289) say the answer 
depends on the nature of the selling tasks and the company's marketing goals 
Churchill et al (1993, p 588) advise that when a company’s primary objectives are 
related to long term sales and relationship building, a higher salary and a lower 
level of incentive pay tied to appropriate performance targets would be more 
effective Pay levels for Insh pharmaceutical salespeople are widely known, the 
average senior medical representative earns around £27,500 with an extra £5000- 
plus in bonuses and commission (Sales Placement, 1995) Kelly (1995, p 114) 
reported that only 6 1 per cent of Insh medical sales representatives received 
straight salary payments, the remaimng 93 9 per cent being paid through varying 
forms of combmation packages
Research earned out by Chonko et al (1992, p 71) provides empincal support for 
the contention that no one reward package will serve all salespeople well So the 
hard-pressed sales manager is yet again faced with the difficulty of designing a 
compensation package that will best meet most of the needs of most sales 
representatives while failing to cater for them all
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2 6 EVALUATION AND CONTROL OF SALEFORCE PERFORMANCE
The third and final set of decisions in Churchill’s framework relates to the policies 
and procedures involved m evaluating and controlling a company's sales 
programme The need to assess sales force effectiveness is an ongoing 
requirement of effective pharmaceutical marketing (Douglass, 1992, p52) 
Dubinsky, Skinner and Whittle (1989, p 10) say there is little doubt that effective 
evaluation plays a particularly vital role in sales success The practice of all sales 
management control is to recognise key results areas, and then to manage by 
analysing performance against standards of performance (Stewart, 1993, p 69)
Such a sales analysis requires accurate, timely and relevant data In an industry 
such as ethical pharmaceuticals, syndicated market research is available to all 
who are prepared to pay for it It is generally based on a combination of 
prescription and doctor data The major outside reporting systems that are 
available on the Insh pharmaceutical market include Sub-Temtory Analysis, 
General Medical Services Reports, Insh Temtory Sales Analysis (I T S A ) 
Reports and International Medical Surveys ( I M S )  Data Internal data can be 
generated through the sales management information system (Donaldson, p 115), 
which harnesses the information from both company records and sales reports 
Additionally, internal data can be gathered in a qualitative way by the sales 
manager through sales force accompaniment and customer contacts
The base reference point for a salesperson's evaluation is "a good detailed job 
descnption” (Stanton and Buskirk, 1983, p 559) This indeed is supported by the 
results of Churchill et al's meta-analysis which found the determinants of 
salesperson performance to be job-specific (1985, p 115) Most texts break 
evaluation tools mto two major categones quantitative and qualitative (Stanton 
and Buskirk, 1983, Lancaster and Jobber, 1994, Dalrymple and Cron, 1995) 
Other areas for measurement include costs and profit
Typical quantitative measures would include average number of calls per day, 
average sales per customer, average cost per call and so forth However many 
aspects of a missionary sales person's selling task are essentially qualitative in
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nature and cannot be measured in such a mechanical way Issues such as the 
quality and durability of relationships with doctors, manner, provision of product 
and company information, and ability to handle differing situations as they arise 
cannot be evaluated without direct observation Dubmsky and Barry (1982, 
p 138) reported that these qualitative dimensions were handled less well by the 
sales managers Shipley and Jobber (1993, p 167) noted informal measurement of 
these qualitative criteria is far more common than formal measurement Lynch 
(1991, p 3) proposes a Code of Conduct Approach based on a range of relevant 
cntical incidents which are sorted mto groups of performance dimensions as a 
possible approach to improving qualitative evaluation attempts
Evidence exists to support the motivational benefits to sales people from 
participating m the setting of their own targets The sales force must be involved 
in the goal- setting process and must consider their goals to be their own (Amott, 
1994, p 116) In a 1976 study of American pharmaceutical salespeople, Futrell, 
Swan and Todd found an association between salesmen's perceived control over 
their work situation and job performance They explain that the most likely reason 
for this association is that the increase in perceived power and the increase in 
participative decision-making create within the pharmaceutical salesperson an 
increased commitment to attain given job goals
Performance appraisals can contribute to this participative process, but problems 
can and do occur with them The main barrier to effective performance reviews is 
avoidance by the supervisor and defensiveness from the subordinate (Beer, 1992, 
p 13) Strategies offered by Beer to overcome these difficulties include 
uncoupling evaluation and development, choosing appropriate performance data 
and the use of mixed model interviews (p 6)
Evaluation without feedback and corrective action is a sign of weak management 
However, Simintiras and Cadogan (1994), m an award-winning paper on the 
adoption of a behaviourist perspective in the study of sales manager-salesperson 
interaction (SMSI) advise that, on its own, feedback on sales performance may 
not provide salespeople with the correct discriminative stimuli and reinforcing
Page 58
consequences to shape and create new behaviours They believe increases in 
market information and guidance concerning tactical responses are also needed 
with the feedback (p 850)
In the only work done in the Insh market in this area, Lambkin and deBurca
(1991) found the following performance data were important in evaluation and 
control
Page 59
Table 2 3 : Top 500 Irish Companies’ Evaluation Mechanisms
R an k order Mean score
Sales Volume 1 2 9
Customer relations 2 3 5
Account profitability 3 3 8
Professional approach 4 3 9
Product/technical knowledge 5 53
Territory management 6 5 6
New customers 7 6 1
Number of sales calls 8 6 8
Order to call ratio 9 7 0
As these results are not representative of the pharmaceutical market solely, the 
only relevant observation here is that there is now empirical evidence that, on a 
total industry basis, Irish sales managers do indeed use a combination of 
qualitative, quantitative and profitability evaluation tools
2 7 FUTURE ROLE OF THE SALES MANAGER
So what does the future hold for today's sales managers9 What changes should 
they be making in order to keep their jobs m the twenty-first century9 Tom Peters 
(1993, p 40) maintains "the essence of selling is really spending time with your 
customers" This maxim must have implications for sales managers William 
Keenan (1994, p 72) takes up Peter's theme and advises current sales managers 
"to build up their book of business", that is, to stay close to the customers as the 
closer the sales manager’s relationship with them, the more valuable he/she is to 
their present company and any future employer
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Professor Don Schultz of Northwestern University, Chicago believes integrated 
marketing is the way of the future and in an interview with Nancy Amott (1994, 
p 82) outlined his vision of the future role of the sales manager The sales 
manager's job will not be sales management, but customer management and this 
will start and end with a database Consequently, he explained that current sales 
managers would need to go back and get further education, particularly in the 
areas of databases, basic research, market information and logistics
Keenan (1994, p 68) sees emerging trends that will inevitably impinge on the role 
of the sales manager These include new communication technology, sales force 
automation, empowerment of sales people, team selling, re-engineering, 
relationship marketing and tele-marketing
Tony Seideman (1994, p60) proposes a less than optimistic scenario for sales 
managers in the future due to sales force automation, the issuing of sales people 
with hardware and software which enables them to have a remote office He 
describes the experience of the insulation division in the U S company Owens 
Coming, who automated their 67 sales representatives, thereby empowering their 
sales team and fundamentally changing the role of the sales managers, essentially 
reducing it to that of a trainer and guider
So what is the future for the ethical pharmaceutical sales manager9 As outlined in 
the Pharmaceutical Marketing chapter there are certainly stormy waters ahead for 
this industry Initiatives to control costs by health funders, increasing pressure on 
health systems caused by the rising number of elderly, and the influence of self- 
medication/OTC preparations will continue to change the nature of the 
marketplace in which the sales managers will be operating Corporate activities 
such as mergers, collaborations, joint ventures and down-sizing appear to be 
increasing in prevalence in the Insh market Research of sales management 
practice in the Insh ethical pharmaceutical market would be incomplete if an 
attempt was not made to assess these managers' opimons of what the future holds 
for them and their industry
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"Can we all sing o ff the same hymn sheet, p lea se? ”
Sales director, Insh fast moving consumer goods company
CHAPTER 3 THE INTEGRATION OF SALES AND MARKETING
3 0 INTRODUCTION
Previous experience as a manager in the Irish medical industry had brought this 
author into contact with managers in the ethical pharmaceutical market It had 
appeared to her that a considerable number of these managers had the designation 
"Sales and Marketing Manager" Subsequent examination of the academic 
literature failed to reveal one single reference to the role and/or functions of this 
"hybrid" manager There therefore follows a brief examination of the literature 
relating to the place of personal selling within the marketing concept, coupled 
with a look at marketing organisations Then the author assesses the literature as 
it exists on the convergence or integration of these two key business areas, prior 
to proposing a possible dual-mandated position This chapter draws heavily on a 
working paper the author had accepted, and subsequently presented, at the 1995 
Marketing Educators Conference in University of Bradford (see Appendix 1)
3 1 SELLING AND THE MARKETING CONCEPT
The role of selling as part of the marketing mix is, by consensus, well understood 
(Donaldson, 1990, p 4)
Marketing and the sales force operate with a duality of purpose, trying to satisfy 
the interests of the customer while at the same time satisfying the objectives of 
the firm Thus, according to Holmes (1991, p 5), selling is an integral part of 
marketing However, separating the functions of selling and marketing 
organisationally must intuitively leave each of them remote, detached and 
standing alone In 1994, Gronroos criticised the marketing department approach 
to organising the marketing function, maintaining that it had "isolated marketing 
departments from other business functions and vice versa" (p 351)
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The marketing concept still attracts a great deal of support but, in its genesis, 
sales and selling were subsumed within marketing with Carson (1968, p35)  
claiming "the chief marketing executive (regardless of his title) has authority over 
selling, advertising and marketing research” Almost thirty years later Donaldson 
noted "there has been a cunous neglect of selling in both theoretical and empirical 
research and as part of the curriculum m marketing education" (1990, p 4) The 
mental picture of selling as a sub-set of one element of the marketing mix, namely 
promotion, should not demean the selling function The fact is that for most 
companies operating in competitive marketplaces, the single largest expense on 
their profit and loss statement will be the cost of the personal selling function 
Autumn 1995 figures released by Sales Placement, a Dublin-based specialist sales 
and marketing recruitment agency, estimate the cost of an average Irish sales 
representative to be £44,723 per annum
Realisation of the growing importance of the salesforce is underlined by Power
(1992) who, when writing the cover story for Business Week, said "many 
companies see selling and service as the latest and best arena for capturing 
customers" and quoted a study which showed that boosting a company's 
customer-retention rate by 2 per cent had the same effect on profits as cutting 
costs by 10 per cent (p 39) As an illustrative example of companies who were 
leading the way in “smart selling” he included the U S multinational ethical 
pharmaceutical giant, Merck, who train their sales representatives over twelve 
months in both pharmaceuticals and trust-building sales techniques (p 40)
3 2  MARKETING ORGANISATION
Marketing authors commonly identify four broad types of organisational forms 
for marketing departments functional, product, market, and matrix organisations 
(Kotler, 1980, p 583, Jobber, 1995, p 623) Ruekert et al (1985, p 13) criticised 
marketing textbooks for "describing a large range of alternative (organisational) 
structures without much analysis of their relative advantages under different 
environmental or strategic circumstances" Although hierarchical organisation
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charts may be necessary as a background control function, m fact today the 
operational side of business is increasingly being organised into strategic business 
units and inter-functional project teams These developments ensure greater co­
operation between sales and marketing In 1985 King (p 18) believed more 
emphasis was needed on the forms of organisation, stating that only features such 
as group work, project management and venture management would break down 
"rigid departmental barriers" If, in 1985, it "becomes increasingly clear that real 
marketing cannot be thought of as a departmental activity" (King, p 15), why does 
the literature not now include references to, or evidence of, more fluid or hybrid 
management roles, particularly that of the dual-role sales and marketing manager?
According to Kotler (1994, p 718) marketing has evolved from a simple sales 
function to a complex group of activities He believes the evolution of the 
marketing department can be traced through five stages
1 Simple sales department
2 Sales department with ancillary functions
3 Separate marketing department
4 Modem marketing department
5 Modem marketing company
Piercy (1986), however, conducted research on medium-sized British 
manufacturing firms and discovered that only 45 per cent of the respondents had a 
marketing department (p269) He also investigated the status of the chief 
marketing executive (CME) m these companies vis-a-vis the heads of sales, 
production and finance (p 282) The results are as indicated m Table 3 1
Table 3*1 CME status vs the chief sales executive
%
The CME has lower status 15
Equal status 49
The CME has higher status 36
( N =  112)
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Piercy observed that " it appears that where sales and marketing are organised 
together the most common position is that the CME has higher status, while in 
one-third of the cases the CME and head of sales are equal” (p 282) He continues 
"where sales and marketing are organised separately, in 60 per cent of cases the 
two executives are seen as equal in status, and m other cases are divided equally 
between the CME having lower or higher status than the head of sales" (p 283)
In an American study (Tull et al, 1991) it was found that the vast majority of 
firms do integrate most marketing activities, with only 2 0  per cent having a 
separate, independent sales department and three quarters incorporating sales 
within their marketing organisation (p 119) The separation of sales from 
marketing was more likely to be found in larger firms (turnover more than $ 1 0 0  
million) and the authors stated the primary reason for this difference was span of 
control Their respondents claimed "as firms get very large it is more difficult for 
a single marketing executive to oversee the full range of marketing activities" 
(P 121)
3 3 SALES AND MARKETING RIVALRY
For marketing to be effective, recognition of the role of selling at the sharp end, in 
front of customers, is required along with more customer-focused approaches to 
the selling process However, where sales is apparently working m isolation from 
marketing, co-ordination and synergy are unlikely, and communication 
breakdowns and inter-functional rivalries and resentments are more likely to 
develop Probable reasons for the existence of these rivalries can be found in the 
marketing literature
Kotler (1977, p 39) maintained that the difference between sales and marketing 
was subtle and "usually hard for sales executives to see", but it spelt the 
"difference between unstable short-term success and stable long-term growth"
While this "short-term perspective” is often used to illustrate the difference 
between selling and marketing, Donaldson (1990, p4) pointed out that " most
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salespeople operate where repeat business is the norm and continuing 
relationships are important”
In his expansion on each of the stages in the marketing department's evolution, 
Kotler (1994) declared that in stage three (separate marketing department), both 
the marketing director and the sales director report to the president/managing 
director At this stage sales and marketing are seen as separate and equal 
functions and are "expected to work closely together”(p 718) However, the 
relation between these two managers is often characterised by rivalry and distrust 
Kotler suggests that when a company, in order to resolve this disharmony, places 
the marketing director in charge of everything, including the sales force, then the 
company moves into stage four of the evolution, and creates a "modem marketing 
department" (p 719) It is the author’s expenence that while these departments 
may resolve the rivalry in some cases, leading to synergy, in many others the 
rivalry continues
The rivalry partly stems from academics' approach to descnbing the evolution of 
marketing, where the "sales era" is generally depicted in derogatory terminology 
such as "hard-sell" and "aggressive" (Stanton et al, 1991, p7) The subsequent 
"marketing era" was presented as a panacea for the ills and wrong-doings of the 
sales era Indeed, when the importance of marketing was growing in the 1960's 
and 70’s, influential commentators added to this perception with their derogatory 
pronouncements on selling and sales management Whyte (1985) proposed a 
number of reasons for this under-evaluation of selling by marketing and business 
people He supported these reasons with documented quotations from Levitt 
(1960, 1962, 1969) and Drucker (1973) and many others, all of which appeared to 
do little for the professionalism or image of selling Kotler and Levy’s (1969, 
p 1 0) relegation of selling with their opening declaration that "marketing is a 
pervasive societal activity that goes considerably beyond the selling of 
toothpaste, soap and steel" is a milder example of these misleading attitudes
Another possible reason for the gulf or rivalry that can exist between sales and 
marketing was identified by Brooksbank (1995, p 61) Again this criticism relates
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to academics but is somewhat different to the one just discussed He argued that 
the explosion in selling literature had been mainly in the "how to do it" category 
and was almost exclusively written from a sales-onented rather than a marketing- 
oriented perspective, and this had done little to "professionalise" the sales 
function
Vieira (1992, p 63) says that rivalry and conflict between sales and marketing is 
most apparent when both the marketing manager and the sales manager report to 
a president or business unit manager who has little or no marketing or sales 
expenence, leaving little chance of knowledgeable tie-breaking He suggests a 
number of actions that management can be taken to reduce this conflict (p 64)
1 Get marketing strategists into the field
2 Rotate assignments
3 Communicate with your salesforce
4 Listen to your salesforce
5 Have an experienced sales and marketing professional at the top
6  Reward teamwork between the two
This gulf between the sales and marketing functions is also apparent in the 
practice of marketing in Ireland, and has been noted by the only professional 
marketing body in the country In an attempt to start a dialogue on this conflict, 
the Marketing Institute ran an evening seminar in November 1995 entitled 
"Typical Bloody Marketing" A sales director of twenty-five years experience 
with a major Insh fast moving consumer goods company called for the 
integration of marketing and selling with the plea "could we have everyone 
singing off the same hymn sheet?" The marketing director of another major fast 
moving consumer company was equally passionate about the need for integration, 
and outlined that company’s attempt at integration through internal re­
organisation and the subsequent development of trade marketing
Page 74
Significantly, in Ireland, the formation of a professional body to represent sales 
people did not occur until November 1995 whereas the Marketing Institute of 
Ireland was founded in 1961
Finally, rivalry between sales and marketing is worrying from a corporate view, 
as it can lessen the effectiveness of a company's strategies In a replication of a 
study earned out in 1988 which looked at the relative importance of the functions 
that make up the marketing mix (Day et al, 1989), the most significant finding 
reported was that marketing strategy now centres around a few critical activities 
namely personal selling, service and research The authors state ” the implications 
are clear, sales managers and the sales force are crucial to success for any 
manufacturer” (p 39)
Thus it is clear that m the increasingly competitive markets of the 1990’s, the role 
of the salesforce m forming and maintaining relationships with customers is more 
important than ever and as a consequence the need for greater integration between 
sales and marketing is growing
3 4 REFERENCES TO SALES MANAGERS AND THEIR MARKETING 
ROLE
Still et al (1981, p 6 ) stated that "the modem sales manager is both an 
administrator in charge of personal selling activities and a member of the 
executive group that makes marketing decisions of all types”
Rosenbloom and Anderson (1984) were among the first academics to recognise 
the need for integration between the top level executives of the marketing and 
sales teams They stated that "the sales organisation needs to be fully integrated 
with the marketing activities of the company, including new product 
development, pncing, marketing research, promotion, and distribution strategies" 
(p 52) Indeed, they proposed that the "modem sales manager commands the field 
marketing team and must master not only the basic sales management functions 
but also diverse marketing and management skills" (p 56)
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Kasharn (1987) took up this clarion cry and, in calling for smoother transition of 
marketing strategy to sales strategy, identified a chain of management decisions 
that aid this process See Figure 3 1
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Figure 3 1 The Cham of Management Decisions
Marketing Management____________ Sales Management ^
From an implementation point of view, it is obvious that sales and marketing 
executives must work together in order to achieve successful implementation of a 
strategy Kashani believes that the critical issue for integration is not so much 
based on organisational structures but more importantly "on the quality and 
quantity of communication between the two executives/functions" (p 14) He 
proposes information systems that encourage a regular flow of relevant 
information between the two areas
Strahle and Spiro (1986) further extended the knowledge for translating a firm’s 
marketing strategy into effective sales management behaviour with their work on 
the linkages between "the four basic market share strategies, build, hold, harvest, 
and divest, and the corresponding functional level sales strategy" (p 11)
While their recommendations for this process were not empirically tested, this 
should not weaken their importance in terms of contributing to a sparse body of 
literature
More recently Andersen, Hair and Bush (1992, p 25) stated that sales managers 
are "in a broad sense really marketing managers with the specific task of 
managing the salesforce"
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In summary, few academics or practitioners appear to have paid much attention to 
the convergence of the sales manager’s and marketing manager’s roles, and the 
consequences of this for the organisation of marketing and sales departments
3 5 THE FUTURE7
The author believes that this unhappy situation between marketing and selling 
may change Hunt (1992, p 310) described marketing as a university discipline 
that aspires to be a professional discipline with consequent responsibilities to 
society, students, marketing practice, and the marketing academy Mitchell (1994, 
p 15) stated that the merging of marketing and sales departments, and the 
upgrading of sales is now becoming a common theme However, while able to 
describe what marketing is, Hunt is unable to describe what marketing will 
become Maybe if we look at the existing practice of marketing and its 
developments in certain industries, a prophesy for its future may be possible
Some indication of the future can be obtained from the fast moving consumer 
goods sector, which appears to be most advanced in the merging of sales and 
marketing departments Mitchell (1994, p 15) states that separate marketing 
departments have disappeared altogether in Elida Gibbs, the toiletries company 
At Colgate-Palmolive, another toiletries and healthcare company, staff are shifted 
between the sales and marketing departments to broaden their perspective These 
changes are being driven by the company’s attempt to please two masters, the end 
consumer and the retail customer This shift of focus has led to the creation of a 
new approach to doing business in this marketplace, known as categoiy 
management
Nielsen (1992, p 9) defines category management as "a process that involves 
managing product categories as business units and customising them on a store- 
by-store basis to satisfy customer needs" Moving to this approach requires a 
partnership between the retailer and supplier, and both must fundamentally 
"redesign their organisations, integrating functions and responsibilities" (Neilsen, 
plO)
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Whereas the sales operation was responsible primarily for implementation and 
execution in the past, they will "now work with marketing through all stages of 
category management They will also interact with other departments such as 
MIS, research and finance, which will integrate and leverage internal data and 
syndicated data to support sales and marketing activities" (p 163) This approach, 
m turn, will have implications for sales managers who will now need strong 
analytical, logistical and communication skills For all these reasons the incipient 
trend to merge sales and marketing departments is likely to continue
Although these developments are taking place in the fast-moving consumer goods 
market, they have knock-on implications for ethical pharmaceutical sales 
managers Many of these are already working with companies selling to the 
grocery trade due to the presence of over-the -counter (OTC) drugs in their 
company’s product portfolio Indeed, pharmaceutical companies are actively 
searching for additional OTC products to strengthen their product base as product 
innovation in the ethical pharmaceutical market becomes increasingly more 
difficult and expensive Thus OTC products are likely to become an even more 
important part of their business
3 6 CREATING THE DUAL ROLE SALES AND MARKETING MANAGER
Given the need for greater integration of sales and marketing outlined above it 
would seem logical to make a single manager responsible for both activities 
Intuitively, such a manager will be in a unique position to drive an effective 
transition between marketing strategy and sales, as outlined by Kasham in Figure 
3 1
Looking at the tasks and responsibilities of both managers is a starting point for 
examining the possibility/compatibility of combining the two roles
Kotler (1972, p49) clearly lays out the tasks of marketing management under 
four headings
1 Analytical market analysis, product analysis
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2 Planning product development, pricing, distribution, and promotion
3 Organising design, staffing, and motivation
4  Control marketing results measurement, marketing cost measurement
Still, Cundiff and Govom (1981, p 18) broadly identify the sales management 
tasks as follows
1 Operating recruitment, selection, training, compensation, supervision and 
motivation
2 Co-ordmation of personal selling across all company functions
3 Planning forecasting, budgeting, temtones, routing, and quotas
4 Control evaluation and analysis
Essentially, the role and functions of the sales manager are similar in structure to 
those of the marketing manager, both have a responsibility to achieve corporate 
goals, but the historical difference between the two is m focus and time-frame 
(Donaldson, 1990) With a clear understanding of each function, it does seem 
possible for one individual to combine both these roles This dual-mandated 
position would intuitively have certain advantages and disadvantages
Possible advantages of the dual-mandated position
1 Smoother transition of marketing strategy to sales policies
2 A reduction in, or even elimination of, the antipathy and conflict that can 
exist between the two departments
3 Improved communications (in both quality and quantity) between the two 
departments
4 A reduction in executive cost to the company, from the amalgamation of two 
management positions into one
Possible disadvantages of the dual-mandated position
1 One or both teams, that is, sales and marketing, feeling "their*’ manager is 
unable or unwilling to devote sufficient time to "their" management, thereby 
causing morale problems for these subordinates
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2 Role conflict and ambiguity for the dual-mandated manager
3 Work overload for the dual-mandated manager
The design of this research is such as to enable the author to explore the existence 
of this dual-mandated position that personal experience has led her to believe is 
prevalent in the Irish ethical pharmaceutical industry In addition, an examination 
of the activities of such a manager may help anchor some of the advantages and 
disadvantages outlined above
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CHAPTER 4  INDUSTRY REVIEW
41 INTRODUCTION
In the 1960's Ireland had a negligible pharmaceutical industry but a strategic 
decision taken by the then Industrial Development Authority to remedy that 
situation has resulted today in a thriving pharmaceutical sector worth £ 2  billion 
Principal incentives (McCauley, 1991,p46) used to attract these companies to 
Ireland included
*
1 Corporation tax at 10% until 2010, which can be even lower in the early 
years of a new project through depreciation and other allowable tax charges
2 Cash grants paid towards capital investment costs and staff training
3 Availability of sites which are particularly suited to pharmaceutical projects 
Coastal sites such as Ringaskiddy, Co Cork are specially designated for 
processing operations such as chemical synthesis and fermentation
4 Availability of English-speaking manpower
5 Large pool o f suitably-qualified graduates in the required areas such as 
science, chemistry/chemical engineering, business and laboratory 
technicians
These incentives have been an excellent stimulus to the pharmaceutical industry's 
growth In addition, Ireland is a highly profitable location Figures produced 
annually by the US Department of Commerce show that the return on investment 
in Ireland has consistently exceeded that of other international locations The 
average rate of return for US overseas investment for selected countries over the 
period 1982-1992 is shown in Table 4 1
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Table 4,1 Average Rate of Return for US Overseas Investm ent
Country Average rate of return
Ireland 25 7%
Portugal 10 3%
Italy 8 0 %
Belgium 6  0 %
Netherlands 7 7%
W Germany 5 9%
UK 5 2%
Spain 6  8 %
France 4 0%
EC 6  5%
World 6  1%
Source US Department o f  Commerce December 1992
Another advantage of attracting the pharmaceutical industry is that over the years 
these companies have built up a huge level of expertise and human resources 
which would be difficult to duplicate elsewhere The investment in both plant and 
personnel has been so large as to make it impractical to start up an operation 
elsewhere By way of proof of this fact, to date there has never been a closure of 
an overseas owned pharmaceutical company in Ireland
John Lloyd, (1993, p 34) manager of the IDA’s pharmaceuticals and healthcare 
division stated "the healthcare/pharmaceutical industry is largely a low bulk/high 
profit margin industry and is not as transport sensitive as other industnes like 
consumer electronics might be" Thus our peripheral location on the edge of 
Europe does not pose a major problem for this industry
A 1995 Economic Impact Survey commissioned by the Irish Pharmaceutical and 
Chemical Manufacturers’ Association (IPCMA) and earned out by Cork Regional 
Technical College concludes there is still an opportunity to attract new companies 
to Ireland (Nolan p 17), particularly international pharmaceutical and chemical 
plants not producing within the EU at the moment
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4 2 INDUSTRY STRUCTURE
In total there are seventy-nine pharmaceutical companies located in the Republic 
of Ireland These can be divided into three broad groupings
1 Indigenous manufacturing firms
2 Multinational manufacturing firms
3 Multinational subsidiaries located here, for import, marketing and 
distribution in the local market
Sixteen of the world’s largest pharmaceutical companies have plants in Ireland, 
Twelve of these are from the top 15 pharmaceutical companies in the world 
Approximately sixty companies are engaged in the manufacture of 
pharmaceuticals m bulk or finished dosage form The remainder fall into the third 
category outlined above
4 3 DISTRIBUTION/SUPPLIERS 
4.3.1 Wholesalers
The pharmaceutical wholesale sector has six major players, and is dominated by 
two Cahill May Roberts (CMR) and Umted Drug They claim market shares of 
36 per cent and 24 per cent respectively The remainder of the wholesale market 
is taken by Allied Pharmaceutical Distributors (APD), Boileau and Boyd, Dublin 
Drug and United Pharmacist's Co-operative
The wholesaling business is becoming increasingly competitive, Higgins (1993, 
p 18) estimated gross margins in this area are only 15 per cent, and nett margins 
as low as three to four per cent
Pharmaceutical wholesaling is a very specialised form of wholesaling As prices 
for drugs are set by the Government, the main players can only compete on 
service Information technology is vitally important in helping to increase speed 
and fast turnaround of orders, most of which are received via individual retail
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pharmacies direct computer link to the wholesaler Distribution costs form a 
major part of the cost structure as most urban retail pharmacies would expect 
deliveries of orders on a twice daily basis Adding to the cost base is the range of 
drugs which must be held by the wholesaler, which can number up to 1 0 , 0 0 0  
different lines at any one time
In addition to then- core business, many of the wholesalers act as sales agents for 
those international drug companies who have not set up their own Irish office 
Seventeen, or 2 2  per cent of the companies in this research had linked up with 
wholesalers from whose premises they operated their sales, marketing and 
distribution
4 3 2 R etail Pharm acies
The principal supplier of ethical pharmaceuticals to the public is the retail 
pharmacy There are approximately 1200 retail pharmacists in the Republic of 
Ireland and currently a number of U K chains are examining the feasibility of 
extending their operations mto this country
The retail pharmacies purchase their supplies mainly from wholesalers at trade 
prices, but many of the larger operators would buy their ethical pharmaceuticals 
directly from the manufacturer or importer, thereby attaining discounts based on 
volume
Typical margins on ethical pharmaceuticals are in the region of 33 3 per cent for 
the pharmacists, though margins of 50 per cent are not unheard of When filling a 
General Medical Services (GMS) prescription, pharmacists receive agreed trade 
prices plus a dispensing fee
It is estimated that 80 per cent of total prescnption medicine sales go through the 
wholesaler or directly to the retail pharmacy sector The remainder would include 
direct sales to hospitals, dispensing doctors, clinics and government/industry
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Ireland is the world's 13th largest exporter of pharmaceuticals and chemicals 
Exports from the pharmaceutical/chemical sector have grown from IR£79 million 
m 1973 to IR£3 2 billion m 1992, representing one-fifth of the country's total 
manufacturing exports IR£1 5 billion represents the pharmaceutical contribution 
to this total Sixty-five per cent of this output goes to the EC Single Market 
Approximately 20 per cent is exported to the United States, with the remainder 
going to the domestic market or to the rest of the world
Pharmaceutical imports account for about 90 per cent o f the country's 
requirements 50 per cent (by value) of our pharmaceutical imports are in the 
form of bulk intermediates which are subsequently re-exported as finished 
product
The industry contributes a very strong positive balance of trade to the Irish 
economy Imports of organic chemicals (raw matenals for the industry) and 
finished pharmaceuticals amounted to £700 million in 1993, thereby giving a 
positive balance of trade of £2100 million Corporation tax receipts to the 
Exchequer exceed IR£100 million White (1995, p 3) estimated the industry 
spends over £1  billion annually in Ireland, which together with corporation tax 
receipts, use of legal, accounting and banking services, transport and 
accommodation helps to bolster the Irish economy
4 5 EMPLOYMENT
In 1994 the Irish pharmaceutical industry employed approximately 8500 people 
A Federation of Irish Chemical Industries (FICI) 1992 report stated the 
employment growth rate for the industry during the years 1982 to 1990 was 70 2  
per cent, compared to the total EU employment growth of 12 3 per cent for the 
same period
4 4 TRADE
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Nolan, in his Economic Impact Survey (1995, p 17) stated "the nature and essence 
of the industry involves well paid full-time, non-seasonal, and stable employment 
and is consequently of strategic and vital importance to the economic and social 
structure of the country" This sector has a high graduate content It employs three 
times as many graduates and ten times as many post-graduates scientists than all 
other manufacturing industries combined Salaries are high, and well above the 
national average Average pay per employee is £18500 per annum
Harvey (1993,p4) adds that in addition to the manufacturing pharmaceutical 
companies there is substantial employment in companies manufacturing allied 
products such as enzymes, food chemicals, diagnostics and speciality chemicals 
Additional expansion of employment opportunities exist through the development 
of downstream activities such as further processing and/or packaging of existing 
product lines pnor to export
4 6 ECONOMIC ENVIRONMENT
The Irish healthcare system compares well with other developed countries The 
most recent major policy document on health strategy is the Department of 
Health's " Shaping a healthier future" issued in 1994 It stated that the 
international experience is, in general, that countries as they become wealthier are 
prepared to devote more of their collective resources to supporting social 
expenditures such as healthcare The Irish government are, however, already 
committing as high a proportion of its national wealth to healthcare as some 
countries that are significantly wealthier The report (p 8) feels this supporting of 
health services may well derive from the long tradition of caring which has been 
intrinsic to the national character down through the years
Spending on health increased during the 1960’s and 1970’s, with rapid growth 
occurring in the early part of the seventies By 1980 total expenditure on health 
had increased by 125 per cent in real terms on the 1970 level During the 1980’s 
both total and public health expenditure were affected by the budgetary crisis
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However, with the significant improvement m the public finances in recent years 
this trend has been reversed, as illustrated in Table 4 2
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Table 4.2.
P U B L IC  N O N -C A P ITA L H E A L T H  E X P E N D IT U R E  1984-1994
As a percentage of GN P
1984 7 4%
1985 7 4%
1986 7 2%
1987 6  7%
1988 6  4%
1989 6  2 %
1990 6  4%
1991 6  7%
1992 7 2%
1993 7 3%
1994 7 5%
Source Department o f  Health 1995
Total health spending fell from 9 2 per cent m 1980 to 7 0 per cent in 1990, while 
public expenditure on health was reduced from 7 5 per cent to 5 2 per cent over 
the same period (Durkan et al, 1994, p 2)
The overall cost of medicines relating to the General Medical Services scheme 
(GMS) has been increasing over the past five years
Tab le  4 .3 : Cost of medicines to the G  M .S
1990 £113,859,000
1991 £120,350,000
1992 £136,070,000
1993 £139,602,000
1994 £147,458,000
Source General Medical Services Report 1994
According to McCreevy (1993,p 1) public and voluntary hospitals in Ireland 
spend in excess of IR£200 million each year on pharmaceuticals and medical 
supplies
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A report in The Irish Times of 25th July 1995 (p 3) quoted a European study 
which shows Ireland has the second dearest drug basket (an expression of 
quantity for comparative reasons) in the EU Methods open to the Government to 
control health expenditure include drug budgets, capping, fund-holding, and 
activity-based costing, though Durkan and Hughes (1994, p 6 ) pointed out that 
none of these methods are without problems
However, the overall picture of health costs should be put in perspective 54 per 
cent of the cost of the Irish health services is attributable to the hospital sector 
Barrett (1995, p 11) stated that the OECD has estimated a pharmaceutical price 
index for its member countries and that today Ireland, Germany, Belgium and 
Finland have their pharmaceutical price inflation broadly in line with general 
price inflation He described this restraint m drug costs as remarkable given that 
Insh hospital bed cost had risen with an 85 3 fold increase m a period where 
general prices rose 10 fold Consequently the managers in the ethical 
pharmaceutical sector feel aggrieved at continued Government efforts to curtail 
drug costs whilst the hospital bed cost situation persists and worsens
4 7 COMPETITIVE ENVIRONMENT
The current competitive environment that faces the industry is much tougher than 
in the halcyon days of the late 1960’s and 1970’s The industry is characterised by 
increasingly tighter cost controls, mergers and acquisitions, and a global shake­
out within the industry The focus of late is towards alliances between over-the- 
counter and ethical drug manufacturers, and also between genenc manufacturers 
and proprietary manufacturers
In the very recent past there have been a number of takeovers within the industry 
with Hoffman La Roche taking over Syntex, SmithKhne Beecham taking over 
Sterling Winthrop and Pharmacia taking over Imed
These taken-over companies had plants in Ireland, and both have subsequently 
announced expansions of their workforce at these plants (Byrne, 1995)
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The most recent high-profile take over was that of Glaxo's hostile bid and 
subsequent acquisition of Wellcome Glaxo argued in the Financial Times of 
February 23rd 1995 (p 11) that " the bringing together of the two companies 
would guarantee that we have a world leader of the pharmaceutical industry" 
This view was not supported by Wellcome's chief executive, Mr John Robb, who 
feared large-scale redundancies Indeed, since the take-over it has been announced 
that one of Glaxo’s objectives is a 30% reduction in the combined research payroll 
of 11500 people The outcome of the take-over in the Irish sales and marketing 
operations of both companies was as feared Subsequently, there were 
redundancies at both sales representative and management levels
Other Irish examples o f alliances would include Roche's Consumer Health 
division giving the consumer goods company, Maguire and Patterson, the brief to 
handle the sales and distribution of its products to the grocery trade, whilst 
retaimng the marketing function for itself
4.7 1 M arket Size
The total market for prescription drugs in Ireland is estimated to be worth about 
£160m at ex-factory prices, with over-the-counter drugs worth another £15m ex­
factory (Higgins, 1993,p 19)
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Table 4.4 The Fifteen Leading Products* in Ireland in 1993
PRODUCT COMPANY
1. Zantac Glaxo
2. Losec Astra
3. Becotide Allen & Hanburys
4. Ventolin Allen & Hanburys
5. Capoten Bristol-Myers Squibb
6 . Augmentin Beecham Research
7. Voltarol Geigy
8 . Adalat Bayer
9. Pulmicort Astra
10. Solpadeine Sterling Health
11. Tagamet SmithKline
12. Clonamox Clonmel Chemicals
13. Prozac Dista
14. Ponstan Parke-Davis
15. Zovirax Wellcome
* Sales through retail pharmacies; ranked in descending order. 
Source: IMS MIDAS database, WDDM.
4.8 REGULATORY ENVIRONMENT FOR THE IRISH PHARMACEUTICAL 
INDUSTRY
Two major regulations cover the advertising, promotion and marketing of 
medicinal products:
4.8.1 Code O f M arketing Practice For The Pharm aceutical Industry 4th Edition 1994.
The new code came about as a result of EU legal restrictions in pharmaceutical 
marketing. Since January 1st, the advertising of medicinal products for human use 
in the European Union Member States, has been governed by Council Directive
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92/28/EEC of March 1992 This Code of Practice fits into the general framework 
established by Article 12 Paragraph 4 of the Directive Acceptance and 
observance of the provisions of the Code are a condition of membership of the 
self-regulatory body, the Irish Pharmaceutical Healthcare Association
Under it, where the committee has found that a complaint against a person or 
company is justified, the committee can reprimand the party, publish details of 
the reprimand in an annual report, order corrective action, and in difficult cases 
refer the matter to the Minister of Health
The new code provides more detailed stipulations about what must be included in 
promotional material, including product authorisation numbers, recommended 
dosage, side effects and a quantitative list of active ingredients
The new code also stipulates that where a company pays for or arranges the 
publication of promotional matenal in medical journals, such promotional 
material must not resemble editorial matter It also stipulates that during each visit 
to a doctor, a representative must give the person visited or have available for 
them a data sheet for each product they present
The code has introduced strict new provisions on samples to reflect similar EU 
legal restnctions Samples are confined to six per year per doctor and supply of 
samples must be in response to a signed and dated request from the recipient The 
code states that gifts of pecuniary advantages from a person promoting a 
medicinal product are banned, unless they are inexpensive and relevant to 
medicine It also requires that hospitality and sponsorship offered to the health 
professionals in the course of sales promotion be reasonable in level and 
secondary to the mam purpose of the occasion at which it is provided Hospitality 
must not be extended beyond health professionals i e spouses and partners are not 
to be entertained Section 12 of the code deals exclusively with pharmaceutical 
company staff, particularly medical representatives
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4.8 2 T H E  M E D IC A L  P R E P A R A T IO N S  (A D V E R T IS IN G ) R E G U L A T IO N S , 
S I  NO.76 O F 1993
These regulations, signed into effect on March 16, 1993, by the Minister of 
Health, cover the advertising of medicinal products for human use to both health 
professionals and the general public It lays down clear and specific guidelines 
regarding what may an may not be included in an advertisment The sections of 
the articles regarding the promotion of these products by medical sales 
representatives has since been superseded by the 1994 Code of Marketing 
Practice
4 9 ENVIRONMENTAL REGULATIONS
In the recent past, environmental control of the industry has tightened This has 
been brought about due to increasing public awareness and concern regarding the 
safety of pharmaceutical and chemical firms' manufacturing operations In the 
past two years, environmental control of the industry has tightened as a result of 
the setting up of the Environmental Protection Agency Part of it's brief is the 
vetting of all the major pharmaceutical and chemical companies who apply for 
pollution control licences The agency must monitor and regulate all emissions 
from Irish plants, all of whom must have applied for licences by March 1996
Recent environmental incidents in the middle of Cork's chemical belt have 
provoked much media coverage m both the general and business press concerning 
the safety of this industry For example, the explosion and subsequent fire at the 
Hickson Pharachem plant in Ringaskiddy, Cork on August 6 , 1993 led to 
Business and Finance producing a cover story on the industry's safety and 
environmental record in their August 19,1993 issue
Flynn, (1994,p 31) carries a table entitled "Greenpeace's Dirty Dozen" which 
gives a ranked order for those Irish companies which have permission to dump 
the most chemical substances into nvers, lakes or harbours Four of the twelve 
companies listed are ethical pharmaceutical firms
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Environmental lobby groups continue to highlight this industry as one which 
needs to be continually momtored
4 10 SUMMARY
In conclusion, although world-wide the pharmaceutical industry is in a period of 
turmoil, Nolan (1994, p 184) stated that the next five years should see the 
pharmaceutical industry in Ireland enjoy a penod of further growth and 
development as new products from new technologies come on stream However 
the widening move towards cost containment will possibly entail a structural 
change favouring branded generics and generics
It is extremely likely that the market will become more concentrated, into fewer 
and much larger customers, who will be increasingly more sophisticated, 
knowledgeable and extremely pnce-conscious As the buying power and 
sophistication of their customers increases, pharmaceutical managers will have to 
strive to develop relationships with these customers in order to compete 
effectively in the new market
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CHAPTER 5 RESEARCH METHODOLOGY
5 1 PREVIOUS METHODOLOGIES
Dubinsky and Barry (1982)
Dubmsky and Barry were the first to attempt "to provide a good starting point for 
sales managers in determining the more frequently used sales practices o f other 
firms" (p 133) through their study Their data was based on the responses of 121 
American chief executives, collected through telephone questionnaires, covering 
seven key managerial areas Their findings were presented m the format of the 
percentage of small and large companies that extensively used the sales 
management tools and practices o f interest in the study
Avlomtis, Manolis and Boyle (1985)
These authors were the first to undertake both a descriptive and prescriptive study 
of British sales management practices They undertook a series of in-depth 
company interviews from which they drew up a mail questionnaire Their sample 
was drawn from a population of 500 manufacturing companies from whom they 
received 113 usable responses, giving them a 23 per cent response rate
Lambkin and deBurca (1991)
The only Irish academic research undertaken in this area was carried out by 
Lambkin and de Burca in 1991 and published in 1993 Their study was based on 
the responses from a self-administered postal questionnaire sent to the managers 
of the Top 1000 Irish firms The questionnaire contained 47 questions and was 
broken into four parts covenng company profile, organisation for selling, 
recruitment, training, and remuneration, and sales management The authors 
achieved a usable response of 23 5 per cent and as a result of the respondent 
profile, state that "their descriptive statistics are biased towards relatively large, 
long-established companies, operating mainly in the domestic market" (p 56)
Shipley and Jobber (1994)
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More recently Shipley and Jobber (1994) conducted research which focused on 
industrial distributors in an attempt to clarify "that sales management situations 
and practices are affected by firm size" (p 31) Their methodology included six 
interviews with distributor sales managers followed by a structured mail 
questionnaire They achieved a usable response rate of 27 1 per cent
Given the documented success of the four previous methodologies for providing 
quality response data, this author decided to follow a similar research process, 
namely a series of m-depth respondent interviews followed by a questionnaire 
mailed personally to each census member The departure from the previous 
methodologies was the author's decision to conduct a census of the industry as 
opposed to the sampling approach adopted by the other researchers This decision 
was taken in the knowledge that a higher response rate than had been achieved by 
the previous researchers was both desirable and necessary
5 2 RESEARCH HYPOTHESIS
As a result of the author's personal expenence of working in, and subsequently 
staying in contact with, this industry she wished to investigate a number of issues 
that had come to her attention
Following a review of the pertinent secondary data and the conducting of six m- 
depth personal interviews with pharmaceutical managers the author set out to test 
her hypothesis
HYPOTHESIS (H1)
The author hypothesised that by virtue of being dual-mandated, the dual­
mandated sales and marketing manager spends proportionately less time on sales 
management activities than does his/her single-mandate sales manager 
colleagues
In addition to these hypothesis the author had a number of additional research 
objectives
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to establish there exists in this industry the position of dual-mandated 
sales and marketing managers whose title is an accurate descriptor of 
the work they actually do
to establish a demographic profile of the sales managers in the Insh 
ethical pharmaceutical industry
to establish a profile of the companies in the Insh ethical 
pharmaceutical market, with special reference to their sales and 
marketing structures
to examine the sales management practices of the managers m the 
Insh ethical pharmaceutical industry
to examine marketing practice in the Insh ethical pharmaceutical 
industry, with special reference to market planning and the 
respondents' attitude to marketing
to assess the managers' views of the Insh ethical pharmaceutical 
industry ten years into the future
5 3 SECONDARY RESEARCH
Secondary data are data already published and collected for purposes other than 
the specific research needs at hand (Parasuramann, 1991 p 181) There are a 
number of advantages to secondary data such as savings in cost and time They 
are also extremely useful for expanding understanding of the problem or issues 
faced by researchers
The sources of secondary data used by this author were journal articles, trade 
penodicals, business penodicals, and research reports These were sourced 
through library and on-line searches, personal contacts, and through official 
contact with the two mam industry bodies, the Pharmaceutical Managers 
Association (P M A ) and the Insh Pharmaceutical Healthcare Association 
(I P H A )
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5 4 DESIGNING THE DATA COLLECTION PROJECT
5.4.1 Basic methods of collecting data
Kinnear (1991, p 309) stated that there are two basic methods of collecting data 
from respondents, the communication method (based on the questiomng of 
respondents), and the observation method
Questiomng, as the name suggests, is distinguished by the fact that data are 
collected by asking questions of people who are thought to have the desired 
information Questions may be asked m person or m writing A formal list of such 
questions is known as a questionnaire
With the observation method , researchers ask no questions Instead they keep 
track of the objects or actions in which they are interested Churchill (1991, 
p 316) noted "observation is limited in scope to information about behaviour and 
certain demographic/socioeconomic characteristics" Hence, the author decided 
this approach would not offer the versatility required in collecting the information 
required from the participants
The advantages of the questioning method compared to the observation method 
are deemed to be versatility, speed and cost Kinnear gives three major limitations 
(p307) unwillingness to provide the necessary data, inability to provide the 
desired data, and influence of the questioning process It was felt that these 
disadvantages would be overcome due to the fact that the respondents were 
interested in the subject matter under discussion, as intimated at an oral 
presentation of the research objectives to the target market, and would be thus 
willing and able to provide the information sought
Kinnear (p 308) suggests a classification scheme to categonse questioning 
techniques by their degree of structure and degree of directness Structured-direct 
approaches are primarily carried out through survey questionnaire, requiring that 
the questions be asked with exactly the same wording and in exactly the same 
sequence for all respondents Given that this was descriptive research, described
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by Churchill (p 157) as being "cross-sectional" and "able to provide a snapshot of 
the variables of interest at a single point in time", and was designed to elicit the 
responses of managers with responsibility for the personal sales force to a 
common range of questions, the structured-direct technique was deemed 
appropriate
In addition, an unstructured-direct approach was used m the exploratory stages of 
the research This took the form of six depth interviews, defined by Kinnear 
(p 315) as "an unstructured personal interview which uses extensive probing to 
get a smgle respondent to talk freely and to express detailed beliefs and feelings 
on a topic" Six in-depth interviews were conducted, three with sales managers 
and three with dual mandated sales and marketing managers The average 
duration of these interviews was one hundred minutes and they took place in a 
venue preferred by the respondent The quality of resulting data, in addition to the 
opportunity of additional issues being raised by the participants are prominent 
examples of the benefits of this method Churchill (p 320) cites lack of structure 
and difficulties with subsequent analysis as the prime disadvantages to this 
approach As the data obtained from these interviews were being used primarily 
to define the universe of variables for inclusion in the mail questionnaire, these 
limitations were not felt to be damming
Communication may be oral or m writing and the author used both approaches 
during the questionnaire design and implementation stages Three communication 
media are available for obtaining data from respondents
(1) Personal interviews
These consist of an interviewer asking questions of one or more respondents 
m a face-to-face situation
(2) Telephone interview
The telephone interview consists of an interviewer asking questions of one or 
more respondents via the telephone instead of by direct personal contact
(3) Mail interview
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The mail interview consists of a questionnaire posted to the respondent and 
the return by post of the completed questionnaire
Kinnear (pp 320-326) gives a checklist o f catena for evaluating which 
communication medium best meets the needs of a research project The cntena 
given are as follows
Versatility
This refers to the ability of the medium to adapt the data collection process to the 
special needs of the respondent Although thr mail interview is considered the 
least versatile of the three media, this research design involved structured 
questions with simple instructions, and was thereby felt to be appropnate for the 
task in hand
Cost
The number of labour hours tends to determine the relative cost of the three 
communication methods The seventy-six managers on the final census list were 
geographically spread around Ireland so the cost of conducting personal 
interviews was considered to be prohibitive Given the content of the 
questionnaire it was deemed too lengthy and costly to admimster over the 
telephone
Time
Among the three communication methods, the telephone is the fastest way to 
obtain data As time was not considered to be a cntical factor in the collection of 
the data, mail interviews were considered to offer a reasonable time scale
Quantity o f data
An established rule is that the largest amount of data can be collected using the 
personal interview, followed by the mail interview As the questionnaire ran to 
sixteen pages covenng eighty-seven questions, a mail interview was deemed 
appropnate Dunng the two pre-testing stages it emerged it would take each 
respondent thirty minutes to complete the questionnaire In order to stimulate
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response and encourage the creation of uninterrupted time for completion, this 
fact was pointed out to the respondents in the covering letter (see Appendix 2)
Quality o f data
This refers to the degree to which the data are free from potential bias resulting 
from the use of a particular communication method Kinnear (p 323) states that 
when the subject matter is unemotional and the questionnaire is properly designed 
and administered, quality data will generally result regardless of which medium is 
used
Bias can arise from a number of sources when using a mail questionnaire Bias 
can result from confusion by respondents regarding the question asked In order 
to minimise the effect of this type of bias, the author undertook extensive pre­
testing of the questionnaire to increase the content validity of the chosen research 
instrument
When the first draft of the questionnaire was completed it was forwarded to two 
industry managers for pre-testing, and the relevant changes to question formation 
and phrasing were subsequently made The second draft was again pre-tested by 
another four industry managers, none of whom had previously seen the 
questionnaire As a result, a small number of minor modifications were made and 
the third draft was issued for the population as a whole Thus the author felt all 
reasonable effort had been made to avoid respondent misunderstanding or 
ambiguity when completing the questionnaire
The mail interview has another potential bias which can result from the 
respondent's reading through the questions before answering them or changing 
answers earlier in the questionnaire as a result of answers given later in the 
questionnaire There is very little the researcher can do to prevent this occurring 
but, on receipt of the completed questionnaires for analysis, the author did not 
note any physical evidence of changes having been made
Response Rate
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Kinnear (p 324) defines response rate as the percentage of the original sample 
that is actually interviewed Non response error, the difference between those who 
do respond and those who do not, is a one of the more serious sources of error 
confronting the researcher In this research the author has a non-response rate of 
26 per cent, which is considerably lower than most industrial marketing surveys 
The issue of this non response is dealt with under the subsequent heading of 
accuracy
SAMPLING METHODOLOGY
Having originally considered it appropriate to take a representative sample of the 
companies in this sector, the author subsequently gathered information in relation 
to the size and the geographic location of the industry which indicated the 
viability of conducting a census
A census is defined by Malhotra (1993,p 351) as "a complete enumeration of the 
elements of a population or study objects" Chisnall (1991,p 20) says "in practice 
a census is rare in commercial research except where the population under survey 
is small and easily located, as may happen in some specialised industrial 
research"
Webb (1992, p46) cautions that "it is neither necessary nor useful to be too 
dingiste about the choice between census and sample" as each situation should 
be assessed solely on its own merits The author used Webb's suggested 
guidelines for guiding her final decision on choice between census and sample 
These were as follows
1 Cost
Although budgetary restrictions were an important element of the decision, 
the author felt it would be preferable to maximise the value of the 
information through a census as opposed to a sample
2 Time
In most instances it is usual for a sample to be drawn more quickly than a 
census, however in this case as only seventy six companies qualified for 
inclusion, the author decided that the time constraint was not a critical 
consideration
3 Accuracy
Webb (1992, p47) says "accuracy is affected, partially, by two factors 
sampling error which is associated with the drawing of a sample and non­
sampling error or bias" With a census there is no sample so there can be no 
sampling error Non sampling error can anse in two forms when conducting a 
census, firstly, if a question is consistently misinterpreted by the population 
the validity of the findings will be reduced Secondly the question of non­
response affects accuracy
Non-response, according to Churchill (1991, p617)," is a problem in any 
survey where it occurs because it raises the question of whether those who 
did respond are different in some important way to those who did not 
respond"
Bagozzi (1994, p 143) details a number of hypotheses in relation to non-response 
One is that individuals who are more interested in the topic of the survey are more 
likely to respond Another is that non-respondents to mail surveys may have 
difficulty answenng the questions
The author acknowledged the issue of non-response as a major consideration m 
the decision to sample or conduct a census The wisdom of her academic 
colleagues and those in the industry itself was to opt for a census due to the 
benefits accruing from such an approach, but it would be necessary to make all 
possible attempts to reduce the number of non-respondents in order to maximise 
the accuracy and validity of the data
Bagozzi's belief that those more interested in the topic under consideration would 
answer, thereby reducing the non-response rate, led the author to believe that a
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formal face-to-face presentation of the proposed research to the managers would 
stimulate interest m the topic and encourage participation
Consequently, the author sought and received permission from the Executive of 
the Pharmaceutical Manager's Association to make a presentation at a monthly 
meeting of the group's members This subsequently took place on 25th March,
1993 in the Stillorgan Park Hotel, Co Dublin
This twenty minute presentation gave the author an opportunity to introduce both 
herself and the proposed research to the target audience, which was widely 
welcomed by the members as they had no relevant benchmark of sales 
management practice in their industry at that time After the formal presentation 
and the subsequent conclusion of the meeting a number of the managers 
approached the author with words of encouragement and offers of information 
which resulted in extra company-specific data which otherwise would not have 
been available to the researcher
«
Subsequent analysis of the non-respondent companies (26 per cent of the 
population) showed no significant differences across the major classification 
variables such as title of respondent, sex of respondent, size of salesforce and 
company turnover
5 5.1 Census L is t Preparation
On advice from industry members a number of lists of pharmaceutical companies 
were gathered The final census list was drawn up from cross-referencing three 
current secondary sources These were as follows
1 The 1994 Irish Pharmaceutical Union Buyers Guide Directory
2  The 1994 Members List of the Pharmaceutical Managers Association of Ireland
3 The January 1994 edition of Monthly Index of Medical Specialities 
( M I M S )  Manufacturers' Index
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The cross-referencing process yielded a total of seventy -nine companies who 
appeared on paper suitable for inclusion As the criterion for inclusion was that 
the company had to have at least two sales people calling to general practitioners' 
(G P s) surgeries, a verbal clarification of that criterion bemg met by each 
company was necessary
Seventy-mne telephone contacts were made between 15th -17th of February 
1994 The telephone survey had two major objectives
1 Verification of company for inclusion under the stated criterion
2 Generation of the Christian name and surname of the person directly 
responsible for the operation of the personal sales force,and the designation 
of that same person This second objective was formulated in the light of 
many academic references to stimulating or improving response rates through 
"personalisation" of the survey (Boyd et al, 1977)
The process resulted in seventy-six companies being deemed suitable for 
inclusion on the census list Two were excluded for not meeting the stated 
criterion and one had recently merged it's salesforce with another company which 
was already included in the census
5 6 QUESTIONNAIRE DESIGN, RATIONALE AND CONTENT
The chosen method for data collection in order to meet the stated research 
objectives was a self-administered, postal questionnaire (see Appendix 3) The 
questionnaire was clearly broken into four parts m order to clarify questions for 
the respondents These parts broadly followed the research objectives, namely a 
profile of the respondent, a profile of the respondent’s company, the sales 
management practices of the respondent, and finally the marketing practices of 
the respondent
The three mam types of question from least structured to most structured are (1) 
open, (2) multiple-choice and (3) dichotomous For the purposes of this survey a
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mixture of all three question types was used Due to the length of the 
questionnaire and for the convenience of the respondent as many closed questions 
as possible were used but open questions were also deemed necessary where 
additional information from the respondent would enhance the quality of the data
Since the questionnaire was to be self-administered, careful attention was paid to 
the wording of the questions during successive drafts and during pre-testing, so as 
to ensure the respondents assigned the same meaning to the questions asked as the 
researcher Kinnear et al (1991,p 347) warn that if this input does not occur 
serious measurement error will be present m the results
The final two questions on the questionnaire sought to discover the attitudes of 
the respondent to statements concerning the future of the industry and the place of 
selling vis-a-vis marketing These had been drawn up as a result of the secondary 
research and issues that were raised by the six managers who had participated in 
the in-depth interviews
Boyd et al (1977) stated that scaling is the most commonly used method for the 
process of measuring attitudes The standard procedure is to measure in two 
directions from some neutral point, such as measuring degrees of agreeing or 
disagreeing with a statement from some point between the two, a point of 
indifference
Several self-report scaling techniques have been developed, Kmnear et al (1991, 
pp 244-257) list ten different approaches From that list this researcher chose to 
use graphic rating scales Respondents were asked to review the list of statements 
and indicate the strength of their beliefs about each of them An example of the 
type of scale used is as follows
Strongly Agree 1 2 3 4 5 Strongly Disagree
Respondents indicated the strength of their beliefs by choosing a number on the 
scale which corresponded most closely with their beliefs There were other
Page 111
questions which required the use o f similar rating scales throughout the 
questionnaire
As the results of the survey were to be analysed using the SPSS (Statistical 
Package for the Social Sciences) computer package, it was necessary to pre-code 
the questionnaire to speed up the process of entenng data from the completed 
questionnaires to the computer Responses to the open-ended questions were 
coded after the completion of the survey to convert them to a form suitable for the 
SPSS package
5 7 SURVEY METHOD
The survey method is the means used to implement a structured questionnaire 
given to a sample of a population and designed to elicit specific information from 
respondents
The questionnaire was posted out on Friday 25th February, 1994, personally 
addressed, to the seventy-six eligible managers accompanied by a covenng letter 
guaranteeing anonymity and with a stamped addressed envelope as the response 
mechanism Both these techniques have been proven to raise response rates to 
industnal mail questionnaires (Jobber and O'Reilly, 1995, p 414)
Three weeks later forty-three completed questionnaires had been returned, giving 
an unprompted response rate of 57 per cent Three questionnaires were returned 
uncompleted, two managers citing company policy as their reason for non co­
operation, and one citing ill-health
A subsequent telephone follow-up was made, starting March 21st, to the non­
respondents in order to stimulate response The author closed the primary data 
collection on April 1st, 1994, at which stage fifty-six usable responses had been 
received, giving an overall response rate for the study of 7 4  per cent
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Upon completion of the data collection process, the data were processed into a 
form suitable for analysis The questionnaires were edited to ensure legibility and 
clarity Responses to open-ended questions were coded and, along with the pre- 
coded data, were prepared for analysis Analysis was performed using the SPSS 
computer package In order to meet the research objectives, both frequency 
distributions and cross-tabulation of variables were employed
5.8 DATA PREPARATION AND STATISTICAL ANALYSIS
Page 113
Avlomtis, G J , C K Manolis, and K A Boyle, 1985, "Sales Mnangement Practices in 
the U K Manufacturing Industry”, Journal of Sales Management. Voi 2, September,
pp 6-16
Bagozzi, Richard P 1994, Principles of Marketing Research. 1st e d , Oxford, Blackwell 
Business
Boyd, Harper, Ralph Westfall and Stanley Stasch, 1977, Marketing Research. Text and 
Cases. 4th E d, Illinois, U S A ,  Irwin
Chisnall, Peter M , 1991, The Essence of Marketing Research. U K , Prentice Hall 
International
Churchill, Gilbert A , 1991, Marketing Research. Methodological PoundatKms.
5th E d, U S A , The Dryden Press
Dubinsky, Alan J and Thomas E Barry, 1982, "A Survey of Sales Management 
Practices", Industrial Marketing Management, Voi 11, pp 133-141
Jobber, David and D O'Reilly, 1995, "Six key methods of increasing response rates to 
industrial mail surveys", Proceedings of the 1995 Annual Conference of Marketing 
Education Group. Voi 1, pp 414-422
Kinnear, Thomas C , and James R Taylor, 1991, Marketing Research. An Applied 
Approach. 4th Ed , U S A , McGraw-Hill
Lambkin, Mary and Sean de Burca, 1993, "Sales Force Management in Ireland", Irish 
Marketing Review. Voi 6 . pp 53-64
Malhotra, Naresh K , 1993, Marketing Research. An Applied Orientation. U S A ,  
Prentice-Hall
Parasuraman, A 1991, Marketing Research. U S A ,  Addison-Wesley
Shipley, David and David Jobber, 1994, " Size Effects on Sales Management Practices 
Of Small Firms A Study of Industrial Distributors", Journal o f Personal Selling and 
SalesJManagement. Voi X l V, No l , p p  31-43
Webb, John R , 1992, Understanding and Designing Marketing Research. London, 
Academic Press
5 9 REFERENCES
Page 114
CHAPTER 6 ANALYSIS OF PRIMARY DATA
The author chose to use the stated hypothesis and the six research objectives as the 
format for analysing the data accumulated
O B JE C T IV E  1
In order to start to fulfill Research Objective One, namely there exists dual-mandated 
managers whose title is an accurate descriptor of the job they actually do, the first 
question the author used asked the respondents to indicate the title which best described 
their current position The responses are illustrated in Figure 6  1 and tabulated in Table 
61
Figure 6.1 Respondents’ C u rrent Position
OTHER
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Tab le  6.1 : Respondents9 C u rren t Position
% Number of resp
Sales Manager 37 5 (21)
Marketing Manager 54 (3)
Sales & Marketing
Manager 35 7 (2 0 )
General Manager 3 6 (2 )
Field/Area G M 89 (5)
Manager/Director 1 8 1
Other 7 1 4
N = 56 100 0 56
The "other” category contained responses such as national sales manager, commercial 
manager and business manager
Although twenty-one of the respondents described themselves as sales managers, one in 
three managers with primary responsibility for the operation of the field sales force also 
claimed a formal responsibility for marketing This confirms the author’s pre-stated 
view that there were a sizeable number of managers holding a dual-mandated 
designation in this industry For the rest of the analysis, these sales and marketing 
managers will be referred to as dual-mandate menagers
Field or area sales management positions are held by five of the respondents, four of 
whom are responsible for sales-forces of four or less
HYPOTHESIS 1
A further question to elicit hypothesis-relevant data asked the respondents to indicate 
the approximate allocation of their management time between sales and marketing The 
results are given in Table 6  2
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Tab le  6 2 : A llocation O f Management T im e Between Sales And M arketing - 
A ll Respondents,
S A LE S 1 M A R K E T IN G % (NO . O F R ESP O N D EN TS )
30 70 10 2 (7)
40 60 14 3 (7)
50 50 10 7 (6 )
60 40 14 3 (7)
70 30 14 3 (17)
Other 102 (5)
1 0 0  0 (49)
(The "other" category asked for specification and all five respondents noted allocations 
greater than 70 30 in favour of sales)
24 5 per cent (14) of all respondents allocated 40 per cent or less of their management 
time to sales, the rest going to marketing On the contrary, 38 8 per cent (29) allocate 60 
per cent or more of their management time to sales, the remainder going to marketing 
One in ten managers split their management time equally between the two
However, the data needed to test the hypothesis must be generated through cross- 
tabulation of two answers, the respondent who identified himself/herself to be either a 
sales manager (37 5 per cent o f total respondents) or a sales/marketing manager (35 7 
per cent of respondents) and allocation of management time This cross-tabulation 
provided the following results
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Tab le  6 .3 : Cross-tabulation of management time by position of respondent
Count
Col Pet SALES M N G R SALES & MKTG
MNGR.
S -M 0 3
30-70 150
1 6
40-60 30 0
2 3
50-50 15 0
3 7
60-40 35 0
4 15 1
70-30 78 9 5 0
5 4
Other 21 1
Here a substantially different picture to Table 6  2 emerged In essence, all single- 
mandated sales managers devoted 70 per cent or more of their management time to 
sales management whereas only 5 per cent of dual-mandated sales and marketing 
managers allocated a similar split
This finding would, indeed, support the author’s first research objective, namely the 
dual-mandated manager is indeed carrying responsibility for both sales management 
and marketing and therefore his/her title is an apt descnption These managers are not 
just sales managers disguised as marketers, but are genuinely managers involved in 
both activities Secondly, Table 6  3 upholds HI in that the dual-mandate manager 
spends proportionately less of their management time on sales management activities 
than his/her sales manager colleague
Further investigation of sales management practice supported her hypothesis For 
example the author asked how frequently the respondents were getting out on their 
sales representatives' territories with them
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Figure 6.2. Frequency of accompanying sales representative on territo ry- 
a ll respondents.
__________ Mssing
QISŒAV\EEK
ONCEAPORTNGHT
ONCEAMONTH
The results for all respondents indicated that 13 per cent of managers were visiting 
their representatives’ temtories once a fortnight, 28 per cent once a month, 2 2  per cent 
once every two months, and a third (33 per cent) only getting out less than once every 
two months
When the question is cross-tabulated with the category of manager the author’s 
hypothesis is again supported in part 52 per cent of sales managers travel with each of 
their reps at least once a month compared to 35 per cent of the sales and marketing 
managers
Similarly, only 20 per cent of sales managers travel with each rep less than once every 
two months compared to 45 per cent of sales and marketing managers It can, therefore, 
be observed that sales people who are led by a sales and marketing manager will be 
accompanied in the field/on territory less frequently than those who are led by a single- 
mandated sales manager
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Further references to the differences/similarities between the single mandate sales 
manager and the dual-mandated sales and marketing manager will be made throughout 
the presentation of the analysis of the stated research objectives
OBJECTIVE 2
The second research objective was to establish a demographic profile of the managers 
with primary responsibility for the field sales force in the Irish ethical pharmaceutical 
industry This information was gathered in Part A of the questionnaire (see Appendix 
3) Prior to sending out the questionnaires, the author had telephoned each company in 
the census list and asked for the name and designation of those said managers in order 
to maximise the number of correctly profiled respondents Fuller explanation of the 
research methodology is included in Chapter 5
An open-ended question asked the respondents the title of the person to whom they 
were immediately responsible This elicited the following results
Table 6.4 • T itle  o f Respondents9Immediate Superior
% No ofResp
General Manager 23 1 ( 12)
Managing Director 26 9 (14)
Sales Manager(nat /general) 7 7 (4 )
Marketing Director 3 8 ( 2 )
Sales and Marketing Director 5 8 (3 )
Report to the United Kingdom 173 (9 )
Financial Director 1 9 (1 )
Other 13 5 (7 )
100  00 52
The most common reporting structure was for the manager to report in to the Managing 
Director or General Manager For clarification, of the four respondents who were 
responsible to a national or general sales manager one was a field sales manager, two 
were sales managers and one was a sales and marketing manager
The results would indicate that the majority of the respondent managers are operating at 
what Ryan and Weinberg (1981) described as strategic and tactical management levels, 
as opposed to an operational level Another fact worth noting is that 17 3 per cent of
managers report immediately to a superior in the United Kingdom
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Question three, the degree of direct responsibility the respondent held for the operation 
of the field sales force, was asked in order to verify that the author had got to the correct 
manager in the respondent company 1 e the manager with primary responsibility for the 
operation of the field sales force
Table 6.5 : Degree of Salesforce Responsibility___________
% No
Total 94 6 (53)
Partial 54 (3 )
None 0 0 ( 0 )
1 0 0  0 (56)
This confirmed that the respondents were indeed the managers for whom the 
questionnaire had been designed
A similar question was asked regarding responsibility for marketing This was mcluded 
to help answer the research question regarding the prevalence of managers carrying 
dual responsibility 1 e both sales and marketing
46 4 per cent of the respondents were totally responsible for the marketing function in 
the Irish market 41 per cent of the respondents said they had partial responsibility for 
marketing with 12 5 per cent saymg they had no responsibility for the marketing 
function
This finding reflects an interesting aspect when compared to the results of the first 
question, asking the respondents to describe their current title
There 35 7 per cent (20) described their role to be dual-mandated but m this question 
we find 87 5 per cent (49) saymg they have total or partial responsibility for marketing 
This would appear to indicate that the vast majority of managers with primary 
responsibility for the operation of the Irish field sales force also have input into the 
marketing function in this market
When the responses to this question were cross-tabulated-current position by degree of 
marketing responsibility*the following results emerged 85 per cent of dual-mandated
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managers have total responsibility over marketing with 15 per cent claiming partial 
responsibility This finding again upholds Research Objective One, namely their title is 
an accurate descriptor of the work they do
Supporting the observation noted regarding the results for all respondents, 65 per cent 
of single mandate sales managers claim partial responsibility for the marketing 
function, indicating a considerable level o f sales and marketing linkages in this market
Some companies (eg  I B M )  require their managers to physically call on a specified 
number of customers each week with the aim of strengthening the business relationship, 
guaranteeing the opportunity for valuable feedback and fostering a customer-oriented 
culture throughout the corporation Loen (1964), held an opposing view Defimng 
managing as "getting things done through others" (p 109), he argued that, on being 
promoted into management, managers must make the transition from "doing" to 
managing, This definition would, therefore, classify personal sales calls by managers as 
"doing"
In this study, 55 4 per cent of all respondents had no personal accounts/calls where they 
were solely responsible for face to face selling 37 5 per cent of all respondents had ten 
or less accounts where they were responsible for selling and 7 1 per cent had ten or 
more personal sales accounts In summary, almost half of all the respondents were 
keeping in touch with their marketplace through responsibility for face to face selling in 
certain accounts
When this question was cross-tabulated with current position of the respondent, there 
are no major differences between the two categories i e sales manager and sales and 
marketing manager with regard to levels of personal selling Yet again, we see half of 
both categories of managers with personal accounts
As part of creating a demographic profile of these respondents, the author attempted to 
establish the length of pharmaceutical selling experience the respondents had prior to 
moving into their first sales management position
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10  7  per cent (6 ) of the respondents moved quickly into their first sales management 
position with less than two years pharmaceutical selling experience However, the 
majority (714 per cent) of all respondents had between two and ten years industry sales 
experience prior to their initial management promotion When this question was cross­
tabulated with current position of the respondent, 25 per cent of sales and marketing 
managers had less than two years experience compared to 5 per cent of sales managers
Meyer (1990, p 11) maintains that management training for newly-promoted sales 
managers should have two basic missions developing the trainees’ skills as managers 
of people and as managers of the sales process
In an open-ended question, the respondents were asked to describe the management 
training they had received in preparation for their moving into management The 
following categories of results for all respondents were recorded
Table 6 .6 : Management Training Received by Respondents
%
In-house 35 3
Formal Management Course 29 4
Insh Mgmt Institute 27 5
Named Mgmt Course 13 7
Marketing Institute 9 8
None 15 7
Other 196
151 0
n-51
Further research would be required to examine the length and depth of the training 
undertaken m order to make any valid comment on this level of management 
development What is noteworthy is that 15 7 per cent of all respondents received no 
preparation for their management position at all Overall, the picture of prior 
management development programmes for Insh sales managers is better than the U S 
Guest et al (1989, p 50) reported only 27 per cent of respondents from the Fortune 500 
list trained their first level sales managers prior to appointment, although 50 per cent 
provided induction training “sometimes”
Page 123
No significant differences appear in the cross tabulation of this by current position with 
the exception of the fact that sales and marketing managers are more likely to cite 
Marketing Institute of Ireland courses than their sales management colleagues who, in 
turn, opt for Irish Management Institute programmes in greater numbers then their dual­
mandated colleagues When asked to rate the adequacy of their management 
development training, four out of five managers expressed an acceptable level of 
satisfaction with the training they received, but 2 0  per cent deemed their training to be 
inadequate
In order to gauge the length of sales management expenence of the respondents, the 
author asked each respondent the total number of years of sales management experience 
they had in the pharmaceutical industry
Table 6*7 . Sales Management Expenence of the Respondents
Years Exp % NO OF RESPONDENTS
Less than 2 36 2
2-5 16 1 9
6 - 1 0 39 3 2 2
1 1 - 2 0 21 4 19
21-30 161 9
30 + 3 6 2
100 0 56
A visual representation of this table is given in Figure 6  3 
Figure 6  3 Respondents’ Sales Management Experience
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TOTAL YEARS EXPERIENCE IN MAN^GENENT
LESSTH4N2 2-5 6-10 11-20 21-30 30+-
80 per cent of managers have considerable industry management experience, ranging 
from six to twenty years This fact adds weight to the results of this study, as the data 
obtained reflects the practice of a cohort of experienced respondents
The drawing together of a demographic profile of the managers with responsibility for 
the operation of the field sales force needs many inputs, education being an integral 
one 39 per cent of all respondents have a primary' degree and 43 per cent of all 
respondents hold a post graduate qualification
On examining a cross-tabulation of educational qualifications by current position, it 
emerges that 20 per cent of single-mandated sales managers and 15 per cent of dual­
mandated sales and marketing managers do not hold a Leaving Certificate qualification 
On pointing out this fact at the presentation of the findings to the Pharmaceutical 
Managers Association meeting on 8/11/95 (see Appendix 4), the consensus of opinion 
was that this result emerged due to the author not having catered for those managers 
who received their secondary level qualification outside the Republic of Ireland, and 
thus were not awarded a Leaving Certificate This presentation, partial participative 
research, was very helpful in the interpretation of the data collected
Further examination of the cross-tabulation revealed that 45 per cent of sales and 
marketing managers compared to 2 0  per cent of sales managers held an undergraduate
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qualification Likewise, 47 per cent of sales and marketing managers reported they had 
a primary degree compared to 20 per cent of the single- role sales managers A similar 
number (47 per cent) of dual-mandate managers claimed to have a post graduate 
qualification compared to 40 per cent of sales managers
These findings would appear to indicate that sales and marketing managers are more 
likely to have advanced qualifications than their sales management colleagues
The author speculates that, in order to be promoted into a sales and marketing 
management position, the dual-mandated manager is more likely to have taken 
marketing courses than a single-mandated sales manager who, according to Loen (1960, 
p 108) generally has been promoted into sales management on the basis of sales 
performance, and tends to learn the sales management tasks by osmosis rather than 
having chosen a sales management discipline m formal study One obvious reason for 
this is the unavailability of formal sales management educational qualifications in 
Ireland vis-a-vis the multitude of marketing education offerings
The respondents were offered a list of professional and trade bodies and asked to 
indicate those to which they currently belonged In rank order, the results were as 
follows
Table 6.8: Respondents’ current memberships held.
%
Pharmaceutical Managers Association 69 8
Federation of Irish Chemical Industries 62 3
Marketing Institute of Ireland 37 7
Irish Management Institute 32 1
Medical Representatives Institute of Irl 26 4
Pharmaceutical Manufacturers Association 38
Irish Pharmaceutical Union 1 0
Insh Medical Organisation 0 0
n = 54 237 7
These findings indicate that each manager has, on average, membership of two of the 
above bodies
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(135 membership yeses) 55 per cent of sales and marketing managers held membership 
of the Marketing Institute of Ireland, as did 14 per cent of sales managers
With reference to on-going management development, the author attempted to profile 
the extent and type of refresher courses taken by the respondents in the previous year 
The respondents were given a list of thirteen areas which had been drawn up by the 
author in conjunction with the managers who participated in the initial depth 
interviews The percentage frequencies recorded were as follows
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Table 6.9 : On-going training taken during last year
Finance 15 9
Marketing 20 5
Sales Management 54 5
Production 0 0
Quality Assurance 6 8
New Technology 136
Strategy/Planning 29 5
Leadership 38 6
Therapeutics 6 8
Pharmacology 0 0
General Management 20 5
Team Building 43 2
Personnel 20 5
Other 179
n=44
Specification of ’’other" areas by the seven respondents included negotiation, time 
management, oncology, new product development, surgery and anatomy/physiology
Further manipulation of these figures gives an interesting picture of the amount of 
courses taken by each respondent
Table 6.10; Amount of training courses taken by each respondent
N O  O F  R E F R E S H E R  C O U R S E S  %  W H O  T O O K  R E F R E S H E R  C O U R S E S
0 214
1 16 1
2 23 2
3 179
4 10 7
5 5 4
7 1 8
8 3 6
10 0
Mean 2  268
Mode 2  0 0
Median 2  0 0
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Here we have evidence of two respondents who covered eight areas in on-going 
training in the previous twelve months and twelve managers who had not done any The 
average number of courses for all respondents was two
Again, for these findings to be more meaningful, further research is necessary to 
determine the length and depth of each of these courses, but it can be inferred that areas 
such as sales management, team building and leadership are currently deemed to be 
relevant by these managers
When the respondents were asked to rate the on-going courses they had attended in 
terms of making them more effective managers, three out of five gave them a 
favourable (1 e good or fair) rating
In order to find the management areas where the respondents felt they had existing 
deficiencies, the respondents were asked to choose three areas, in rank order, in which 
they would like further training
The summation (3x2x1) of the responses were as follows
Table 611 Deficient Management Skills
%
Finance 73
Marketing 45
Sales Management 29
Production 2
Quality control 0
New Technology 15
Strategy /Planning 63
Leadership 2 2
Therapeutics 4
Pharmacology 2
General Management 43
Team Building 11
Personnel 12
Other 2
n = 55
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Accordingly, finance is seen as the area m which the respondents feel most vulnerable 
Strategy/planning is the second most cited area followed at a distance by marketing and 
general management The respondents’ perceived weakness in finance would uphold 
Shepherd and Ridnour’s assertion (1995,p 73) that management development training 
for sales managers “should be refocused on profitably running a business in the 
increasingly competitive and volatile economic climate”
Combimng the results of questions 20 and 21, for visual purposes, gives the following 
picture regarding turnover (job switching) by the respondents, both m their careers as 
sales representatives and now as managers
Table 6.12. No.of pharmaceutical companies worked for 
N o  O f  C o m p a n i e s  S a l e s  R e p r e s e n t a t i v e  S a l e s / S a l e s &  M a r k e t i n g  M a n a g e r
% %
0 7 6
1 42 58
2 27 2 0
3 13 9
4 9 4
5 + 2 1
100 100
N = 55
It would appear that turnover rates are quite low with almost half the respondents 
having worked with only one other employer as a sales representative Kelly (1995, 
p i l l )  also recorded similar turnover rates for pharmaceutical salespeople in Ireland 
She found that 52 per cent of pharmaceutical sales representatives had more than eleven 
years experience, and of these, 65 per cent had been employed by the same company 
for that entire penod of time A strongly contrasting situation regarding American 
heathcare representatives was reported by Bowers et al (1994), who found that the 
average time in their present position was only 2 75 years Kmghtley (1993, p 28) 
reported that pharmaceutical sales representative turnover in the U K was at the level 
of 15-25 per cent every two years
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With regard to pharmaceutical managers the turnover figure is even less, with two out 
of three respondents havmg worked for only one other employer as manager Given 
Armstrong’s (1993, p22) finding that sales management change leads to improved 
salesforce performance it may be argued that Irish pharmaceutical companies are 
missmg one particular opportunity to increase sales Conversely, Guest et al (1989, 
p 51) reported U S first level sales manager turnover rates at 11 per cent p a  to be 
unacceptably high
Perhaps the reluctance of Insh pharmaceutical sales managers to move may, in part, be 
explained by job satisfaction experienced in the respondent’s current position as 84 per 
cent of them reported that they were very satisfied with their current position For 
comparison purposes, 40 2 per cent of Insh nurses indicated that they would be “quite 
likely/very likely” to leave nursing, assuming the availability of another job (Statiscope, 
1996)
The final demographic areas researched were gender, age and remuneration
90 per cent of all respondents were male This is a somewhat surprising result given 
that the subsequent analysis of Question 32b showed that 33 per cent of the sales force 
are female Evidence from the Insh pharmaceutical sales managers would appear to 
support Comer et al’s (1995,p 18) assertion that “the female sales manager is still a 
rarity” It would appear that féminisation of sales management in the ethical 
pharmaceutical industry is not too likely in the short-term Cross-tabulating sex of 
respondent with other demographic variables highlighted some interesting issues All 
six of the female respondents were in the 30-39 age bracket compared to 4 5  per cent of 
all respondents 6 6  per cent of the female respondents had less than five years sales 
management expenence compared to the 2 0  per cent industry average 83 per cent of 
the women had less than five years selling expenence before being promoted into 
management compared to 50 per cent of all respondents In addition, a cross tabulation 
of gender by current position showed that of the five female managers, four are sales 
and marketing managers
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The age profile of the respondents indicated a relatively young management structure 
with almost half being under thirty mne years of age
Figure 6 4 Age Profile of Respondents.
Of note here is the fact that none of the respondents are over sixty, perhaps indicating a 
management option of early retirement in this industry The cross tabulation of current 
position by age shows that 60 per cent of the sales and marketing managers fall into the 
30-40 age category compared to 38 per cent of the sales managers Likewise 29 per 
cent of sales managers are between 50-59 years compared to 10 per cent of the sales 
and marketing managers Thus the age profile of the sales and marketing managers is 
younger than that of the single mandated sales managers
Figures from Profile of a Salesforce, published in Autumn 1995 by Dublin-based Sales 
Placement Ltd showed remuneration for sales managers in the healthcare category to be 
as follows
10+ years expenence £38,740
5-10 years expenence £36,750
Under 5 years expenence £34,667
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Total earnings for the respondents participating m this research are represented as 
follows
Figure 6 5 Total Annual Earnings Of Respondents
ANNUAL EARNINGS
601-----------------------------------------------------------------
Mssmg 21-30K 31-40K 41-50K 50K AND MORE
WHAT IS YOUR ANNUAL EARNNGS
82 per cent of respondents were earning between IR£31,000-IR£50,000 Cross 
tabulating annual earnings by current position showed sales managers were more likely 
to be in the lower band of earmngs than sales and marketing managers (Table 6  13) 
However, there was no difference between the two groups in the IR£31-40,000 band 
and again, sales and marketing managers are more likely to be in the IR£41,000-50,000
group
Table 6.13: Cross Tabulation Of Earnings By Current Position
C O U N T S A L E S  M N G R S S A L E S  &  M A R K E T I N G
E a r n i n g C O L  P C T M A N A G E R S
2 1 - 3 0  K 3 1
1 1  5 5  3
3 1 - 4 0  K 1 5 11
5 7  7 5 7  9
4 1 - 5 0  K 6 6
2 3  1 3 1  6
5 0  K 2 1
7 7 5  3
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Finally, the author attempted to find the prevalence and level of incentive-related pay 
for managers m this market A number of percentage bands were given and the 
respondents asked to indicate which band best represented the amount of bonus-related 
pay in their remuneration The results were as follows
Table 6.14: %  Of Remuneration That Is Bonus-Related
%
Nil 20 4
Less than 5% 167
5-10% 33 3
10- 20% 27 8
More than 20% 1 9
100 0
n = 54
One in five managers do not have any form of incentive-linked remuneration in their 
remuneration structure In the cross tabulation of bonus-related pay by current position, 
25 per cent of sales and marketing managers receive no incentive-linked pay compared 
to 16 per cent of their single-mandated sales management colleagues
OBJECTIVE 3
The third stated research objective was to draw a profile of the companies m this 
industry, with specific reference to their sales and marketing structure
Figure 6 6 World Headquarters of Respondent's Company
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One in three of the respondents are working for American companies as the Table 6 15 
below illustrates
Table 6.15: Headquarters Of Respondents’ Employer
%
Ireland 12 5
The UK 179
TheU SA 35 7
An E C Country 196
Other European Country 12 5
Elsewhere 1 8
n = 56 100 0
A similar question asked of British pharmaceutical sales representatives by Dr Justin 
Greenwood (1985) indicated 44 per cent were working for a British firm, 31 per cent 
for companies with other European headquarters and 25 per cent for Amencan-owned 
companies
Turnover of the respondents' companies gave the following picture 
Figure 6 7 Turnover of Respondents’ Companies (IR£)
30
153M 45M M0FETHÛJSI6M
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Here we have a considerable spread of responses, with over half (51 8 per cent) of 
companies having an annual turnover of IR£3 million or less from their ethical 
pharmaceutical business The next largest category (17 9 per cent) was companies with 
a turnover of IR£6  million or more
75 per cent of the sales and marketing managers were with companies with turnover of 
IR£5 million or less compared to 66 per cent of sales managers The other 25 per cent 
of sales and marketing managers were with companies whose turnover exceeded IR£6 
million compared to 15 per cent of sales managers
An open-ended question regarding sales force size resulted m the following categones
Table 6.16: Number Of Full-Time Sales Representatives
No Of Full Time Sales Representatives %
Less than 5 38 2
6-10 41 8
11- 15 12 7
16- 20 73
(n=56) 100 0
This result is visually represented in Figure 6 9 
Figure 6 8 Salesforce Size.
20*1-----------------------
1 3 5 7 9 12 14 16
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The majority of companies (44) have sales forces of less than eleven people and oniy 
three have the maximum quoted size of twenty representatives This finding is 
consistent with the Lambkin and deBurca data which showed that 41 per cent of 
companies employ fewer than 10 representatives and 68 per cent fewer than 20 
Further cross tabulation of annual turnover by number of full time sales representatives 
showed that the largest sales forces came from companies with turnover in excess of 
IR£5 million
In the cross tabulation of current position by size of sales force, it emerged that no dual­
mandated sales and marketing manager was responsible for a sales force of greater than 
twelve representatives
Typically selling has been a male-dominated career but in recent years women have 
become more numerous in this employment sector Responses to an open-ended 
question on female representation in the ethical pharmaceutical sales force yielded the 
following table
Table 6.17. Number Of Female Sales Representatives.
No Of Female Representatives %
0 109
1-3 65 5
4-6 20 0
7 + 36
(n = 56) 100 0
In total, the census yielded four hundred and nine full-time ethical pharmaceutical sales 
representatives of which 136 (33 per cent) are female Conflicting figures abound, the 
Lambkin/de Burca (1991) study had found that in the chemical/pharmaceutical 
industry, 43 per cent of sales representatives were female However they counsel that 
the respondents to their research were typically representative of larger, long- 
established companies as their sample was drawn from the Top 1000 Irish companies 
list Kelly (1995) reported that 29 per cent of this sales force were female What is 
certain is that the Irish situation is very different from that in America, where Bowers et 
al (1994) reported that U S healthcare sales forces are made up of 68 per cent females
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and 32 per cent males This study did not give the breakdown between full-time and 
part-time representatives so speculation that the high female representation may be due 
to part-time participation cannot be grounded
The use of contract or part-time sales people is a phenomenon which is increasing in 
many types of selling today
Lopuch and Mummers (1994, p23) had predicted that m the ethical pharmaceutical 
industry, with its heavy reliance on expensive personal selling, more of the players in 
the industry would increasingly use interim salespeople 16 4 per cent of respondents in 
this census employed part-time sales people As this study is the first attempt to 
benchmark sales management practice in the Irish pharmaceutical market, the author is 
unable to support or refute Lopuch and Mummers’ assertion because of the non­
availability of historical data
On cross-tabulating employment of part-time sales people by turnover of company, it 
appeared that these were most likely to be found in companies with annual turnover of 
IR£1 5-3 million, however 33 per cent of respondents who answered yes were in the 
IR£6  million plus bracket Interestingly, sales and marketing managers are three times 
as likely to use part-time sales people than their single-mandated sales manager 
colleagues
With regard to the previously discussed trend of companies turning to over-the-counter 
products to support ethical sales revenue (Chapter 1), 41 per cent of the respondents 
said they had over the counter products (OTC) in their product portfolio An interesting 
finding of the research, however, was that two thirds of all managers required their 
representatives to call on retail pharmacies despite the fact 64 per cent of these did not 
have OTC offerings in their product portfolio These managers obviously deemed it 
important to keep in regular contact with non-hospital pharmacists Further open-ended 
questioning as to why they required these retail pharmacy calls produced the following 
answers
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Table 6.18: Major Reasons For Retail Pharmacy Calls.
%
Information gathering 63 5
Maintaining contact 46 2
Sales 36 5
Product monitoring 28 8
Other 154
190.4
As well as looking at the profile of the companies the author had an additional research 
objective of looking at the existence and structure of these companies’ marketing and 
sales organisation
A large variety of organisational structures exist in the Irish ethical pharmaceutical 
industry Nine of the companies have separate sales and marketing managers, both 
based in Ireland Approximately twelve of the companies have sales managers in 
Ireland with their marketing function overseas Eight of the companies have appointed 
Irish dual-mandated managers responsible for a field sales force but with the marketing 
function overseas There are also twelve companies who have appointed dual-mandated 
managers who have responsibility for both sales and marketing from an Irish based 
structure
46 per cent or twenty five companies have marketing departments that are separate 
entities to their sales department This percentage is extremely close to the 45 per cent 
Piercy (1986) recorded in his research into the existence of marketing departments in 
UK manufacturing firms, perhaps indicating a stability in marketing thinking with 
reference to the need for such departments On examination of the integration of 
marketing functions in these UK companies, Piercy also found that nearly 40 per cent 
organised sales separately from marketing, in this industry 46 per cent separate the two
80 per cent of these Irish organisations who do not separate sales and marketing have 
turnovers of less than £4 million compared to 65 per cent of all companies in this 
industry category
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In cross-tabulation 80 per cent of sales and marketing managers said that in their 
company the marketing department was not a separate entity from sales whereas 68 per 
cent of sales managers said marketing was a separate entity in their companies This, 
along with the fact that 54 percent of all respondents said sales and marketing 
departments in their companies are not separate entities helps us understand the reason 
behind the prevalence of the dual-mandated sales and marketing manager
Those twenty five respondents whose companies have separate marketing departments 
were asked to indicate the positions that existed m that department in an attempt to 
establish the depth of marketing activity m the Insh-based department The author had 
gathered from the in-depth interviews that a lot of the marketing activities were 
designed for the UK market and local adaptations made for the Republic of Ireland
Table 6 19: Positions in Respondents’ Marketing 
Department
%
Marketing Director 23 1
Marketing Manager 57 7
Product/Brand Manager 65 4
Marketing Assistant 42 3
Market Researcher 23 1
2116
Nine of the twenty-one sales manager respondents indicated there was a marketing 
manager position in their company, while two of the twenty dual-mandated managers 
indicated this position existed in their companies No single-mandate sales manager 
reported to a marketing person, while just one dual-mandated manager did, and that was 
to a marketing director
Carpenter (1992, p 31 ) documented the results of developing strong communication 
between marketing and selling All respondents were asked to rate the quality of (a) 
communication and (b) co-operation between the two, Table 6 20 gives the results
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Table 6 20: Rating The Quality Of co-operation and
Communication Between Marketing and Sales.
Communication Co-operation
% %
Excellent 40 0 51 0
Very good 42 3 34 7
Fair 154 12 2
Poor 1 9 2 0
100.0 (n=52) 100 0 (n=49)
Perhaps not surprisingly, sales managers were less likely to give positive ratings to 
these factors than the sales and marketing managers For example, 25 per cent of sales 
managers said the quality of communication between the two departments was fair or 
poor, whereas no sales and marketing manager felt this
Similarly, 22 per cent of sales managers rated co-operation between the two 
departments as fair or poor compared to 6 per cent of sales and marketing managers
OBJECTIVE 4
The fourth research objective was to examine the sales management practices of the 
managers in the Irish ethical pharmaceutical industry The results which follow have 
been drawn from the responses to the third section of the questionnaire
With reference to sales force organisation three out of five companies (60 per cent) opt 
for using some form of specialisation in structuring their sales force
It may be inferred that those who do not opt for specialisation use a standard 
geographical/territorial basis No significant difference between the sales and marketing 
manager and the sales manager in their approach to sales force structure emerged An 
open-ended question probing further information on the type of structure used yielded 
the following results
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Table 6.21: Forms Of Specialised Structures Used
%
Hospital Sales Force 54 5
GP Sales Force 42 4
Product-based structure 45 5
Other 24 2
n = 33 166 7
Territory boundaries do not last forever, sales managers need to adjust them continually 
to resolve local issues This industry is no exception, substantial adjustment has taken 
place, with over three-quarters of the respondents having undertaken territory revision 
in the previous two years Four out of five sales managers answered yes compared to 
three out of four sales and marketing managers In an effort to establish the extent of 
revision that had taken place in the previous two years the following results were 
recorded
Figure 6 9 Frequency of Territory Revision within previous two years
Msang ONCE TWŒ TI-FŒ TIMES
The pnme reasons mentioned for these revisions were as follows
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Table 6.22: Reasons For Territory Revision
%
Equalisation of territories 27 9
Increased Sales Force size 20 9
Personnel changes 32 6
Market-driven 41 9
123 3
Market-driven reasons included such responses as "competition", "changing market 
requirements", "increasing importance of hospital business", and “increased penetration 
at general practitioner level" It is heartening to see such evidence of response to 
customer-related factors
“The fundamental task of an administrator is to staff the organisation with the right 
people” (Stanton and Buskirk, 1983, p27) In order to assess the importance of this 
sales management function to the managers in the Irish pharmaceutical market six 
questions were asked to get a picture of their selection and recruitment practice
Firstly, the respondents were asked to rank eight sources of recruits in terms of their 
usefulness in providing successful pharmaceutical sales representatives The 
respondents were required to circle a number between one and five to indicate the 
usefulness of each source, with one representing a very useful source and ascending to 
five, meaning a source that is not at all useful In the analysis for a mean, a score of +2 
was awarded to 1, +1 awarded to 2 and in decreasing units down to -2 for a 5 rating
The following results were recorded
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Table 6.23 : Usefulness Of Recruitment Sources
Mean Std. Dev
Advertisements .25 1.08
Personal contacts .67 1.38
General recruitment agencies -.57 1.29
Sales recruitment agencies .67 1.29
In-Company promotion .02 1.49
Educational institutions -.98 1.17
Unsolicited applications -.87 1.24
Personal referrals .24 1.30
Here we can see that the respondents rate personal contacts and sales recruitment 
agencies to be equally good at providing successful recruits. Advertising and personal 
referrals followed, both with a similar score.
In the Lambkin/de Burca study (1991) personal contacts also got the highest score, with 
the authors reflecting that this is probably influenced by the relatively small size of the 
business community here in Ireland. Likewise, in the Avlonitis, Manolis and Boyle 
(1985) study of sales management practices in the U.K. manufacturing industry, the 
responses of the group which included proprietary pharmaceuticals also ranked personal 
contacts as the best source for providing successful sales people (p.9), followed by 
press advertisements and in-company transfers.
Knightley (1993) highlighted evidence of U.K. pharmaceutical companies including 
new graduates in their recruitment pool (p.28) but it appears that Irish sales managers 
rate this as the least useful source for obtaining successful pharmaceutical 
representatives.
As part of a planned recruitment process and in order to increase the effectiveness of 
matching the candidate to the job the preparation of a job description and personnel 
specification are widely recommended. In this industry the majority of managers 
responsible for the recruitment of the field sales force have both these documents 
prepared prior to starting the recruitment and selection process.
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Table 6.24: Prior Existence Of Recruitment Tools
Always Sometim Never
% es %
%
Job Description (n = 56) 87 3 9 1 36
Personnel Specification^ = 52) 65 4 23 1 11 5
With regard to the existence of job descriptions there is no significant difference 
between sales managers and sales and marketing managers in their use of this tool
Personnel specifications were not used as frequently as job descriptions by the 
respondents Again, there was very little difference between sales managers and sales 
and marketing managers regarding their preparation and use
Cross-tabulating respondent satisfaction with their selection procedure and the 
preparation of job description showed that of those respondents who always prepare job 
description (87 per cent), 71 per cent find their overall selection and recruitment 
procedure satisfactory However, only 20 per cent of those respondents who sometimes 
draw up a job description find their overall recruitment process very satisfactory
There is a significant body of literature regarding the personal characteristics and 
abilities required for effective selling (Churchill, Ford & Walker 1985, Weilbaker 
1990) In an attempt to find the abilities deemed relevant by Irish ethical 
pharmaceutical sales managers the respondents were given a five point rating scale and 
asked to rank the importance of fifteen given abilities for effective pharmaceutical 
selling The deriving of the mean score followed the same procedure outlined before 
Table 6 23
The following rank order emerged in this analysis
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Table 6.25* Abilities Deemed Necessary For Effective 
Pharmaceutical Sales People
Mean Std Dev.
Communication skill 1 62 1 01
Listening 1 57 101
Enthusiasm 1 48 1 09
Perseverance 1 36 1 00
Confidence 1 35 1 05
Ability to learn 1 27 1 14
Observational skill 1 24 84
Ability to handle rejection 1 19 1 01
Adaptability 1 18 1 11
Empathy 1 16 1 11
Organisational skill 1 04 98
Comprehension 96 86
Interrogative skill 83 1 12
Creativity 69 98
Likability 53 121
(n=56)
This list of fifteen abilities had emerged from a study earned out by Weilbaker (1990) 
in the US He had taken the responses of three groups, pharmaceutical salespeople, their 
sales managers and the physicians on their temtones and compiled the fifteen abilities 
from their opimons As Table 6 25 shows, Insh pharmaceutical sales managers put 
communication as their first pnonty when trying to match applicants to the job 
available
The author acknowledges that while one should be careful not to place too much 
significance on the mean importance rating of closely ranked attributes, it is certainly 
possible to determine which attnbutes are regarded as important and which are less 
important
For comparison purposes Table 6 26 illustrates the ranking assigned by both the US 
sales managers and the Insh respondents The rank ordenng was as follows, the ability
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with the highest frequency of mention is ranked one, the ability with the second highest 
mention is ranked two and so on In the case of a tie within any one party, the tied 
abilities were given the same rank and the next most important ability is assigned the 
rank equal to the number of the ability
Table 6 26 Ratings from US and Irish Sales Managers
Adaptability
US
1
Ireland
9
Communication skill 1 1
Comprehension 1 12
Ability to learn 4 6
Interrogative skill 4 13
Observational skill 6 7
Confidence 7 5
Organisational skill 7 11
Empathy 7 10
Ability to handle rejection 7 8
Perseverance 7 4
Enthusiasm 12 3
Creativity 12 14
Likability 14 45
Listening as an ability had come m as the second most important ability in the Irish 
research Weilbaker did not include this ability per se m his study, though he defined 
the comprehension ability as the salesperson’s ability to actively absorb the verbal 
messages presented by physicians in sales interactions However the author included 
the description “listening” as a result of the six m-depth interviews and latterly from the 
pre-test of the questionnaire Indeed Ingram et al (1992, p 26) had identified “poor 
listening skills” as the most predominant reason for salesperson failure, as seen by sales 
managers
Using the selection criteria from the Lambkin/de Burca study, the respondents were 
asked to rank them one, two and three m order of importance Table 6 27 shows the
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summation for each criterion and the order in which the criteria were ranked in the 
Lambkin/deBurca study
Table 6*27: Important Selection Criteria
Sum (3x2x1) Rank Order 
Lambkin
Personal characteristics 132 0 ) 1
Ambition/ development 
potential
68 (2) 2
Educational standards 52 (3) 6
General sales experience 50 (4) 3
Industry specific experience 26 (5) 4
Personal mobility 8 (6) 4
(n = 56)
Comparing these results to those of the M Lambkin/de Burca study the most important 
two were similar but educational standards had received the lowest score in the earlier 
study Avlomtis et al (1986, p 49) had found that the responses of the pharmaceutical 
managers in the UK ranked relevant product experience, ambition development 
potential and personal characteristics as the most important selection criteria However 
it appears from this research that Irish sales managers do not put the same value on 
relevant product experience as their counterparts m the UK
The prevalence of the use of supplementary selection aids to augment the objectivity of 
the selection and recruitment process is varied as Table 6 28 illustrates
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Frequency Of Use
%
Table 6.28: Respondents’ Use O f Supplementary Selection Aids
Written references 76 4
Oral references 72 7
Medicals 69 1
Psychometric tests 38 2
Role play 23 6
Psychological tests 21 8
Graphology 55
Other 1 8
(n = 56) 309.1
In total, 171 instances of use were recorded giving a picture of each manager using an 
average of three supplementary selection aids Wotruba (1970, p45) had asked about 
the prevalence of use of salesmen selection tools In that study although 83 per cent of 
respondents were using physical examinations only 35 per cent considered them to be 
very helpful in selecting salesmen Also, although 83 per cent used physical 
examinations only 74 per cent used references, a reversal of the usage pattern of Irish 
pharmaceutical sales managers
When examining the differences in the use of supplementary selection aids by sales 
managers compared to sales and marketing managers, very little differences emerged 
except the observation that the dual mandated managers are higher users of both forms 
of references than their sales manager colleagues
Figure 6 10 illustrates the overall level of respondent satisfaction with their selection 
and recruitment procedure
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Figure 6 10 Satisfaction With Current Recruitment Procedure
Two thirds of the respondents were very satisfied that their current selection and 
recruitment process was delivering them effective sales people No respondent 
considered their procedure to be unsatisfactory
Questions 45-51 examined the training function and practices in the Insh 
pharmaceutical industry These questions were designed so as to replicate the process 
Honeycutt et al (1994) outlined, described in Chapter 2, Section 5 2
The types of training, both for induction programmes and ongoing training, being used 
by the respondents are as follows
Table 6.29; Training Methods Used
Induction Ongoing
% &
On-the-job 83 9 78 6
Formal courses (in-house) 96 4 85 7
Formal course (external) 26 8 57 1
Self-study programmes 58 9 64 3
(n = 56) 266 0 285 7
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Pharmaceutical companies invest considerable time and effort and financial resources in 
training their sales people This is partly evidenced by the high number who can offer 
formal training, both induction and ongoing, in-house Many Insh pharmaceutical 
companies send their sales people to their overseas head office for both these types of 
training, though all the respondents who have their head quarters in Ireland (12 5 per 
cent) provided their in-house training here
The in-depth interviews had pointed the author to the fact that self study is a growing 
area m pharmaceutical sales force training Some of the programmes mentioned 
included a combination of printed material, audio and video tapes, and examinations, 
with the individual learning at their own speed but not progressing onto the next stage 
of learning until certification of sufficient knowledge at the current level had been 
verified
On-the-job traimng plays an extremely important role in both types of training, thus 
underlining the need for having a sales or sales and marketing manager who has 
training skills The only observable difference between the two categories of managers 
in types of training used is that almost half (46 7 per cent) of sales managers are likely 
to use external courses for their induction programmes compared to one in three sales 
and marketing managers
The respondents were asked to indicate all relevant trainer options in order to find out 
who carries out the training in these companies Table 6 30 documents the responses
Table 6 30- Position Of Trainer In Respondent Companies
Induction Ongoing
Sales Manager 69 6 86 5
Senior Sales person 32 1 32 1
Full-time Company Staff trainer 35 7 34 0
Outside training consultant 23 2 49 1
Overseas Company training division 43 6 34 0
204.2 235 7(n=56)
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Approximately one in two companies will send their new recruits to an overseas sister 
organisation for training
There is a heavy dependence on the sales manager himself/herself doing the training 
with marginally more sales and marketing managers doing it for the induction 
programme (75 per cent Vs 65 per cent) However, there is no difference between them 
when it comes to ongoing sales training programmes, both being equally involved (85 
per cent) This dependence on the sales manager as trainer has implications for their 
selection and recruitment, maybe somewhat supporting Lynch’s (1990, p 13) assertion 
that the appointee should have a proven track record as a successful salesperson 
Obviously he/she also needs training skills
The Lambkin/de Burca study for all respondents across Irish industry found on-going 
courses typically lasted up to one week The picture emerging from the ethical 
pharmaceutical industry is significantly different
Table 6.31: Annual Training Duration For Representatives
Annual Duration Of Training
Induction Ongoing
% %
Up to one week 74 43 1
2-4 weeks 55 6 54 9
1-6 months 35 2 2 0
More than 6 months 1 8 0 0
(N=54) 100 0 100 0(n=51)
Here we can see that there is a substantial investment in training sales people by these 
companies with 90 per cent of them allowing training to last somewhere between two 
weeks and six months for new recruits Over half of the respondents give their existing 
sales people on-going training programmes lasting between two and four weeks, thus 
being substantially different to the overall industry findings of Lambkin/de Burca
No significant differences occur when examining differences in the length of induction 
training programmes by category of manager However, sales managers are more likely
Page 152
to allow longer on-going training time than their sales and marketing manager 
colleagues as Table 6 32 illustrates
Table 6.32: Duration Of On-Going Training By Manager Type
On-Going Training POSITION
Sales Manager Sales&Mkt Mngr
Up toi Week 7 7
29 2 38 9
Two-Four Weeks 16 11
66 7 61 1
1-6 mths 1
42
A subsequent question was devised to elicit the prevalence of companies who formally 
evaluated the effectiveness of their training programmes
Table 6.33* Existence Of Formal Evaluation Of Training
Induction Ongoing
% %
Always 80 8 47 1
Sometimes 96 43 1
Never 96 98
Total (n=52)100 0 (n=51) 100 0
Obviously, formal evaluation is more prevalent with induction training programmes 
Future research would need to probe more deeply into the evaluation methods used by 
these companies in order to get a more meaningful picture From cross-tabulation, it 
appeared that sales managers are more likely to always carry out formal evaluation than 
their dual-mandated colleagues
In the open-ended question designed to uncover the most important areas to be covered 
in an induction training programme, the following results emerged
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Table 6.34: Areas Included In Induction Training Programmes
% inch Area In Programme
IRISH AVLONITI
s
Product knowledge 96 4 95
Selling skills 74 5 80
Self management 47 3 63
Medical knowledge 43 6 NA
Communication skills 36 4 NA
Market orientation 27 3 50
Company orientation 27 3 45
Competitor knowledge 12 7 NA
365 5
Avlomtis et al (1985) surveyed U K sales management practices and among their 
categories of respondents were U K pharmaceutical manufacturers When looking at 
training programme content Avlomtis grouped market and competitor knowledge 
together 50 per cent of U K respondents included it in training programmes as did 40 
per cent of Irish respondents Additionally, Irish respondents placed less emphasis on 
company orientation in their training programmes than did the U K managers
Membership of the Medical Representatives Institute of Ireland (M R11 ) requires the 
candidates to pass examinations set by the teaching staff of University College 
Hospital, Galway These examinations cover the major medical and therapeutic areas 
Given the importance of product and medical knowledge for the job, the author wanted 
to assess if the employers were using this examination as a minimum requirement for 
selling in the ethical pharmaceutical area 56 per cent of the respondents do indeed 
stipulate membership, which may in turn have an impact on their training programme 
content and opens up a possibility for assessment of medical knowledge
Questions 52-55 were designed to understand the remuneration practices for sales 
people used by the respondents
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Figure 6.11* Type of Remuneration Plan Used
STRAIGHT SALARY
COMBINATION
Nine out of ten (94 per cent) of the respondents use a combination structure for their 
sales peoples' compensation plan None used commission only This would verify 
Kelly’s (1995, p 114) finding that 94 per cent of Irish pharmaceutical sales people were 
being paid by a combination-type package
Further questiomng of the respondents indicated which given base or bases they used 
for the incentive pay element of the remuneration
Table 6.35: Base/s Used For Incentive Pay Element
%
Sales volume (target achievement) 57 7
Growth 13 5
Activities/tasks performed 13 5
Market Share 96
Profit contribution 58
(n=52) 100 0
Over half the companies tie the incentive to achievement of targets, with a considerably 
smaller group equally using growth and activities performed as the linked element Of 
some surprise is the very low number using a profit contribution linkage, though this 
may be explained by the dominant role of the Government in setting prices in this
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industry, thereby giving the individual representative very little scope to influence 
profit contribution
However, fairly substantial differences in approach to base used appeared in the cross 
tabulation with category of manager -
Table 6 36* Cross-tabulation of manager position with incentive base Used
Sales Manager Sales&Mkt Mngr
12 8
Sales Volume 63 2 40 0
Profit 1 2
Contribution 53 10 0
Activities / 3 1
Tasks 13 8 50
Market 1 4
Share 53 20  0
Growth 2 5
105 25 0
19 20
Sales Managers tended to prefer using sales volume as a base to link incentive pay 
(63 2 Vs 40 0 per cent) whereas, sales and marketing managers, when not using sales 
volume, are more likely to use market share and growth as the bases than sales 
managers
A further question to elicit the actual practice of paying an incentive element gave the 
following picture
Table 6 37. Practice For Paying Incentive Element
%
Primarily team based 170
Primarily individual based 62 3
Team based followed by individual achievement 20  8
(n=52) 100.0
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In order to uncover the approximate portion incentive pay had of the sales 
representative's overall remuneration package, the following results emerged
Figure 6 12 Approximate Portion Of Incentive Element To Overall Remuneration
Msang LESSTH^ M10% 11-25%
64 per cent of the respondents indicated that the bonus element made up less than 10 
per cent of the salesperson’s overall remuneration 36 per cent said the portion was 
somewhere between 11 and 25 per cent with no company paying over 25 per cent of 
total pay through some form of incentive element A considerably different picture had 
previously been identified on the UK pharmaceutical sales area In Dr Justin 
Greenwood’s 1985 survey of U K sales representatives in this industry, 42% did not 
receive any incentive pay at all Of those who did, 94 per cent operated on a basis of 10 
per cent or less and only 6 per cent receiving more than ten percent of their total 
remuneration package on the basis of some form of incentive Clearly Irish ethical 
pharmaceutical sales representatives remuneration is much more closely linked to 
performance than their colleagues in the United Kingdom
Motivation of sales people is a much debated issue, both in the literature and by 
practitioners In addition to remuneration, this study attempted to find out what were 
the major motivational tools used in this industry
The respondents were given a five point scale and asked to rate motivational factors for 
their usefulness Table 6 38 illustrates the respondents scores
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Table 6.3$: Ranking For Effectiveness Of Motivational Tools.
Mean Std, Dev
Recognition of achievement 1 57 84
One to one meetings 98 79
Sales meetings 95 94
Objective setting 91 84
Bonus schemes 89 107
Pay plan (salary) 85 1 04
Promotion opportunities 49 1 19
Clear job description 35 1 02
Sales contests 02 1 05
Discipline -25 88
With a maximum score of +2 and a minimum score of -2, clearly recognition of 
achievement is seen as the most useful motivator and, in agreement with all the 
literature, discipline is perceived as being the least useful The only significant 
difference between sales managers and sales and marketing managers in rating the 
effectiveness of the motivator factors was in objective setting where 10 5 per cent of 
sales managers gave a nvery effective" rating compared to 30 per cent of their dual­
mandated colleagues
The author also included an open-ended question asking the respondents to mention 
other factors not mentioned m question 56, which contributed to sales force motivation 
in this industry This addition was included after the second pre-test of the 
questionnaire, at the suggestion of the industry pre-testers Unprompted results 
subsequently were coded into four categones
Table 6.39: Unprompted Motivator Factors
%
Other 46 7
Good management 40 0
Team spirit 26 7
Car 20 0
133 3
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The other category included many varied single mentions such as training and 
development, freedom/autonomy, good products, conferences, fair play, company 
position in industry and such like. The frequency of mention of “good management” 
intrigues the author, one could speculate that these respondents, as managers, attributed 
some of their sales force’s success to their own personal management style. Further in- 
depth exploration of the reasons behind this prevalence would be welcomed.
In order to ascertain the quantity and formal flow of written communication from the 
sales people back to the office, a number of reporting devices were listed and the 
respondents were asked to indicate how frequently they required these reports returned.
Table 6.40: Use And Frequency Of Reporting Devices
Device No. Requiring Daily/Weekly
%
Monthly
%
Expense Sheets 54 31.5 68.5
Competitor Activity Sheets 40 50.0 50.0
Exhibition reports 37 75.0 25.0
Meetings reports 47 75.6 24.4
Lunches hosted 42 66.7 33.3
Dinners hosted 40 71.8 28.2
Customer call reports 55 96.4 3.6
20 per cent of companies looked for the customer call reports on a daily basis, but the 
vast majority of market contact communication is required by most managers on a 
weekly basis. This would tend to indicate that these managers are quite up to date with 
marketplace happenings, presuming they are actively using the information that their 
representatives are feeding back.
When looking at the communication requirements of the individual category of 
manager the only significant difference observed was that sales and marketing 
managers were more likely to want competitor activity sheets weekly (59 per cent Vs 
43 per cent) than their sales manager colleagues.
A much-quoted benefit of sales force automation is the speed of information flow that 
can take place between the “remote” representative and the head office. In an attempt to
Page 159
ascertain the extent of sales force automation in this industry, the first investigations 
took place at the in-depth interview stage One of the six managers had introduced 
automation the previous year and was not totally happy with it’s results Two others 
were carrying provision for sales force automation in then: budgets, one for the previous 
three years, but as yet had not found a system which they were prepared to commit 
themselves and their financial resources The other three interviewed managers were 
familiar with the concept of automation but did not see it being useful to them at that 
time The author followed up this investigation in the questionnaire by asking the 
respondents how the salespeople returned the contact reports outlined in Table 6 40 
Figure 6 13 visually illustrates the responses
Figure 6 13* Mode of return for reports
Overwhelmingly, this industry is still not buying into the computer/information 
technology currently available for sales forces 82 per cent of the respondents used 
post/hand for exchange of information, with only 15 per cent using computers/ 
electromc territory management systems Clearly, computer hardware and software 
providers have significant work to do yet in relation to convincing this industry of the 
ments of their product and service offerings
The author wished to ascertain the extent to which the respondents used commercial 
market research for evaluation and decision-making purposes
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Table 6.41: Respondents’ Use Of Commercial Market Research
Research No. Of % %
Respondents Continually Never
AXIS 27 66.7 25.7
I.M.S. 43 76.7 7.0
I.T.S.A 42 92.9 7.1
Walsh Report 15 40.0 53.3
Irlem 17 29.4 52.7
Strata 17 41.2 47.1
Sub-territory Analysis 30 83.3 13.3
G.M.S 40 75.0 2.5
Further analysis showed the average sales manager in this industry is using three 
sources of commercial research on a continuous basis.
In an attempt to examine the prevalence of segmenting doctors for targeting purposes, 
the author asked about segmentation existence and practice. The results clearly 
demonstrate the industry’s belief in improving the efficacy of personal selling. 85.5 per 
cent of all respondents segment/categorise the G.P.'s that their sales people call to. The 
base/s of segmentation used are as illustrated in Table 6.42:
Table 6.42: Base/s For Segmentation Of G.P’s.
%
Size of practice 36.8
Prescribing power 36.8
Potential 21.1
Type of practice 15.8
Doctor's attitude 13.2
Other 50.0
173.7
The responses were generated from an open-ended question and subsequently coded 
into categories. ’'Other" responses included “generic friendly”, “priority selection by 
representative”, “size of GMS list”, “doctor interest”, “specialism” and “product 
usage”. From the segmentation bases mentioned it would appear that the Irish
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pharmaceutical industry is ahead of it’s U K counterparts who were only just moving 
from technical to marketing segmentation criteria (Doyle & Monteno,1994,p 283)
As previously illustrated in Figure 6 2 almost half of all respondents travelled out on 
territory with their sales people at least once a month In the in-depth interviews the 
author had raised the issue of double calling with the six interviewees Double calling is 
the practice of more than one person from the representative’s company being in the 
doctor’s surgery during a call All six were agreed that double calling gave immense 
opportunities to a sales manager, in that it facilitated training, qualitative evaluation, 
and afforded the manager a chance to meet the “customer” However, two of the 
interviewees had expressed a belief that double calling was not liked by doctors 
Consequently, through the primary research instrument the author attempted to 
ascertain the respondents’ belief about double calling and how much double calling was 
happemng in practice Figure 6 14 illustrates their belief
Figure 6 14 Respondents9 belief regarding double calling
CAN NOT BE DOE
CM.Y CEHTAIN DOC
86 per cent of the respondents felt double calling was acceptable to certain doctors and 
of the remaining 14 per cent seven per cent felt it was not a problem with any doctor, 
whilst the other seven per cent felt double calling could not be done at all The author 
therefore concludes that in some instances sales managers do get considerable
Msang
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opportunity to observe their salespeople in action, which has consequent influence on 
those salespeople’s training and evaluation
The extent of double calling was investigated through a question asking each 
respondent how many doctors they would personally see while spending a day on 
territory Figure 6 15 illustrates the responses
Figure 6.15* No. of doctors seen by respondent.
Thus one in four of the managers with responsibility for the field sales force do not 
accompany sales people into the actual call However 63 per cent reported that they 
would see on average one to three doctors while on a temtory-based day with their 
sales representatives No significant difference showed up between the categories of 
managers when looking at the 25 per cent who do not get into doctors’ surgeries, 
however, 69 per cent of sales managers see 1-3 doctors compared to 58 per cent of sales 
and marketing managers
The author asked an open-ended question looking for the four major objectives a 
manager would have when accompanying a sales representative into a call The 
responses of forty-four managers were grouped as follows
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Table 6.43: Major Objectives Of A Double Call
Evaluation of Sales person
Frequency Of Mention
%
84 1
Market knowledge 68 2
Traimng 50 0
Communication 36 4
Motivation 31 8
270 5
The author infers from this finding that with 84 per cent of mentions for evaluation, 
these managers are taking a "back seat" in the call and are primarily observing as 
opposed to participating
As this question referred specifically to objectives for going into a call, it is not so 
surprising that motivation got such a low mention because calls are not a suitable forum 
for one-to-one communication with the representative
The training objective is again more than likely fulfilled by observing the sales 
representative’s performance and interaction with the G P and subsequently 
praising/counselling him/her Finally, no significant differences were noted between 
sales managers and their dual-mandated colleagues in the objectives for double calling
Questions 67-69 were designed to obtain information on the way sales managers m this 
industry evaluate their salespeople Responses to frequency of formal face-to-face 
evaluation gave the following results
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Figure 6.16 Frequency of face-to-face evaluation
40
MORE THAN ONCE QUART EVERY 6 MONTHS
ONCE A QUARTER ONCE A YEAR
45 per cent of respondents perform formal face-to-face evaluation with their sales 
people at least once every three months while 30 per cent of the respondents do so only 
once a year When this question is cross-tabulated with category of manager, it becomes 
apparent that sales and marketing managers are more likely to evaluate at least once a 
quarter compared to their sales manager colleagues (50 per cent Vs 34 per cent)
Recogmsing the literature which supports the use of qualitative data in addition to 
quantitative data for good evaluation, the author attempted to ascertain the industry's 
emphasis on qualitative or soft evaluation data The nature of the missionary sales job 
makes quantitative evaluation somewhat less relevant than qualitative evaluation Issues 
such as the quality and durability of the of relationships with doctors, manner, 
provision of product and company information, and ability to handle differing situations 
as they arise are often best assessed through qualitative approaches based on 
observation of the salesperson at work
Three quarters of respondents deemed qualitative evaluation data to be very important 
However, one third of the forty respondents who deemed qualitative data to be very 
important travelled with their sales people less than once every two months
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No appreciable difference between the two categories of managers regarding their 
beliefs about qualitative information was noted
The author suggests that further research in this area should include questiomng on how 
the managers use this information in feedback to the salespeople in order to give a fuller 
picture of this important sales management function
Amott (1994, p 116) is one of many who support the practice of involving the 
salesforce in the setting of the goals which will play a part in their performance 
evaluation This industry obviously supports this contention as only one respondent 
claimed not to include the salespeople in setting the goals used m their evaluation
Table 6.44: Extent Of Salesperson Involvement In Goal Setting 
Used In Evaluation.
%
To a large extent 72 7
To a partial extent 25 5
Not at all 1 8
(n=55) 100  0
Questions 70-75 were designed to research the practice of sales forecasting in this 
industry
Lancaster and Jobber (1994, p 265) stated that many sales managers did not recognise 
that sales forecasting was one of their responsibilities and left such matters to their 
accountants To investigate this, the author asked who was responsible for the 
preparation of the annual sales forecast
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Figure 6.17: Extent Of Respondents9 Responsibility For
Preparation Of Annual Sales Forecast
Mssng
Thus, in this industry, one third of the sales managers take total responsibility for the 
preparation of the annual sales forecast Further research should examine more closely 
the entire forecasting process The author only asked about the preparation of the sales 
forecast and did not address the issue of who had responsibility for the ultimate 
decision as to the final forecast figure
However, the cross-tabulation of this question with category of manager showed an 
appreciable difference between the two types of manager Only 12 per cent of sales 
managers said that the preparation of the annual forecast was their total responsibility 
compared to 47 per cent of the dual-mandated sales and marketing managers
Those respondents who had indicated a shared responsibility in the preparation of the 
sales forecast were asked to indicate with whom they interacted
Table 6 45: Influence Of Others On Sales Forecast.
%
Very Influenced
Local Marketing Dept 65 5
Parent Company 65 7
Production Dept 45
Finance Dept 39 3
Other 0 0
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The only appreciable difference between the responses of the two categories of 
managers regarding the influence of the other partner is that 87 per cent of sales 
managers say the finance department influenced the end result compared to 67 per cent 
of sales and marketing managers
Stanton and Buskirk (1983, p 402) maintained that the sales manager is not faced with 
the choice of which forecasting method to use so much as in which one to place most 
faith In order to investigate this in the Irish ethical pharmaceutical industry 
respondents were asked to indicate all the methods they normally used to arrive at the 
annual sales forecast Table 6 46 illustrates the industry practice
Table 6.46: Forecasting Methods Used.
% Using
Judgmental forecasting 84 9
Time series analysis/historical sales 79 2
Sales force composite 43 4
Statistical demand analysis 22  6
Market test 15 1
Sales managers were more likely to use sales force composites (43 per cent Vs 33 per 
cent) than the sales and marketing managers
Again, in an attempt to establish the use of computers in sales management practice the 
respondents were asked whether they used computer packages to help their forecasting
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Figure 6 18* Respondents’ Use Of Computer Packages In Sales Forecasting.
Msang
NO HRhR- YES
Thirty of the fifty-four respondents answered in the affirmative Further analysis 
revealed 63 per cent of sales and marketing managers use computer packages compared 
to 52 per cent of Sales Managers
Those who answered in the affirmative were asked to rank the effectiveness of the 
packages One in four considered them to be “very effective” with another 62 per cent 
considering them to be somewhat effective Packages named by respondents were either 
of a spreadsheet nature or a statistical package Brand names mentioned included 
Dataview, Futurcast, Supercalc and Lotus
Given the range of functions for which a sales manager has responsibility, the author 
was anxious to know how much time was devoted to the strategic aspects of the sales 
management role Respondents were asked to estimate how many hours per week they 
allocated for private thinking and planning
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Table 6.47* No. of hours allocated to private thinking and Planning
%
5 or less 60 4
6-10 33 3
11 or more 63
(n=48) 100.0
Mean = 5 5 hours
Median = 5 000
Std dev = 4 115
Min = 0 00
Maximum = 23 00
When this question was cross-tabulated with category of manager, the following results 
emerged
Table 6.48: Private Hours By Category Of Manager
Sales Mgr Sales & Mktg Mgr
5 or less 56 3 64 8
6-10 37 6 29 5
11 or more 6 1 57
100 0 100 0
Thus approximately two out of three sales and marketing managers are unable to devote 
more than five hours to private thinking and planning compared to 56 per cent of 
single-mandated sales managers Although not directly linked to the author’s 
hypothesis of dual-mandated managers being unable to devote as much time to the 
practice of sales management, this result underscores the “busier” role that a sales and 
marketing manager performs However, the picture could be different if the author had 
also assessed the amount of group thinking and planning in which each respondent is 
involved Notwithstanding this, the above finding has implications for companies who 
appoint dual-mandated managers, particularly regarding the area of strategic planning 
and direction for the company
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The fifth research objective was “to examine marketing practice in the Insh ethical 
pharmaceutical industry, with special reference to market planning and the respondents’ 
attitude to marketing” This objective was addressed by questions 77-86 Although 
sales forecasting is part of the market planning process it was dealt with in Objective 3 
due to its importance as a sales management activity
Given that 87 per cent of respondents were working for companies of non-Insh 
parentage the author attempted to discover the degree of autonomy the Insh operation 
had in the Insh market A senes of five questions were asked to ascertain this
86 per cent of respondents stated that the Insh operation developed marketing plans for 
the Insh market
The 86 per cent of respondents whose organisations developed marketing plans for the 
local market were asked to indicate the level of involvement the parent company had in 
the finalising of these pnor to their adoption The results were as follows
Figure 6 19 Level of parent company involvement
OBJECTIVE 5
Mssng SOUBAHMINMXVBD
HOLY INMCLNG) NOT AT ALL INMOLV0D
38 per cent of the forty-seven organisations are completely autonomous In contrast, 17 
per cent of the managers stated their parent companies were highly involved
Respondents were asked to indicate the level of their personal involvement in the 
planning process
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Figure 6 20 Respondents’ personal involvement in the marketing planning process.
Overall 73 per cent of the forty-eight who responded to the question described 
themselves as being very involved and no respondent claimed to be not at all involved 
All of the dual-mandated managers indicated that they were “very involved” compared 
to 40 per cent of sales managers This finding may go some way to explain the results 
given m Table 6 48 If every sales and marketing manager is heavily involved in 
marketing planning it must reduce the available hours for other aspects of the job
Questions 80 and 81 were for those respondents whose Insh operation did not wnte 
marketing plans specifically for the Irish market These eight respondents were asked if 
their parent company prepared the Irish marketing plan to which 75 per cent answered 
yes
These six respondents were then asked to indicate their level of satisfaction with this 
practice The results showed a considerable level of dissatisfaction as Table 6 49 
illustrates
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Table 6.49: Respondents9 satisfaction with Head Office 
Imposed Marketing Plans
%
Very satisfactory 16 7
Satisfactory 50 0
Unsatisfactory 33 3
(n-6) 100 00
Although only six respondents were involved in this answer it was interesting to note 
that both sales and marketing managers who fell into this category gave an 
“unsatisfactory” rating to this practice compared to only one of the four sales managers 
who were in a similar situation
To examine marketing practice and the respondents’ level of involvement in it, the 
respondents were asked to indicate their level of input into five marketing activities
As with the previous rating scales a score of +2 was awarded to a “very involved” 
rating and so on through to -2 for a “not at all involved” rating The means and 
standard deviations for the three management categories of interest are as follows
Table 6-50* Involvement In Marketing Activities By Category Of Respondent 
Activity All Sales &
Respondents Sales Mgrs Mkt Mgrs
Mean Std Dev Mean Std Dev Mean Std Dev
Market Strategy Planning 1 05 1 30 258 1 31 1 75 91
Obj setting for local market 1 34 1 05 109 99 1 70 92
Marketing campaigns 1 02 1 14 55 94 1 45 1 05
Market research 05 1 35 -71 1 18 65 1 22
Sales promotion 1 64 86 1 86 48 1 60 99
As a group of managers the marketing activity in which they were most involved was 
sales promotion This may indicate a belief among these managers that they are more 
knowledgeable about what will and will not work in the area of sales promotions than 
the marketing people As a large proportion of the sales promotions are “imported”
Page 173
from their parent company’s offering on the British market, involvement can be as little 
as giving the Insh address line to the parent company promotion purchaser However, 
there may be promotions that are for the Insh market which have to be planned, sourced 
and implemented solely by the Insh sales manager A more detailed question about 
what exactly the respondents did in the area would have provided more useful 
information
In addition, there are significant differences in levels of involvement between the two 
categories of managers and their input into the five marketing activities
90 per cent of sales and marketing managers say they are very involved in market 
strategy planning compared to 27 per cent of sales managers
85 per cent of sales and marketing managers say they are very involved in objective 
setting for the local market compared to 38 per cent of sales managers
70 per cent of sales and marketing managers are very involved in marketing campaigns 
compared to 21 per cent of sales managers
35 per cent of sales and marketing managers are very involved in market research 
compared to 8 per cent of sales managers The relatively low levels of involvement in 
this area are probably due to the industry’s heavy use of syndicated research where the 
individual manager does not design or collect the data as shown in Table 6 41
However, sales managers are marginally more involved in sales promotion than their 
dual-mandated colleagues with 85 per cent of them saying they are very involved 
compared to 80 per cent of the sales and marketing managers
In summary, those respondents who descnbed themselves as dual-mandated have 
significantly higher levels of involvement in four of the five marketing activities These 
findings again give support to Research Objective 1, i e that the sales and marketing 
manager has indeed an applied marketing role which justifies the dual-mandate title It 
should also be noted however that though 38 per cent of the respondents described 
themselves as sales managers some of them have a significant involvement in certain 
marketing activities, notably sales promotion
Page 174
A further element of marketing practice is the use of such emerging marketing tools as 
telesales and direct marketing
Table 6.51: Use Of Newer Marketing Tools
(n=49) (n=53)
Tele-Sales Direct Marketing
Never 75 5 39 6
Occasionally 184 50 9
Always 6 1 94
100 0 100 0
As expected direct marketing techniques have been adopted more widely in this 
industry then tele-sales The 1994 Code of Practice (outlined in 4 8 1) for ethical sales 
representatives has outlawed the active detailing (giving product information) of drugs 
over the telephone, so the respondents who use this technique are referring to their 
practice in the over-the-counter market
The author believed that it would be revealing to find out where preference for 
additional manpower lay Consequently respondents were asked a hypothetical 
question regarding the likely immediate recruitment preference for one additional 
employee in sales or marketing
Overwhelmingly, 66 per cent of all respondents felt that, given the resources, they 
would immediately employ a sales representative 17 per cent of all respondents said 
they would immediately recruit a product manager, while 15 per cent would opt for an 
area/field sales manager
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Figure 6 21: Respondents9 immediate recruitment preference
Mssng PRXLCTMANAGBR MARKEHN3 MANAGER
SALESFB3 AREA SALES MANAGER
However, as Table 6 52 illustrates, a substantially different picture emerges when the 
recruitment preferences are examined by category of manager
Table 6.52 Recruitment Preference By Category Of Manager
Sales Mgrs Sales & Mktg
% %
Sales Rep 85 0 316
Product Mgr 50 316
Area/Field Sales Mgr 10 0 31 6
Marketing Manager - 53
(n=20) 100 0 /■—soTc'—'ooo
Sales managers voted overwhelmingly (85 per cent) to commit any additional resources 
to recruiting a sales representative whereas the dual-mandated managers were equally 
divided between employing a sales representative, a product manager and an area/field 
sales manager (32 per cent each)
Interestingly, only one sales and marketing manager would recruit a marketing 
manager There are a number of possible reasons for this One could speculate that the 
level of reported job satisfaction level (84 per cent very satisfied) may somewhat 
explain this finding, thus indicating that the respondents did not want their job to
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change A more likely reason is that because dual-mandated managers are more 
mvolved in planning, goal setting, and other marketing activities than sales managers, 
as shown by this research, they find their jobs more rewarding and have more control 
over their own destiny In addition, given their different backgrounds and training one 
would expect them to regard marketing as important to their job and therefore not an 
activity they would want to give away
The final element of Objective 5 was to examine the managers’ attitudes to marketing 
The author used four well-established statements about marketing to assess their 
attitudes In addition she included two statements that had come from the m-depth 
interviews, but these were not specifically related to attitudes to marketing The 
respondents were asked to indicate their level of agreement with each statement by 
choosing a point on a five point scale In the analysis a score of +2 was given to a 
“strongly agree” response and -2 to a “strongly disagree” response All fifty-six 
respondents answered every element of this question
The results were as follows
Statement 1
"Marketing strategy must lead a firm’s sales activities"
This statement received the second highest endorsement from all respondents It can be 
inferred that the majority of respondents agree with this very basic marketing tenet 
However, when isolating the responses received from the single-mandate and dual­
mandate managers a considerable difference in strength of agreement is revealed 75 per 
cent of all sales and marketing managers strongly agreed with the statement compared 
to 27 per cent of sales managers Clearly, sales managers need to be further convinced 
that selling is a function, albeit an important one, of marketing
All respondents
Mean
1 16
Std Dev
1 11
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Statement 2
"The primary role of marketing is to provide support to the Sales Force"
Mean Std Dev
All respondents 35 128
27 per cent of respondents strongly agreed with this statement, and another 7 per cent of 
respondents strongly disagreed This particular element of the question got the highest 
number of mid-point responses There was very little difference m the spread of 
agreement between the two categories of managers, with the small exception of 16 per 
cent of sales and marketing managers strongly disagreeing compared to 4 per cent of 
sales managers
Statement 3.
"Good sales managers make their sales people independent"
Mean Std. Dev
All respondents 1 05 98
This statement received a robust approval from all respondents No manager strongly 
disagreed with it, but 27 per cent of single-mandated managers showed some levels of 
disagreement compared to 15 per cent of sales and marketing managers
Statement 4
"The heart of marketing is selling"
Mean Std Dev
All respondents 45 133
Here there was practically no difference among the respondents who agreed with this 
statement but 35 per cent of sales and marketing managers showed certain levels of 
disagreement by scoring it at four and five (disagree and strongly disagree) compared to 
15 per cent of sales managers
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’’Marketing is about the long term, selling is more short term”
Statement 5*
All respondents
Mean
-0 2
Std Dev
1 31
This was the only statement to receive a negative mean mark Clearly, the respondents 
overall are not in agreement In cross-tabulation 50 per cent of the sales and marketing 
managers scored it at 4 or 5 (disagree and strongly disagree) compared to 38 per cent of 
sales managers
Statement 6:
’’The establishment of long-term relationships with doctors is vital"
This statement was accorded the highest mean mark by all respondents In addition this 
view was held across all categories of managers, emphasising the industry’s belief in 
the way forward for the future
OBJECTIVE 6
The sixth and final objective of this research was to assess the managers’ views of the 
Irish ethical pharmaceutical industry ten years into the future
Consequently, the final question of this research asked the respondents to indicate their 
agreement with a range of eight statements concerning the future of their industry in ten 
years time As with the previous question, a +2 score was allocated to a “strongly 
agree” response and so on down to -2 for a “strongly disagree” response
Statement 1
"Information technology will play a major role in day-to-day sales management”
All respondents
Mean
1 18
Std Dev
1 10
All respondents
Mean
1 72
Std Dev
45
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There was a resounding belief that this statement is an accurate reflection of the 
situation which will prevail in 2004 Not one manager gave it a negative score 
Interestingly, when the reader looks at the responses to preferred areas of further 
management development programmes (Table 611) computer skills was only 
mentioned by one respondent in the “other” category Consequently, we can surmise 
either all the respondents do have adequate information technology knowledge or that 
they omitted to mention that they were deficient m this area when responding to 
Question 19 Given the relatively low number of companies (14 per cent) who have 
their contact reports returned electronically (see Fig 6 12), the author personally 
believes the second of the two possibilities is the more likely
Additionally, single-mandated sales managers were more convinced than their dual­
mandated colleagues, with 76 per cent of them strongly agreeing compared to 60 per 
cent of the sales and marketing managers
Statement 2
"Women will be very much more prevalent in management positions"
Mean Std. Dev
All respondents 1 28 94
This statement was deemed necessary for inclusion by the author after the conducting 
of the in-depth interviews At that stage it had become apparent to her that the majority 
of managers in the industry were male although there was a considerable body of 
female sales representatives Analysis subsequently gave support to this perception, 
nine out of ten managers in the industry are male, and 33 per cent of the sales 
representatives are female The fifty four respondents by and large agreed that there 
would be more women managers in 2004
48 per cent of sales managers agreed strongly compared to 40 per cent of sales and 
marketing managers, while 10 per cent of the dual-mandated managers strongly 
disagreed compared to 4 per cent of sales managers
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When this statement was cross-tabulated by gender of respondent, 67 per cent of the 
female respondents strongly agreed compared to 42 per cent of male respondents Only 
6 per cent of male respondents strongly disagreed compared to no female respondents
Statement 3
"Pharmaceutical sales force sizes will have decreased"
Mean Std Dev
All respondents 94 132
This statement again emerged from the m-depth interviews where some of the 
managers were somewhat pessimistic about the ability of this industry in Ireland to 
maintain the current level of sales personnel, given decreasing sales force sizes m the 
UK, North American and some European markets
39 per cent of all respondents strongly agreed and another 46 per cent agreed In cross- 
tabulation with respondent title it emerged that 90 per cent of sales and marketing 
managers were in agreement with this scenario compared to 80 per cent of sales 
managers Overall, it can be presumed that the current sales force size of approximately 
five hundred will be somewhat diminished by 2004
Statement 4
"Key account management positions will be commonplace"
Mean Std Dev
All respondents 1 12 1 03
With an increasing concentration of buying power in the wholesale pharmaceutical 
business (60 per cent of the total Irish ethical pharmaceutical sales volume goes through 
two major wholesalers), coupled with the prevalence of Health Board buying 
committees and retail pharmacy chains, there are indications of a number of features 
which point to the need for national or key account management structures
Only 8 per cent of all respondents strongly disagreed with this assertion The 
emergence of such a position will require a new type of individual in the ethical
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pharmaceutical industry with skills in negotiation, relationship-building, teamwork, co­
ordination, conflict resolution and presentation (Wotruba and Castleberry, 1993). 
Clearly, sales representatives looking for a promotional opportunity would do well to 
equip themselves with some of the afore-mentioned skills prior to 2004.
No significant difference was found regarding the views of the two categories of 
managers.
Statement 5:
’’Ireland will be a 32 County territory"
Mean Std. Dev
All respondents .20 1.69
This statement had been included because the six in-depth interviewees had expressed 
this opinion very strongly. However, overall the respondents do not appear to strongly 
hold the view that the Southern Irish operation will assume the responsibility for the 
performance of the six counties of Northern Ireland by 2004. In fact 35 per cent of the 
respondents strongly disagreed with it. On cross-tabulation it emerged that 38 per cent 
of sales managers strongly rejected this statement compared to 29 per cent of sales and 
marketing managers.
Statement 6:
"Sales managers will have advanced business qualifications"
Mean Std. Dev
All respondents 1.17 1.03
Again, this assertion arose from the in-depth interviews and the strength of agreement 
from all respondents underlines its relevance to the future of this industry. Once more 
the results reported in Table 6.12 corroborate this particular statement. 44 per cent of 
sales managers strongly agreed with the statement compared to 26 per cent of sales and 
marketing managers, though when overall levels of agreement are examined there is 
virtually no difference in the beliefs held by the two management categories.
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Statement 7:
"The single market will have created a very different market place"
All respondents
Mean
128
Std Dev
1 16
Undoubtedly, the industry is very aware of the implications of the European Umon the 
future shape of the Irish ethical pharmaceutical market Perhaps the biggest issue will 
be that of parallel importing which destabilises pnces and inevitably, profit margins 
More sales managers were of this opinion (96 per cent) than sales and marketing 
managers (85 percent)
Statement 8
"Sales and marketing decisions will increasingly be made on the basis of profit rather 
than sales volume"
Without doubt, the future sales manager will need to be both quantitatively and 
financially competent in addition to the other requirements of his/her job This 
statement brought an emphatic level of agreement from all respondents, 100 per cent of 
sales and marketing managers agreed as did 92 per cent of sales managers
All respondents
Mean
1 61
Std, Dev
83
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The author set out to do this research with one hypothesis and six research objectives 
Both hypotheses were supported by the data, and the five research objectives were 
fulfilled A considerable amount of data was generated as a result of both the size of the 
questionnaire and the willingness of the industry to co-operate with the author 
Consequently, the author needs to highlight some conclusions from the study
The findings from the research upheld the author’s belief that there exists a dual­
mandated sales and marketing position which is an accurate descriptor for the work that 
the incumbent carries out With reference to those dual-mandated managers in the Irish 
ethical pharmaceutical industry, they were found likely to be younger, slightly better 
paid, more likely to be female and more likely to hold formal qualifications than their 
single-mandate colleagues The position is more likely to exist m companies where 
marketing and sales are not two separate departments The finding that no dual­
mandate manager had responsibility for a sales force of greater than twelve sales 
representatives lends weight to Tull et al (1991, p 121) belief that span of control is a 
major reason for the separation of sales and marketing
The hypothesis proposed that the dual-mandated sales and marketing manager would 
devote proportionately less time to sales management activities than his/her single 
mandate sales manager colleagues This was upheld by the data (see Table 6 3) but the 
research also showed that with the exception of taking time out to travel on the territory 
with the sales representative, sales and marketing managers are as involved in sales 
management activities as their single-mandate sales manager colleagues
Therefore, given the sales and marketing managers level of involvement in and 
commitment to both marketing activities and sales management activities it does beg 
the question as to how they find enough hours in the day to carry out their 
responsibilities Are they working at twice the pace of their single-mandate colleagues 
or are they making more effective use of their time9 Further exploratory research is 
necessary to address this conundrum
CHAPTER 7  CONCLUSIONS
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A second issue that the author would like to draw attention to is that of the female 
manager m this industry Currently, only one in ten of the managers are female 
However, the research indicated a strong opinion that more female sales managers will 
be found in the industry m the next ten years The existing female managers were, on 
average, younger, had been more quickly promoted and had less years selling 
experience than their male colleagues These findings would indicate that these females 
had been relatively recently promoted and given that, at the time of the research, 
females comprised 33 per cent of the salesforce it is highly likely that more female sales 
managers will emerge
Traditionally the literature has inferred that where separate sales and marketing 
departments exist, integration of sales and marketing activities has been difficult 
However, this research has shown that in this industry this is changing and there is 
integration of the two, both in the existence of the dual-mandated managers involved in 
both sales and marketing activities, and also through the finding that 65 per cent of the 
single-mandate sales managers indicated partial responsibility for the marketing 
function in their organisation
The reader may ask why this new position has been created at this time The more 
cynical may argue that pressures from business process redesign (BPR), forcing 
companies to look for ways to become more competitive through cost-efficiency are the 
cause
The advantages and disadvantages as seen by the author are already dealt with in 
Chapter 3, section 6 She believes that it is more effective to have one person 
responsible for both sales and marketing, thus integrating both functions Whyte (1985, 
p 15) had stated “selling has a much larger and more significant part to play in 
marketing strategies than has been ascribed to it hitherto” Ten years later the 
importance of the customer is forcing many organisations to rethink existing structures 
and practices Relationship management and trade marketing both essentially take place 
at the selling front Combimng sales skills and marketing skills in one individual can
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give a competitive advantage to an organisation in its marketplace The documentation 
of the existence of this dual-mandated position in this research extends the work of 
Kashani (as outlined in Figure 3 1) and, uniquely, benchmarks the role of such a 
manager in this position which is likely to become more prevalent in many industries in 
the near future
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Abstract
This paper sets out to mark the existence of a present, yet undocumented, 
management position, namely that of the sales and marketing manager There is a 
copious literature on the role of the marketing manager ranging from Kotler's (1973) 
view of marketing management being a demand management process and therefore 
necessitating certain corresponding tasks being fulfilled, right through to Murray and 
O’Dnscoll's (1993) view that the role is one o f " taking charge of creating and 
maintaining the reality of a market - focused organisation " Definitions of marketing 
management abound, leaving students and practitioners in no doubt as to the nature, 
and mdeed practice, of this discipline
Correspondingly, the art of sales management has been well - attended to m the 
literature, ( Churchill 1993, Donaldson 1990, Lancaster and Jobber 1994), and equally 
its’s role and functions are, by and large, agreed and unambiguous
The grey area arises when one goes in search of a literature on the role of the sales and 
marketing manager Most up - to - date marketing texts do not make any reference to 
the position and academic journals provide little help However trade press articles 
consistently refer to, and quote, people with this designation, thereby appeanng to 
confirm it's existence
Empirical research of the Insh ethical pharmaceutical industry, conducted by the 
author, showed that one in three managers descnbe themselves as sales and marketing 
managers, being totally responsible for the operation of their sales force and also 
responsible for the marketing function This paper explores the role and nature of the 
work of a pharmaceutical sales and marketing manager, comparing it to that of their 
single - role colleagues in the industry, and attempts to proprose a framework to help 
define and structure this " undocumented, over - worked and unsung hero"
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APPENDIX 2
COPY OF LETTER TO CENSUS POPULATION
1NSTITIÜ1D TE1CNEOLAÎOCHTA BHAILE ÀTHA CL1ATH
DUBLIN INSTITUTE OF TECHNOLOGY
College of Marketing & Design. 40 -4 5  Mountjoy Sq.. Dublin 1 Tel: 01-363000. Fax: 01- 8740505.
25th February, 1994
Dear
I am  a lecturer in the College of Marketing and am currently undertaking a Research M.B.S. with the co-operation of the Pharm aceutical M anufacturers Association. I am  anxious to do a comprehensive census of sales m anagem ent practice in the Irish Ethical Pharm aceutical Industiy. It is with this objective in mind th a t I enclose a questionnaire and would greatly appreciate your support in completing it.
There will be no m echanism  for co-operating sales m anagers to be identified, total confidentiality is guaranteed to every respondent.
No comprehensive study has been undertaken in the Irish sales m anagem ent field and I wTould like to redress this imbalance. I chose your industry  for two major reasons, namely your reliance on the role of personal selling to bring your products to the m arket; and the acknowledged level of professionalism exhibited by sales m anagers in your industiy .
The resu lts of the research will be available to any participating sales m anager and it is proposed th a t I make a formal presentation of the findings to the Pharm aceutical M anufacturers Association in the near future.
A researcher only gets one shot a t tying up respondent's valuable time hence the com prehensiveness of this questionnaire. It has been p re­tested by a num ber of your colleagues and the concensus is th a t it would require approximately thirty  m inutes to complete. I accept th a t th is may be a tall order in view of the dem ands on your time b u t I do th ink  the benefit of having an  accurate benchm ark of sales m anagem ent practice in your industry  should help you in the future.
The Dublin Institute o f Technology is established by the Dublin Institute o f Technology Act 1992 and is constituted from:
College o f Technology. Bolton Street College o f Catering, cathal Brugha street College o f Commerce. Rathmines
College o f Technology. Kevin Street College o f Marketing & Design. Mountjoy Square College of Music. Adelaide Road
In summary, I am very dependent on your co-operation and earnestly ask you to consider participating I enclose a S A E for ease of return I would like to start the analysis on Monday 14th March, 1994
I am contactable at the above number or at home on 2875445 should you like any point clarified Thank you in advance for your time, I look forward to completing the re sea rch  and hopefully contributing to the knowledge and professionalism of sales management in your industry
Yours sincerely,
LAURA CUDDIHY,LECTURER IN SALES MANAGEMENT AND MARKETING
APPENDIX 3
THE MAIL QUESTIONNAIRE
P A R T  A  R E S P O N D E N T  P R O F IL E .
1 W hich of the following titles best describes your current position9
Sales M anager [ ]0
M arketing M anager [ ] i
Sales and M arketing M anager [ ]2
General M anager [ ]3
Field/Area Sales M anager [ ]4
M anaging D irector [ ]5
Product M anager [ ]«
Other (please specify)
2 Please indicate the title of the person to whom you are im m ediately 
responsible
3 In  your current role what degree of direct responsibility do you assume 
over the management of the In sh  sales force?
Total [ ]0
Partia l [ ] l
None [ ]2
4 In  your current role what degree of responsibility do you assume over the 
m arketing function in  the In sh  m arket7 
Total [ ]o
P artia l [ ] l
None [ ]2
5 I f  ’total' or 'p artia l' is  ticked above, please indicate the approxim ate 
allocation of your management time between sales and m arketing9
Sales M arketing
50 50 [ ]0
40 60 [ ] i
60 40 [ ]2
70 30 [ ]3
30 70 [ ]4
Other (please specify)
6 How many personal accounts/calls do you currently have where you are 
solely responsible for face to face selling9
None [ ]o
Less than 10 [ ] i
10 or more [ ]2
l
7 How many years sales expenence in  the pharm aceutical industry did you 
have pnor to moving into your F IR S T  sales management ro le9
Less than 2 [ 1«
2 - 5 [  ] i
6 - 1 0 [ ]2
11-20 [  ] 3
2 1 -3 0 [  ]4
30+ [ 15
8 Have you O T  C  products in  your product portfolio in  addition to ethical 
products9
Yes [ ]0
No [ ]1
9 A re your sales representatives required to call to retail pharm acists on 
their terntones
On a regular basis [ ]0
On an occasional basis [ ] l
Not at a ll t ]2
10 I f  yes, please indicate the m ajor reasons you require these calls
11 Please describe the management training you received in  preparation for 
moving into your management position9
12 In  your opinion how adequate was this tra in ing9
V ery Adequate [ ]0
Adequate [ ] i
Inadequate [ ]2
13 How many years expenence, in  T O T A L ,  have you now got m 
Sales/M arketing management in  the pharm aceutical industry9
Less than 2 [  10
2 - 5 [  J1
6 - 1 0 [  ]2
11-20 [  ] 3
2 1 -3 0 [  14
30+ [  ] 5
u
14 Which of the following educational qualifications do you have9
(Please tick A L L  that apply)
Leaving Certificate [ ]0/l
Undergraduate qualification [ ]0/l
P rim ary Degree [ ]0/l
Postgraduate qualification [ ]0/l
15 Please state the title and year of your most recent educational
qualification
16 Please indicate to which of the following bodies you currently belong. 
(Please tick A L L  that apply)
In sh  Management Institute [ ]0/l
Pharm aceutical Managers Association [ ]0/l
M arketing Institute of Ireland [ ]0/l
Pharm aceutical M anufacturers [ ]0/l
F I C  I [ ]0/l
M P S I [ ]0/l
I P U [ ]0/l
I M O [ ]0/l
M R I I [ ]0/l
Other (please specify)
o / i
17 Dunng the last year, did you take any refresher or on-going 
development/training in  the following areas9
(Please tick  A L L  that apply)
Finance [ ]0/l
M arketing [ ]0/l
Sales Management [ ]0/l
Production [ ]o/i
Q uality Assurance [ ]0/i
New Technology [ ]0/i
Strategy/Planning [ ]o/l
Leadership [ ]o/i
Therapeutics [ ]0/l
Pharmacology [ ]o/l
General Management [ ]0/l
Team Build ing [ ]0/l
Personnel [ ]0/l
Other (please sp ecify )_________________________________________
o/i
HI
18 How would you rate these courses in terms of making you a more effective
manager9
Good Fair Poor
Finance [ 1« [ ]i [ ]2
Marketing [ ]» [ ]1 [ ] 2
Sales Management [ ]o t ]l [ 12
Production [ 1« [ ]1 [ 12
Quality Control [ ]o [ ]l [ ]2
New Technology [ Jo I ]1 [ ] 2
Strategy/Planning [ 1» [ ]l [ 12Leadership [ !» [ ]i [ 12
Therapeutics [ ]« [ ]l [ 12
Pharmacology [ ]» [ ]1 [ ] 2
General Management [ ]o [ ]1 [ ] 2
Team Building [ ]» [ H [ 12Personnel [ ]« [ ]i [ ]2Other (As per Q 12) [ 1« [ ]1 [ ]2
19 If you were offered the resources to attend any further management 
development programmes of your choice, what 3 areas would you be most likely 
to choose9  (Please rank 1,2,3 in order of preference)
Finance [ ]0Marketing [ ]1Sales Management [ ]2
Production [ ]3
Quality Control [ ]4
New Technology [ ]5
Strategy/Planning [ ¥Leadership [ ]7
Therapeutics [ !»Pharmacology [ I»General Management [ ]io
Team Building [ HiPersonnel [ ]1 2Other (please specify)_______________________________________________ 14
_________________________________________________________15
20 How many different companies have you worked for as a pharmaceutical 
sales representative9
(Please count affiliated companies owned by the same group as one company)
21 How many different companies have you worked for as a pharmaceutical 
sales/marketing manager9
(Please count affiliated companies owned by the same group as one company)
IV
22 Please indicate your gender, 
Male [ ] 0
Female [ ]1
23 Please indicate your level of job satisfaction with your current position9
Very Satisfied [ ] 0
Neither Satisfied nor Dissatisfied [ ]1
Dissatisfied [ ]2
24 In which of the following age categories do you belong9
Under 30 [ ] 0
30-39  [ ]1
40-49  [ ]2
50-59  [ ]3
60+ [ ]4
25 Please indicate the band which best represents your annual earnings 
(Including bonuses, commission, e tc)
Less than IR£20,000 [ ]
IR£21- 30,000 [ ]
IR£31 - 40,000 [ ]
IR£41 - 50,000 [ ]
IR£50,000 or more [ ]
26 Approximately what percentage of your salary is, bonus-related9
Nil [ ]0Less than 5% [ ]15-10% [ ]2$®1O1-H [ ]3More than 20% [ 14
P A R T  B  C O M P A N Y  P R O F I L E
27 In your Insh operation, is your marketing department a separate entities 
to your sales department9
Yes [ ]0
No [ ]1
28 If yes, which of the following positions exist within that department9 
(Please tick all relevant options)
Marketing Director [ ]0/i
Marketing Manager [ ]0 /i
Product/Brand Manager [ ]0 /i
Marketing Assistant [ ]0 /i
Market Researcher [ ]0 /i
Other (please specify)______________________________________________
0/1
V
29 How would you rate the Q U A L IT Y  of (a) communication and (b) co­
operation between the sales and m arketing functions in  your company9
Communication Co-operation 
Excellent [ ]o [ ]o
Very good [ ]1 [ ] l
F a ir [ ]2 [ ]2
Poor [ ]3 [ ]3
30 Does the company you currently work for have its worlds headquarters in
Ireland [ ]«
The U K [ ] i
The USA [ ]2
An E C  country [ ]3
Other European country [ ]4
Elsewhere (please specify)
31 Please tick  the category of annual turnover in  Ire land  which best indicates 
the position of your company9
Less than IR£1 5 m illion [ 1«
IR£1 5 - 3  m illion [ ] i
IR £3  - 4 m illion [ ]2
I R £ 4 - 5 m illion [ ]3
IR £ 5  - 6 m illion [ 14
More than IR £ 6  m illion [ 15
32(a) How many full-tim e sales representatives do you employ for the Irish  
m arket9 (1 e 26 counties)
32(b) How many of these fu ll time sales representatives are females9
33 Do you employ any part-tim e sales representatives9 
Yes [ ]0
No [ ]1
P A R T  C  S A L E S  M A N A G E M E N T  P R A C T IC E .
34 Is your sales team structured/organised by any form  of specialisation9 
Yes [ ]o
No [ ] l
vi
35 I f  yes, what form  of structure/organisation do you use9
36 In  the last two years have you undertaken revision of the sales territo ries9 
Yes [ ]0
No [ ]1
37 I f  yes, how often have you revised them9
Once [ ]o
Tw ice [ ]1
Three times [ ]2
M ore than three times [ ]3
38 W hat were the pnm e reasons for these revisions9
39 Please rate the following sources of recruitm ent in  terms of their 
usefulness in  providing successful pharmaceutical/medical sales representatives.
(Please circle the appropriate number)
Very Not at a ll
Useful Useful
Advertisements 1 2 3 4 5
Personal Contacts 1 2 3 4 5
General Recruitm ent Agencies 1 2 3 4 5
Sales Recruitm ent Agencies 1 2 3 4 5
In-Com pany promotion 1 2 3 4 5
Educational Institutions 1 2 3 4 5
Unsolicited Applications 1 2 3 4 5
Personal referrals 1 2 3 4 5
40 P rio r to recruiting sales representatives do you have the following drawn 
up9
Alw ays Sometimes Never
Job Description [ ]o [ ] i [ ]2
Personnel Specification [ ]0 [ ] i [ ]2
VII
41 Please indicate the im portance of the following abilities in  an effective
pharmaceutical/medical sales person?
V ery Very
Im portant Iln u r
Adaptability 1 2 3 4 5
A b ility  to learn 1 2 3 4 5
Communication sk ill 1 2 3 4 5
Comprehension 1 2 3 4 5
Interrogative sk ill 1 2 3 4 5
Observational sk ill 1 2 3 4 5
Confidence 1 2 3 4 5
Organisational sk ill 1 2 3 4 5
Enthusiasm  1 2 3 4 5
Em pathy 1 2 3 4 5
A b ility  to handle rejection 1 2 3 4 5
C reativity 1 2 3 4 5
Perseverance 1 2 3 4 5
L ika b ility  1 2 3 4 5
Listening 1 2 3 4 5
42 Please rank 1,2,3 in  order of im portance, the following selection crite ria  
when selecting a pharmaceutical/medical sales person
General sales experience [ ]0
Personal characteristics [ ] l
Industry specific experience [ 12
Am bition and development potential [ ]3
Personal m obility [ ]4
Educational standards [ ]5
43 W hich of the following supplementary selection aids do you commonly use 
to augment your selection process9 (Please tick A L L  that apply)
Psychological tests [ ]0/l
Psychom etric tests [ ]0/l
W ritten references [ ]0/l
O ral references [ ]0/l
M edicals I ]0/l
Graphology [ ]«/!
Role play [ ]0/l
Other (please sp ecify )_______________________________________________________________
___________________________________________________________________________________ o / i
44 How satisfactory is your current selection and recruitm ent procedure in  
providing you with effective pharm aceutical/m edical sales representatives9 
V ery satisfactory [ ]0
Satisfactory [ ] i
Unsatisfactory [ ]2
Very unsatisfactory [ ]3
VIII
45 W ith regard to training for your sales representatives, please indicate 
what type of training they receive, both induction, i e on joining your company
and on-going (Please tick ALL that apply)
Induction On-going
On-the-job [ ]o/i [ ]o/l
Formal courses (in-house) [ ]0/l [ ]0/l
Formal courses (external) [ ]0/i [ ]0/l
Self-study [ ]0/i [ ]o/i
46 Who carries out this training9 
(Please tick ALL relevant options)
Induction On-going
Sales M anager [ ]0/i [ ]o/i
Senior salesperson [ ]0/i [ ]0/l
Full-time company staff trainer [ ]0/i [ ]o/i
Outside training consultant [ ]o/i [ ]0/l
Overseas company training division [ ]0/i [ ]0/l
47 Approximately what would be the total training duration, per 
representative, per annum 9
Induction On-going
Up to one week [ ]0 [ ]0
2 - 4 weeks [ ]l [ ]l
1 - 6 months [ ]2 [ ]2
More than 6 months [ ]3 [ ]3
48 Do you establish training objectives prior to embarking on a training 
programm e9
Induction On-going
Always [ ]0 [ ]0
Sometimes [ ]1 [ ]1
Never [ ]2 [ ]2
49 Are there formal evaluation procedures in place to guage training 
effectiveness9
Induction On-going
Always [ ]0 [ ]0
Sometimes [ ]l [ ]l
Never [ ]2 [ ]2
50 Please indicate the 4 m ajor areas you feel m ust be covered dunng  an 
induction training program m e for new pharmaceutical sales recruits to your 
company
1  __________________________________________________________________________________________________________________
2 ____________________________________________________________
3 .___________________________________________________________________
4 _______________________________________________________________
IX
51 Do you require your sales representatives to pass the Medical 
Representatives Institute examinations9 
Yes [ ]0
No [ ]l
52 Please indicate the method of rem uneration you use for your sales 
representatives
Straight salary only [ ]0
Straight commission only [ ]l
Combination (salary plus commission/bonus) [ ]2
53 If you use a combination rem uneration plan please indicate the base/s you
use for the incentive pay elem ent
Sales volume (target achievement) [ ]0
Profit contribution [ ]l
Activities/Tasks performed [ ]2
M arket share [ ] 3
Growth [ ] 4
54 Would the incentive pay be prim arily
team based [ ]o
individual based [ ]l
team based followed by individual achievement [ ]2
55 Approximately, what percentage of the sales representatives rem uneration 
is, bonus-related9
Less than 10% [ ]0
11 - 25% [ ]l
More than 25% [ ]2
56 Please rate the effectiveness of each of the following factors in motivating 
your sales people
Pay plan (salary)
One to one meetings 
Promotion opportunities 
Clear job description 
Objective setting 
Discipline 
Sales contests
Recognition of achievement 
Bonus schemes 
Sales meetings
Very
Motivational 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2
Not a t all
M otivational
5
5
5
5
5
5
5
5
5
5
57 In  your experience are there factors other than those listed above which 
contribute to sales force m otivation9 Please elaborate
58 W hich if  any, of the following form al reports do you require your sales
representatives to return to you9
D aily W eekly M onthly Q uarterly Annually
Expense sheets [ ]o [ 11 [ 12 [ ]3 [ ]4
Com petitor activity  sheets [ ]0 [ ]1 [ ]2 [ ]3 [ ]4
Exhib ition reports [ ]0 [ ]1 [ ]2 [ ]3 [ ]4
Meetings held t ]0 [ ]1 [ ]2 [ ]3 [ ]4
Lunches hosted [ ]o [ ]1 [ ]2 [ ]3 [ ]4
D inners hosted [ ]0 [ ]1 [ ]2 [ ]3 [ ]4
Customer call reports [ ]o [ ]1 [ ]2 [ ]3 [ ]4
59 A re  these reports returned by
Post/hand [ ]0
Com puter/ETM S [ ]2
Other (please sp ecify )________________________
60 W hich i f  any, of these outside reporting systems do you use9
Continually Occasionally Never
Charles Russell (A X IS ) [ ]» [ 1 [ ]2
IM S [ ]o [ 1 [ ]2
I T S A [ ]0 [ 1 [ ]2
W alsh Report [ ]o [ 1 [ ]2
Irlem [ 1» [ 1 [ ]2
Strata [ !» [ 1 [ ]2
Sub-territory Analysis [ Jo f 1 [ ]2
G M S [ ]0 [ 1 [ ]2
Other [ ]0 [ 1 [ ]2
(Please specify)
61 How often do you travel w ith each representative dunng their working 
day9
Once a week [ ]o
Once a fortnight [ ] i
Once a month [ ]2
Once every two months [ ]3
Less than once every two months [ ]4
xi
62 Approxim ately how many doctors would Y O U  personally see with the 
representative dunng this day of accompaniment9 
None [ ]0
1 - 3  [ ] l
4 - 6  [ ]2
More than 6 [ ]3
63 Please give the 4 m ajor objectives you would have fo r accompanying a 
representative on a call
1  __________________________________________________________________________________________________________________
2 _____________________________________________________
 3 ______________________________________________________________________________________
4 ______________________________________________________________________________________
64 Would you agree that double calling is
not a problem with any doctor [ ]0
can be done w ith certain doctors [ ]1
can not be done at a ll [ ]2
65 Do you segment/categonse general practitioners that your sales 
representative call on9
Yes [ ]0
No [ ]1
66 I f  yes, please indicate the base/s you use fo r categorisation/segmentation
67 How often do you perform  form al face-to-face evaluation w ith your sales 
people9
More than once every quarter [ ]o
Once every quarter [ ]1
Once every six months [ ]2
Once a year [ ]3
68 How im portant is qualitative data to your overall representative 
evaluation programme9
V ery im portant [ ]0
Somewhat im portant [ ] l
Not im portant [ ]2
69 To what extent does your sales representative get involved in  the 
evaluation of their perform ances9
To a large extent [ ]0
To a partia l extent [ ]1
Not at a ll [ ]2
Xll
70 Is  the preparation of the annual sales forecast your 
Total responsibility [ ]o
Shared responsibility [ ] l
71 I f  shared, how influenced is the end result by
Very Somewhat
Influenced Influenced
Local m arketing department 
Parent company 
Production department 
Finance department
Other___________________________
(Please specify)
[ ]0
]0
]0
]0
]0
Not at a ll 
Influenced 
[  ]2 
[ ]2 
[ 12 
[ ]2 
[ ]2
72 Please indicate the method/s you norm ally use to a rn ve  at your annual 
sales forecast
(Please tick A L L  relevant options)
Sales force composite [ ]0/l
M arket test [ ]0/l
Tim e senes analysis/H istoncal Sales [ ]0/l
Statistical demand analysis [ ]0/l
Judgemental forecasting [ ]0/l
73 Do you use computer packages to aid sales forecasting9 
Yes [ ]0
No [ ]1
74 I f  yes, how effective do you find them9
V ery effective 
Somewhat effective 
Neither
Somewhat ineffective 
V ery Ineffective
[  ]0 
[  ]1 
[ ]2 
[ ]3 
[ ] 4
75 I f  possible, please name the package/s you use
76 Approxim ately how many hours per week can you allocate to private 
thinking and planning9
Xlll
PART D MARKETING PRACTICE,
77 Does your local operation write marketing plans specifically for the Insh  
m arket9
Yes [ ]0
No [ ]i (Go to Q 80)
78 If yes, what level of involvement does your parent company have in the 
finalising of these p n o r  to their adoption9
Highly involved [ ]0
Somewhat involved [ ]l
Not a t all involved [ ]2
79 Please indicate the level of your personal involvement in the preparation 
of these marketing plans
Very involved [ ]o
Somewhat involved [ ]l
Not a t all involved [ ]2
Please go to Q82
80 If no, does your parent company prepare m arketing plans overseas for 
your Irish operation9
Yes [ ]0
No [ ]l
81 If yes, how satisfactory do you feel is this practice9
Very satisfactory [ ]0
Somewhat satisfactory [ ]1
Neither satisfactory nor unsatisfactory [ ]2
Somewhat unsatisfactory [ ]3
Very unsatisfactory [ ]4
82 How formally are the m arketing and sales strategies set down from overall 
Insh  strategy9
Very formally [ ]0
Somewhat formally [ ]i
Informally [ ]2
83 Please indicate your level of input into the following activities 
(1 for very involved to 5 not a t all involved)
M arket strategy planning 
Objective setting for local m arket 
M arketing campaigns 
M arket research 
Sales promotion
2 3 4 5
2 3 4 5
2 3 4 5
2 3 4 5
2 3 4 5
xiv
84 Do you (a) use any of the following and (b) how frequently do you use 
them9
Never Occasionally Always
Tele-sales [ ]0 [ ]l [ ]2
Direct marketing [ ]0 [ ]l [ ]2
85 Should your general manager make the additional resources available 
which of the following would you immediately recruit9
(Please only tick one)
Sales representative [ ]o/i
Product Manager [ ]0/i
Area/Field Sales Manager [ ]0/i
Marketing Manager [ ]0/i
86 Please indicate your level of agreement with the following statements
Strongly Strongly
Agree Disagree
’’Marketing strategy must lead a firms
sales activities” 1 2  3
’’The primary role of marketing is to provide 
support to the salesforce” 1 2  3
’’Good sales managers make their salespeople 
independent” 1
’’The heart of marketing is selling” 1
’’Marketing is about the long term, selling 
is more short-term” 1
”The establishment of long-term relationships 
with doctors is vital” 1
XV
87 Please indicate your level of agreement w ith the following statements 
regarding the industry in  ten years time 1 e , 2004
Strongly Strongly
Agree Agree Disagree
’’Inform ation technology w ill play a m ajor
role in  day-to-day sales management” t ]o [ ]1 [ ]2
"W omen w ill be very much more 
prevalent in  management positions” [ ]o [ ]1 [ 12
’’Pharm aceutical sales force sizes w ill have 
decreased” [ ]0 [ [ ]2
” Key account management positions w ill be 
commonplace” [ ]o [ ]1 t ]2
’ ’Ire land w ill be a 32 county te rrito ry” [ ]0 [ ]1 [ ]2
’’Sales managers w ill have advanced business 
qualifications” [ ]o [ [ ]2
’ ’The Single M arket w ill have created a very 
different m arketplace” [ ]o [ ]1 [ ]2
’ ’Sales and m arketing decisions w ill 
increasinglybe made on the basis of profit 
rather than sales volume” [ ]0 [ ]1 [ ]2
TH A N K  YO U  FO R  Y O U R  C O -O PER A T IO N
xvi
APPENDIX 4
PROGRAMME OF MEETING FOR PRESENTATION 
OF RESULTS TO THE PHARMACEUTICAL 
MANAGERS
THE PHARMACEUTICAL MANAGERS' ASSOCIATION OF IRELAND
1. Cars, B.i.K., Taxation, Leasing.
2. Industry Management Survey
AT
THE MONTROSE HOTEL 
On Tuesday No\ ember 8th 1994: Refreshments 6.00 p.m.
Speakers. 
1
Cotnuic McCatthx 
John Hayes
"The Funding o f  Business Transport" (sponsored) 
Financial Controller, Woodchester Credit L)onn<m 
Fleet & Leasing Manager, M S Limited and 
President of Vehicle Leasing Association
Investigation of Sales Management Pi act« t  
in the Irish Ethical Pharmaceutical IndusU \ 
Lecturer in College of Matketing & Design
Members/Guests welcome
2
Laura Cuddihy
Thank you
Joe Hoban 
Honorary Secretary
1 INTERESTED SB PEOPLE SHOULD CONTACT 30E HOBAN AT EXT 261 *
